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1 Introduction 
The studies presented in this thesis focus on the spontaneous pattern of motor 
activity and autonomic cardiac functioning in healthy subjects and patients with a 
major depression, which is a common psychiatric disorder. The 24-hour pattern of 
motor activity and the sympathetic and parasympathetic regulation of the 
cardiovascular system were examined to enlarge the knowledge about the 
psychomotor and autonomic cardiac dysfunction in major depressive disorder, and to 
obtain insight in the potential determinants. At the same time, parameters of 
spontaneous motor behavior and parasympathetic activity were evaluated for their 
usefulness in providing indirect (peripheral) information about the cholinergic 
dysfunction in depressed patients. 
In this ftrst chapter the characteristics of major depressive disorder are 
described and a concise overview is given of the role of genetic, psychosocial and 
neurobiological factors in the etiology of this affective disorder. In addition, 
developmental strategies, efficacy and pharmacological mechanisms of antidepressant 
treatments are explained, with special attention to the tricyclic antidepressants (TCAs) 
and selective serotonin reuptake inhibitors (SSRis). Subsequently, the psychomotor 
dysfunction in depressed patients, general aspects of the daily pattern of motor 
activity, the method of wrist-actigraphy, and several factors that may determine the 
24-hour motor activity in depressed patients are discussed. Furthermore, the 
autonomic cardiac dysfunction in depressed patients, the neural short-term regulation 
of the cardiovascular system, the method of spectral analyses of heart rate (HR) and 
blood pressure (BP) variability, and the factors that may influence the autonomic 
regulation in depressed patients are clarified. Finally, the aim of the studies and the 
structure of the thesis are presented. 
2 Major depressive disorder 
In the Dutch population between 18-64 year, the lifetime prevalence of all affective 
disorders (major depressive disorder, dysthymic disorder, and bipolar disorder) is 
19.0%, and of major depressive disorder 15.4% (Bijl et al., 1997). The lifetime risk to 
develop an affective disorder is nearly 2 times higher for women than for men. Major 
depression is the fourth leading cause of disease burden in the world, and is projected 
to be the second leading cause in the year 2020 (Murray and Lopez, 1997a, 1997b). 
According to the DSM-IV (Diagnostic and Statistical Manual of Mental Disorders) 
(APA, 1994), the essential feature of a major depressive disorder is a clinical course 
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that is characterised by one or more major depressive episodes without a history of 
manic mixed or hypomanic episodes. During a depressive episode subjects have a 
depressed mood and/ or loss of interest and pleasure in nearly all activities. 
Additionally, depressed subjects may experience several other symptoms such as 
changes in appetite and weight, alterations in the sleep/wake pattern, disturbances in 
psychomotor activity, decreased energy, feelings of worthlessness or guilt, cognitive 
dysfunctions (e.g. impaired concentration and memory) and thoughts of death or 
suicide. Major depressive disorder is recurrent, but it is also progressive in the sense 
that successive episodes occur after shorter intervals of remission (Post, 1992; Onnel 
and Sytema, 1999). Most depressive episodes vary between several weeks and several 
months, but a minority become chronic (lasting more than 2 years) (Angst, 2000). 
Depression has a negative impact on social and occupational functioning, and severe 
symptomatology results in disabilities in the family role and affects the self care 
(Ormel et al., 1993; Ormel and Sytema, 1999). 
2.1 Etiology of depression 
The three important factors in the etiology of depression concern genetic, 
psychosocial and neurobiological factors. There exist a large number of theories 
about how these different types of factors contribute, alone or by interaction, to the 
development of a depressive disorder. 
2.1.1 Genetic factors 
A meta-analysis of studies to the genetic epidemiology of major depression showed 
that the heritability of major depression is likely to be in the range of 31%-42% 
(Sullivan et al., 2000). Yet, it is unknown which specific chromosomal areas are 
involved in major depression (Souery et al., 2000). Probably the genetic component is 
more related to alterations in the expression of neurotransmitters, receptors and 
neuropeptides from the DNA matrix than to structural gene changes (see also 2.1.3 
Neurobiological factors) (Post, 1992). This principle is also found in the gene-
environment interaction theory proposing that genetic vulnerability to major 
depression comes to expression if an individual is exposed to specific environmental 
factors such as stress (Sullivan et al., 2000). Furthermore, repeated exposure to 
stressors and depressive episodes themselves may leave residual traces in gene 
expression processes that predispose to further occurrences of affective illness (Post, 
1992). 
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2.1.2 Psychosocial factors 
Impaired social relationships, stressful life events, cognitive dysfunction, economic 
status and personality are all psychosocial factors that are associated with major 
depression. However, it is difficult to make general statements about the etiological 
role of these factors, because the number of theories of psychosocial factors 
underlying depression is large, and they all use different concepts. To illustrate, Street 
et al. (2001) made a single framework for the psychosocial determinants of 
depression based on 29 theories with 99 concepts in totaL Additionally, it is difficult 
to unravel the cause and consequence in the relationship between psychosocial 
factors and depressive disorder. Psychosocial factors are often integrated in 
multifactor models for the origin of major depressive disorder. The above mentioned 
gene-environment theory is one example. Another example is provided by the 
biosocial personality model of Cloninger, which comprised originally three genetically 
independent temperament dimensions: Harm Avoidance, Novelty Seeking, and 
Reward Dependence (Cloninger, 1987; Cloninger et al., 1993, 1994). Cloninger 
developed the Tridimensional Personality Questionnaire (TPQ) to measure these 
personality traits. Later on a fourth temperament dimension, Persistence, emerged 
from normative studies (Cloninger et al., 1993). The temperament dimensions are 
theorised to have predictable patterns of interaction with specific classes of 
environmental stimuli and to be related to single monoamine systems. However, the 
next chapter about neurobiolog1cal factors makes clear that the suggested link 
between temperament and specific neurotransmitters is an oversimplification (Tuinier 
and Verhoeven, 1995; Verhoeven and Tuinier, 2001). A high score on Harm 
Avoidance, which is the tendency to respond intensely to signals of aversive stimuli, 
is predicted to increase the susceptibility to depression (Cloninger, 1994). 
Presumably, individuals high in Harm Avoidance learn to inhibit behavior to avoid 
punishment, novelty, and nonreward: they tend to be cautious, fearful, tense, 
apprehensive, and passive. Individuals low on this dimension tend to be carefree, 
relaxed, daring, courageous, and composed. So far, the predictive value of Harm 
Avoidance for developing major depressive disorder has not been established in 
longitudinal studies, but many studies have found increased Harm Avoidance scores 
in depressed patients in comparison to healthy subjects (Brown et al., 1992; Joffe et 
al., 1993; Hansenne et al., 1999; Marijnissen et al., 2001). 
2.1.3 Neurobiolog1cal factors 
With respect to the orig1n of major depression, neurobiolog1cal factors are most 
frequendy studied. Disturbances in various neurotransmitter and neuroendocrine 
systems (e.g. monoaminerg1c system, cholinerg1c system, glutamaterg1c system, 
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GABAergic system, hypothalamic-pituitary-adrenal (HPA) axis, hypothalamic-
pituitary-thyroid (HPT) axis) are considered to be responsible for depressive mood 
and other symptoms of major depression, such as psychomotor dysfunctions, 
alterations in sleep, and cognitive dysfunctions. The major hypotheses about the 
neurobiological basis of depression are the monoamine hypothesis and the HPA axis 
hyperactivity hypothesis. In contrast, less attention has been paid to the etiological 
role of the cholinergic system in depression. 
Monoamine hypothesis 
The monoamine hypothesis was postulated in the 1960s and assumes that the 
neurobiological basis of depression is a deficit of one or more monoamine 
neurotransmitters (serotonin, noradrenaline, and/ or dopamine) in synaptic clefts of 
the central nervous system (Bunney and Davis, 1965; Van Praag eta!., 1970; 
Schildlcraut, 1965). This hypothesis was based on the sequence of finclings in the 
1950s that depletion of central monoamine stores by reserpine, an antihypertensive 
drug, was followed by symptoms of depression (Muller eta!., 1955; Shore eta!., 1955) 
and that elevation of monoamine levels by iproniazid, a drug for tuberculosis, and 
imipramine, developed as tranquilliser, had an antidepressant effect (Kline, 1961; 
Kuhn, 1958). The latter agents were considered to establish their effect by inhibition 
of the metabolising enzyme monoamine oxidase (MAO) and the transporter-
mecliated reuptake of serotonin and noradrenaline from the synaptic cleft 
respectively. Two important limitations of the original hypothesis are the inconsistent 
findings about a dysfunctional metabolism of monoamine neurotransmitters, and the 
delay of clinical improvement after raising monoamine levels by antidepressant 
treatment (see review Verhoeven and Tuinier, 1999; Hirschfeld, 2000; Leonard, 
2000). Recent neurobiological research at the cellular and molecular level suggests 
that there are dysfunctions in the pre- and postsynaptic receptors of the monoamine 
system due to changes in postsynaptic cellular signal pathways with the G protein as 
component, and in the gene expression of neuronal proteins via nuclear transcription 
factors (Leonard, 2000). The G protein plays a central role in coupling membrane 
receptors to various intracellular effector systems (Holsboer and Barden, 1996). 
HP A axis hyperactivity hypothesis 
The first inclication of a hyperactivity of the HP A axis in depression also dated from 
the 1950s, when plasma cortisol levels, generally released by stress, were observed to 
be increased in depressed patients (Board eta!., 1956; Gibbons, 1964). Later on, it 
was found that depressed patients had no or a reduced suppression of cortisol 
secretion by the adrenal cortex in response to the glucocorticosteroid 
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dexamethasone, an exaggerated cortisol secretion in responses to the 
adrenocorticotropic hormone (ACTH) released by the pituitary, and a hypersecretion 
of the corticotropin-releasing hormone (CHR) by the hypothalamus, which 
stimulates the release of ACTH (Holsboer and Barden, 1996; McQuade and Young, 
2000). Hypercortisolaemia in other disorders than depression, e.g. Cushing's disease, 
and corticosteroid manipulations are known to impair cognitive and emotional 
functions (Holsboer and Barden, 1996; McAllister-Williams et al, 1998; McQuade 
and Young, 2000). These dysfunctions probably originate from neurodegenerative 
and neural plastic effects of cortisol in the hippocampus (McQuade andY oung, 2000; 
Reid and Stewart, 2001 ). In depressed patients changes in the hippocampal function 
due to hypercortisolaemia can explain memory and learoing deficits and may be 
responsible for the induction and maintenance of depressive mood (Reid and 
Stewart, 2001). The HPA axis hyperactivity is thought to be the result of a 
dysregulated feedback inhibition by endogenous corticosteroids due to an 
impairment of the glucocorticoid receptor (GR) system in HPA-axis tissues 
(hypothalamus and pituitary) and the hippocampus (De Kloet et al., 1996; Holsboer, 
2001; Pariante and Miller, 2001). This impairment may be related to reduced GR gene 
expression caused by genetic factors and/ or chronic stress. At the moment, there are 
unequivocal data that support the concept of an improvement of the GR function 
underlying the mechanism of action of antidepressant treatments (Holsboer, 2001). 
Cholinergic dysfunction 
The cholinergic system with acetylcholine as neurotransmitter is one of the important 
neurotransmitter systems in the central and autonomic nervous system (Guyton, 
1991; Hyman and Nesder, 1993; Powley, 1999). Acetylcholine is synthesised from 
choline and the acetyl coenzym A by the enzyme choline acetyltransferase. In 
contrast to monoamines, acetylcholine is inactivated through enzymatic degradation 
by the enzym acetylcholinesterase in the synaptic cleft within a few seconds. Free 
choline is then actively taken up by a specific transporter protein in the cholinergic 
nerve terminals, where it is again acetylated to form acetylcholine. In 1972 Janowsky 
and colleagues proposed that depression is a manifestation of central cholinergic 
predominance. This hypothesis was based on the finding that in animals central 
acting cholinomimetics (cholinergic agonists and cholinesterase inhibitors) produce 
behavioral inhibition (including reduced motor activity) and decreased self-
stimulation. In human, the central cholinesterase inhibitor physostigmine and other 
central cholinomimetics induce depressive mood accompanied by lethargy, apathy, 
drained feelings, and motor retardation Ganowsky eta!., 1972;Janowsky and 
Overstreet, 1995). Central cholinergic activation also results in changes in the rapid 
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eye movement (REM) sleep (mcluding decreased REM movement and increased 
REM density), which are similar to the changes in REM sleep observed in depressed 
patients Qanowsky et al., 1994;Janowsky and Overstreet, 1995). These findings 
suggest that symptoms of depression are linked to increased presynaptic cholinergic 
function. Further support for an etiological role of the cholinergic system in 
depression is provided by the exaggerated responses of depressed patients to 
cholinomimetics, which are attributed to hypersensitivity of merely muscarinic 
receptors in the central nervous system. The underlying mechanism of the cholinergic 
hypersensitivity may be an increased number of postsynaptic receptors or an 
activation of the postsynaptic intracellular second-messenger systems via muscarinic 
mechanisms Qanowsky et al., 1994). Overstreet and coworkers developed a genetic 
animal model of depression based on rats selectively bred for their cholinergic 
hypersensitivity in order to obtain more insight in the cholinergic dysfunction in 
depressed patients (Overstreet, 1986; Overstreet et al., 1992). These rats show 
reduced motor activity and increased immobility during the forced swimming test. 
Indirect (peripheral) information about alterations in the cholinergic function in 
depression can be obtained by assessing spontaneous motor behavior and measuring 
the parasympathetic regulation of the cardiovascular system in depressed patients. 
The role of the cholinergic system in these neurobiological functions will be 
explained later on. 
Interactions between neurotransmitter and neuroendocrine rystems 
It should be emphasised that although the above hypotheses focus on one specific 
neurotransmitter or neuroendocrine system, they recognise interactions between the 
described system and other neurotransmitter and endocrine systems. For instance, 
mood and behavioral effects of central acting cholinomimetics can be counteracted 
by (nor)adrenergic/ doparninergic activation and vice versa, and cholinomimetic 
agents have a stimulating effect on the CHR factor and thus elevate serum ACTH 
and cortisol levels Qanowsky et al., 1994;Janowsky and Overstreet, 1995). More 
recent studies also demonstrated that glucocorticoids regulate the neurotransmission 
by arnines through controlling the gene expression of aminergic receptors (Holsboer 
et al, 1996; Holsboer, 2001). 
3 Antidepressant treatment 
One of the therapeutic strategies of major depressive disorder is the pharmacological 
treatment with antidepressants, which started in the 1950s after the unexpected 
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discovery of the antidepressive effect of the tricyclic antidepressants (TCAs) and the 
nonselective monoamine oxidase inhibitors (MAOis). The conventional 
antidepressants are clinically effective, but they induce several and sometimes severe 
side effects and can be toxic when used in overdose. To illustrate, TCAs inhibit the 
reuptake of serotonin and noradrenaline (and to a lesser extent dopamine), but also 
antagonise acetylcholinergic muscarinic (M1), histaminergic (H1), and adrenergic (a1) 
receptors (Stahl, 1998; Berman eta!., 1999). The anticholinergic side effects ofTCAs 
are dry mouth, blurred vision, constipation, urinary retention, memory impairment, 
and altered cardiovascular regulation (e.g. tachycardia). In addition, the 
antihistaminergic properties ofTCAs may cause sedation and weight gain and the 
anti-adrenergic properties postural hypotension. The novel antidepressants are 
considered to lack the troublesome side effects of the conventional antidepressants, 
because they have more selective acting pharmacological profiles. For instance 
selective serotonin reuptake inhibitors (SSRis) retained the ability to block the 
serotonin (SHT) reuptake, but have no effect on M1, H1, and a1 receptors and no 
noradrenaline reuptake blocking properties. However, they induce other side effects 
because they agonise 5-HTz postsynaptic receptors, with as consequence agitation, 
motor resdessness, insomnia, and sexual dysfunction, as well as agonise S-HT3 
postsynaptic receptors, leading to nausea, diarrhea and headache (Stahl, 1998). 
TCAs and SSRis belong to the first choice pharmacological treatments in 
depressed patients. The efficacy ofTCAs and SSRis in terms of absolute response 
rates is still unclear, because the reported response rates vary enormously. Pardy, this 
is the consequence of methodological shortcomings of prior clinical trials in study 
desigu, sample size, treatment duration, and control of drug plasma levels. Anderson 
(2000) compared the therapeutic efficacy ofTCAs and SSRis in a meta-analysis (out-
and inpatients, n = 10706; studies, n = 102) and concluded that SSRis had an 
equivalent therapeutic efficacy in reducing depressive mood as the TCAs in general 
practice and outpatients. However, SSRis were less effective than TCAs in 
hospitalised patients (23% less reduction of clinical rating scale scores for 
depression). The favourable effects ofTCAs in comparison to SSRis in depressed 
inpatients may be explained by more adequate treatment regimes due to the control 
of drug plasma levels (Bruijn eta!., 1999; Bruijn, 2000). This would be especially true 
for TCAs, such as imipramine, amitriptyline and nortriptyline, with a proven 
therapeutic plasma level. Furthermore, it is possible that inpatients are more 
responsive to TCAs because of their severity of depression, the presence of 
melancholic and/ or psychotic features, and their course of illness and treatment 
history. However, Anderson (2000) concluded that there was no relationship between 
the clinical superiority of TCAs and age, severity of depression and antidepressant 
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dose in the inpatients, and stated therefore that differences in pharmacological 
profiles played a role. 
As discussed above, TCAs and SSRis increase monoamine levels in the 
synaptic cleft immediately (within days), while the therapeutic response occurs after 
several weeks. One hypothesis is that the increase in monoamine levels reduces the 
fire rate of monoamine neurons over time by inhibition of presynaptic 5-HT, 
serotonergic and ctznoradrenergic autoreceptors (Duman, 1999). Another possibility 
is the down regulation (decreased sensitivity) of 5-HTz serotonergic and j3 adrenergic 
postsynaptic receptors, and the up regulation (increased sensitivity) of 5-HT, 
serotonergic postsynaptic receptors. During the last few years it has been theorised 
that the elevation of monoamines stimulates the intracellular second messenger 
pathway by activating specific 5-HT serotonergic and j3 adrenergic postsynaptic 
receptors. The second messenger pathway regulates many cellular processes and the 
gene expression of proteins. As stated above, the improvement of the corticosteroid 
receptor function also seems to play a role in the efficacy of antidepressants 
(Holsboer, 2001). 
Antidepressants may also have favourable effects on disturbances in 
neurobiological functions, such as psychomotor activity and autonomic cardiac 
functioning. These effects can be established directly by pharmacological actions or 
by the induced improvement of clinical state. However, it is often difficult and 
complex to unravel the underlying mechanisms, because at the same time some 
antidepressants have negative effects on these functions. The effects of TCAs and 
SSRis on the daily pattern of motor activity and the autonomic regulation of the 
cardiovascular system will be discussed below. 
4 Psychomotor dysfunction in major depressive disorder 
The psychomotor dysfunction in depressed patients is characterised by psychomotor 
retardation and agitation. According to Wiclliicher (Wiclliicher, 1983; Dantchev and 
Wiclliicher, 1998) psychomotor retardation is a central feature of depressive illness. 
Psychomotor retardation is reflected in the slowing down of motor activities. 
Retarded patients show for instance slowed speech, fixed facial expression, less 
spontaneous movements of the limbs and trunk, and impaired gait and stride. Psychic 
activity is also slowed down which is reflected amongst others in reduced fluency of 
speech, loss of interest, and impaired memory and concentration (Wiclliicher, 1983). 
According to the SADS (Schedule for Affective Disorders and Schizophrenia) the 
most important manifestations of agitation are: unable to sit still, pacing, 
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handwringing, pulling or rubbing hair, skin, clothing, outbursts of complaining or 
shouting, talking on and on or unable to stop talkiog (Endicott and Spitzer, 1978). 
Parker et al. (1990, 1991, 1993) outlined that the fundamental construct of the 
psychomotor disturbance in depressed patients is a neurocognitive-based disturbance 
which is expressed in both retardation and agitation. They recognised 18 observer 
rated sigos of psychomotor disturbance in depressed patients. Factor analyses 
distinguished signs that were present in the case of retardation, as well as of agitation, 
signs that were exclusive for retardation and signs exclusive for agitation. The 
psychomotor disturbance was suggested to be specific for the melancholic subtype of 
depression (Parker et al., 1990, 1993, 1999). 
Sohin and Sackeim (1997) gave an overview of the involvement of 
dopaminergic dysfunctions in psychomotor disturbances in depressed patients. 
Originally, Van Praag and Korf (1971) proposed that disorders of central dopamine 
metabolism are related to motor states of depressed patients. In various studies 
evidence was found that disturbances in the basal ganglia and the ganglia/thalamo-
cortical circuit play a role in the psychomotor dysfunction. More recently mesolirnbic 
and mesocortical projections of the dopamine system were found to be directly 
involved in motor behavior through their regulation of purposeful behavior, 
motivation and the ability to experience pleasure, instead of decreased dopamine 
metabolism in the nigrostriatal dopamine system (see overview Verhoeven and 
Tuinier, 1999). However, the studies ofJanowsky et al. (1972, 1994, 1995) and 
Overstreet (1986) indicated that also cholinergic mechanisms are involved in the 
psychomotor retardation, because cholinergic stimulation results in the reduction of 
explorative behavior and the inhibitory behavioral effects of this stimulation are 
exaggerated in depressed patients. These views are not contradictory because 
dopaminergic and cholinergic neurotransmitter systems are known to interact with 
motor functions Oanowsky et al., 1994). 
4.1 Daily pattern of motor activity 
The number of studies to the normal24-hour profile of motor activity is limited. 
Renfrew et al. (1987) studied the diurnal patterns of motor activity in healthy males 
between 21-83 years, and Lieberman et al. (1989) in healthy males and females 
between 19-35 years and between 65-94 years. The diurnal patterns in both studies 
were characterised by a large increase in motor activity in the early morning and a 
decline in motor activity during the evening and night. Renfrew et al. (1987) found 
smooth diurnal patterns, whereas Lieberman et al. (1989) reported diurnal patterns 
that were characterised by one or two peaks dependent on age and gender. Figure 1 
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presents the 24--hour pattern of motor activity in a group of healthy persons between 
30-65 years based on our own data (Volkers et al., 1997; Tulen et al., 2001). 
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Figure 1 Daily pattern of motor activity in healthy persons (33 males and 31 
females; mean age: 48.5 years, SD: 9.9) based on mean half-how: motor activity 
counts, averaged for three 24-hour periods (adapted from Volkers et al., 1997 
and Tulen eta!., 2001). 
Among the methods of measuring the psychomotor dysfunction in 
depression, perhaps none is as intuitively apparent as the continuous monitoring of 
motor activity in a natural environment (Sobin and Sackeirn, 1997). Tryon (1991) 
discussed the validity, reliability, and (clinical) applications of the available devices for 
ambulatory motor activity. The first activity monitors were in essential self-winding 
mechanical wrist-watches with a limited recording period (maximal several hours). 
Subsequendy, wrist activity monitors were developed that detected by means of tilt 
sensors the frequency of tilt from the horizontal plane or from any plane in the case 
of a triaxial device. These tilt counters were telemetric, which means that each 
movement resulted in a FM signal transmission that was detected by a nearby 
receiver. Wrist-actigraphs are the most advanced and most frequendy used 
ambulatory activity monitors. When measured from the non-dominant wrist, it is a 
valid and reliable method (Tryon, 1991; Patterson et al., 1993; Middelkoop et al., 
1997a). These actigraphs contain a piezoelectric sensor that measures the number of 
movements above a certain acceleration threshold during a fixed time epoch. Wrist-
actigraphy is an easy-to-use method for quantifying spontaneous motor activity 
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during a continuous period of several days in the habitual environment of subjects. 
Diurnal variations in motor activity provide insight in alterations in day- and 
nighttime motor activity levels, the distribution of motor activity over the day (e.g. 
fragmentation of motor activity, immobility, phase and daily peak(s) of the circadian 
activity-rhythm) and, in combination with sleep logs, the changes in the sleep-wake 
pattern. 
4.2 Determinants of the 24-hour pattern of motor activity in depressed patients 
Clinical state 
Studies to the daily pattern of motor activity in depression have mainly focused on 
differences between unipolar and bipolar depressed patients, and suggest that the 
mean motor activity level in bipolar depressed patients is lower than in unipolar 
patients (I<::upfer eta!., 1974; Kulis and Reschke, 1992; Wolff et al., 1985; Teicher, 
1995). As a consequence, there is only a limited number of studies comparing the 24-
hour motor activity patterns between unmedicated depressed patients and healthy 
control subjects. Unmedicated depressed patients demonstrated decreased motor 
activity levels and reduced fragmentation of motor activity during daytime, and an 
earlier timing or phase of the circadian rhythm of motor activity (Wehr et al., 1980; 
\Volff eta!., 1985; Van Landen eta!., 1998). Equivocal results were reported about 
changes in the motor activity during the sleep period. Thus, the clinical state may 
affect both motor activity levels and the distribution of motor activity over the day in 
depressed patients. Shortcomings of the referred studies were the small number of 
patients included in the studies and the fact that two studies were performed in 
patients with different subtypes of depression. Therefore, previous findings should 
be replicated in a larger group of depressed patients with one subtype of depression. 
To understand the origin of interindividual variations in the daily pattern of motor 
activity within unmedicated depressed patients, it is relevant to study additionally the 
relationship between 24-hour motor activity and specific clinical features. In 
depressed patients, motor activity levels were found to be positively associated with 
anxiety and hyperactivity rating scores (I<::upfer eta!., 1974;Joffe eta!., 1987) and 
negatively with clinical ratings of retardation Qoffe et al., 1987; Royant-Parola et al., 
1986; Raoux eta!., 1994). Yet, psychotic features (delusions and hallucinations) have 
not been explicidy studied with respect to 24-hour motor activity. 
Antidepressants 
There are a few studies that have evaluated the effect of antidepressant treatment on 
the 24-hour motor activity pattern. Increased daytime motor activity levels were 
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observed after treatment with lithium (K.upfer et aL, 1974), treatment with 
carbamazepine Ooffe et aL, 1987) and a combined treatment with TCAs and 
benzodiazepines (Raoux et aL, 1994; Royant-Parola et aL, 1986; Benoit et aL, 1985). 
After the latter treatment also less periods of immobility during day- and nighttime 
were found. In general, changes in motor activity levels have been attributed to 
improvement of depressive mood state (Teicher, 1995). However, studies in rats 
suggest that antidepressants may also have a pharmacological effect on overt motor 
behavior. Prolonged treatment with the TCAs imipramine and desipramine had a 
stimulating effect on overt motor behavior (Overstreet et aL, 1995; West and Weiss, 
1998). This was also found for the SSRI sertraline, but not for the SSRI fluoxetine. In 
humans, a single dose or dose administration for several days with TCAs, but not 
with SSRis, impaired the psychomotor performance on laboratory psychomotor tasks 
(Fairweather et aL, 1996; Hawley et aL, 1997). In congruence with this finding, 
depressed patients treated with dothiepin (TCA) showed lower motor activity levels 
after 10 days of treatment than patients treated with fluoxetine (SSRI) (Stanley et al., 
1999). The different effects between TCAs and SSRis in healthy subjects and 
depressed patients were explained by the sedative side effects of TCAs. However, the 
sedative effects of antidepressants may disappear in depressed patients after one or 
two weeks of treatment due to the development of tolerance to these side effects 
(O'Hanlon and Freeman, 1995). More research is necessary to clarify the effect of 
TCAs and SSRis on the 24-hour motor activity in depressed patients after several 
weeks of treatment, and to unravel the contribution of pharmacological effects and 
improvement of clinical state to changes in the daily pattern of motor activity after 
antidepressant treatment. 
Personality, age and gender 
The interpretation of data in depressed patients can benefit much from quantitative 
knowledge of the spontaneous motor activity patterns in healthy subjects. Normal 
data can be used as a reference for the clinical data, but also provide information 
about which factors are responsible for the diversity in spontaneous patterns of 
motor activity. There are several wrist-actigraphy studies in healthy adults addressing 
aspects of normal motor activity patterns in a natural environment. The influence of 
age and gender is most frequendy studied with respect to interindividual variations, 
but the large discrepancies in findings do not allow us to make general statements 
about the effect of age and gender on day- and nighttime motor activity levels and 
the circadian rhythm of motor activity (Renfrew et aL, 1987; Lieberman et al., 1989; 
Brown et aL, 1990; Witting et aL, 1990; Van Hillen et aL, 1993). Personality is also of 
interest as determinant of overt motor activity. King (1986) theorised that overt 
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spontaneous motor activity was positively associated with extroversion and histrionic 
personality traits. The theorised relationship between histrionic traits and motor 
activity level was demonstrated in patients with a panic disorder, though no 
relationship was found between extroversion and motor activity level (King et al., 
1988). Positive results were also found with children. More energy, less inhibition, 
more attention seeking, more dominance, more engagement in social play, greater 
assertiveness and less compliance were related to higher ambulatory measured levels 
of motor activity among 3 and 4 years old (Buss et al., 1980). Even in younger 
children (2.5 years), ratings of 'negative peer interaction' and 'excitability' were found 
to be positively correlated with motor activity levels, whereas ratings of 'seeking help 
with object blocks' were negatively correlated (Halverson and Waldrop, 1973). The 
outcome of studies to the effect of personality in healthy subjects may be supportive 
for our assumption that personality traits contribute to the altered daily pattern of 
motor activity in depressed patients. 
5 Autonomic ca.rdiac dysfunction in major depressive disorder 
Over the years many clinical and epidemiological studies have reported an increased 
risk of cardiovascular morbidity and mortality in patients with a depressive disorder 
(Malzberg, 1937; Hayward, 1995; Glassman and Shapiro, 1998; Musselman et al., 
1998). The risk may be enlarged in patients with a major depression in comparison to 
patients with a minor depressive disorder (Penninx et al., 2001). The autonomic 
cardiac dysfunction, as demonstrated by a decreased heart rate (HR) variability and 
reduced baroreflex, is one of the biological mechanisms that may underlie the 
increased risk of cardiovascular disease (Dalack and Roose, 1990; Y eragani, 1995; 
Musselman et aL, 1998; Watkins et aL, 1999; Gorman and Sloan, 2000). Decreased 
HR variability and a reduced baroreflex are observed in several cardiovascular 
diseases (Dalack and Roose, 1990; Huik:uri, 1995; Huikuri et al., 1996; Parati et al., 
2001). Furthermore, they increase the risk of arrhythmic events and sudden death 
after an acute myocard infarct (Hohnloser et al., 1994; Stys and Stys, 1998; La Rovere 
et al., 1998), and are suggested to be predictors for cardiovascular morbidity and 
mortality in community based studies (Tsuji et al., 1996; Singh et al., 1998; K:ikuya et 
al., 2000). 
5.1 Autonomic regulation of the cardiovascular system 
The cardiovascular system is regulated by several complex control processes in order 
to supply blood to all body tissues and to maintain cardiovascular homeostasis 
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Figure 2 A schematic representation of the central and autonomic (sympathetic and 
parasympathetic) nervous system pathways .involved in the regulation of the cardio-
vascular system. Afferent neurons transmit sensory output from the cardiovascular 
and respiratory systems to the central regulatory centers, whereas efferent neurons 
transmit signals to the heart and blood vessels (adapted from Chapleau and Abboud, 
2001). 
(Guyton, 1991; Malliani et al., 1991; Sved, 1999). The neural pathways involved in the 
short-term regulation of HR and blood pressure (BP) are illustrated in figure 2. The 
autonomic nervous system regulates the heart and circulation by their effect on the 
heart and blood vessels. Sympathetic activity to the heart leads to an increase in HR., 
whereas activation of the vagus nerves to the heatt has an antagonising effect, thus a 
decrease of HR (Guyton, 1991; Sved, 1999). Sympathetic innervation of the blood 
vessels is directed primarily at the precapillary arterioles, which are the main source of 
vasoconstriction with subsequent increases in vascular resistance and central arterial 
blood pressure. The sympathetic and parasympathetic (vagal) outflow to the heart 
and blood vessels is determined by the cardiovascular control center in the caudal 
brain stem (medulla) (Guyton, 1991; Sved, 1999; Chapleau and Abboud, 2001). 
Principally, the vasomotor center in the rostra ventrolateral medulla (RVLM) 
transmits excitatory signals to sympathetic preganglionic neurons that innervate the 
heart and blood vessels. The cardiomotor center in the nucleus ambiguus (NA) and 
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the dorsal motor nucleus (DMN) of the vagus stimulates the vagal outflow to the 
heart. The RVLM and NA/DMN are innervated by neurons of the nucleus of the 
tractus solitarius (NTS), which is modulated by higher brain centers (e.g. 
hypothalamus and motor cortex) and is the endpoint of the reflex projections of the 
arterial baroreceptors and the venous cardiopulmonary baroreceptors (Guyton, 1991; 
Sved, 1999; Chapleau and Abboud, 2001). 
The baroreflex is the best known and probably most important negative 
feedback mechanism to maintain the arterial pressure within a narrow normal range 
(Guyton, 1991; Parati, 2000). Baroreceptors in the aortic arch and carotid sinuses 
(figure 2) are stimulated by vascular stretch due to increases in arterial blood pressure. 
Increased baroreceptor afferent activity inhibits sympathetic activity and stimulates 
parasympathetic activity, which is rapidly followed by a decrease of the arterial 
pressure due to a decrease in vascular resistance and HR (Sved, 1999; Chapleau and 
Abboud, 2001). In contrast, when the arterial pressure decreases the baroreflex has 
an opposite effect and causes a rise in blood pressure. The relationship between 
alterations in arterial BP and changes in HR is indicative for the baroreflex function. 
The short-term cardiovascular regulation is reflected in sinusoidal rhythmic 
oscillations with different frequencies. Figure 3 shows the variations in HR 
(presented as interbeat intervals (IBI) and systolic blood pressure (SBP) during a 5 
minute period of supine rest. The baroreflex control induces spontaneous BP 
variations with a frequency around 0.10 Hz (Mayer waves) that may be the result of 
resonance in the vasomotor system (De Boer eta!., 1985; 1987; Mulder, 1985; 
Wesseling and Settels, 1985; Mulder, 1988a; Guyton, 1991). The baroreflex response 
is also reflected in HR variations with a frequency around 0.10 Hz. These BP and HR 
variations are considered to be associated with changes in sympathetic activity (Tulen 
eta!., 1994; Pagani and Malliani, 2000), although the HR variations around this 
frequency may also represent parasympathetic activity. Akselrod eta!. (1981,1985) 
and Pomeranz et a!. (1985) demonstrated in dogs and humans respectively that the 
blockade of parasympathetic activity to the heart by a peripheral muscarinic agent 
abolished the respiration-linked fluctuations in HR, but also diminishes HR 
fluctuations around the 0.10 Hz. 
Variations in the HR related to the respiratory frequency (usually between 
0.2-0.4 Hz) are called sinus respiratory arrhythmia (RSA) or high frequency (HF) 
variations (Porges and Byrne, 1992; Parati eta!., 1995). In figure 3 the fast rhythm of 
the respiratory signal is illustrated and this rhythm is also visible in the IBI and SBP 
time series. This phenomenon is mainly caused by vagal activity to the heart due to 
the respiratory control center in the medulla which inhibits the vagal output to the 
heart during inspiration (Berntson et a!., 1993; Grossman and Kollai, 1993; Guyton, 
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1991; Pagani and Malliani, 2000). The dominant role of parasympathetic activity in 
these HR variations is inferred from clinical and experimental observations of 
autonomic manoeuvres such as vagal stimulation, muscarinic blockade by drugs and 
the vagotomy (Malliani et al., 1991). It should be realised that respiration related BP 
variations do not represent vagal activity, but are caused by the mechanical effects of 
respiration on the pressure gradients, size, and functions of the heart and large 
thoracic vessels (Parati et al., 1995). HR variations around the frequency of 0.04 Hz 
are caused by various mechanisms involved in the vascular modulation including 
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Figure 3 Examples of spontaneous variations in interbeat interval (IBI), systolic blood 
pressure (SBP) and respiration (RESP) during a 300 sec period of supine rest. The power 
spectra (presented on the right) of the time series show the variation per frequency point 
in the frequency range bet\veen 0.02-0.50 Hz. The spectral power was assessed by the 
squared modulation index (Van Dellen eta!., 1985). 
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local influences of thermoregulation, renin-angiotensin system, and endothelial 
factors (Parati et al., 1995). 
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Spectral analysis is an adequate tool to unravel the sympathetic and 
parasympathetic processes involved in the short-term modulation of the 
cardiovascular system (Akselrod et al., 1985; Malliani et al., 1991; Montano et al., 
1994; Parati et al., 2000). The variation or 'power' of HR and BP per frequency and 
frequency range can be quantified by spectral analysis (Parati et al., 1995). Figure 3 
shows a power spectrum obtained in the frequency range between 0.01 to 0.50 Hz 
for the IBI and BP time series and the respiratory signal. The power spectra of the 
IBI and BP are characterised by a peak around 0.10 Hz and all spectra show a 
respiration related peak (with a frequency around 0.35 Hz). There is consensus that 
the H.R power in the frequency range between 0.15-0.50 Hz is an index for 
parasympathetic activity and that the BP power in the frequency range around 0.10 
Hz is an index for sympathetic activity (Parati et al., 1995; Task Force, 1996). As 
argued above the HR power around this frequency range is suggested to reflect both 
sympathetic and parasympathetic activity (Parati et al., 1995). Moreover, spectral 
analysis is appropriate to estimate the sensitivity of the spontaneous baroreflex in the 
different frequency ranges (Robbe et al., 1987; Saul, 1991; Parati et al., 2000). HR 
variability in the HF range may be a peripheral noninvasive indicator of the 
cholinergic dysfunction, because acethylcholine is an important neurotransmitter of 
the parasympathetic nervous system. 
5.2 Determinants of autonomic cardiac functioning in depression 
Clinical state 
Dalack and Roose (Roose et al., 1989; Dalack and Roose, 1990) monitored the HR 
over a 24-hour period in 11 unmedicated patients with major depression and were 
the first who reported that high frequency variations in HR of depressed patients 
were diminished in comparison to healthy subjects. However, the majority of later 
studies comparing unmedicated depressed patients and healthy subjects provided less 
evidence for a decreased HR variability or reduced baroreflex sensitivity (BRS) 
(Yeragani et al., 1991; Rechlin et al., 1994a; Tulen et al., 1996a; Lehofer et al., 1997; 
Moser et al., 1998). Nevertheless, these studies reported increased HR levels and 
altered (increased or decreased) BP levels, indicating that alterations in the autonomic 
regulation in unmedicated depressed patients may be restricted to overall HR and BP 
levels. On the other hand it is plausible that the decrease in HR variability and BRS 
can not be detected on group level, because these cardiovascular parameters are only 
affected in subgroups of depressed patients with specific clinical features. Anxiety 
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and agitation in depressed patients may be accompanied by elevated HR levels (Stein 
et a!., 1994) and more anxiety was reported to be associated with lower HR variability 
and less baroreflex control (Rechlin eta!., 1994b; Tulen eta!., 1996b; Watkins eta!., 
1999). Furthermore, cardiovascular control mechanisms may be influenced by 
psychotic features, because Parker eta!. (1995) hypothesised that psychotic patients 
in comparison to nonpsychotic patients were more likely to demonstrate disturbances 
in vegetative functions. A relationship between psychomotor retardation, which is 
probably characterised by less overall physical activity, and autonomic cardiac 
functioning, in particular a decreased HR variability, was also suggested (Thayer et a!., 
1998; Watkins eta!., 1999). It is surprising that so far this relationship has not been 
examined. 
Antideprmant treatment 
It is well known that treatment with conventional antidepressants induces various 
cardiovascular side effects. For instance, TCAs have the potency to cause tachycardia, 
orthostatic hypotension, conduction delays, and cardiac arrhythmias (Littman, 1993). 
TCAs also decrease the HR variability, indicating diminished vagal cardiac control 
due to the anticholinergic properties ofTCAs (Yeragani eta!., 1995; Tulen eta!., 
1996a). The novel antidepressants, such as the SSRis, are developed to be free of 
cardiovascular side effects, but some influence on the autonomic cardiac function 
should not be excluded. For instance, Lederbogen eta!. (2001) demonstrated recently 
in depressed patients that paroxetine treatment with a high dose ( 40 mg) resulted in 
decreased HR variability, probably due to the anticholinergic properties of 
paroxetine. In contrast, no changes in HR variability were reported after treatment 
with fluvoxamine in depressed patients (Rechlin eta!., 1994b), although fluvoxamine 
treatment has the tendency to decrease the mean HR (Wakelin, 1986; Hewer et a!., 
1995; Laird eta!. 1993; Rechlin eta!., 1994b). The effects of SSRis should be further 
clarified, especially on HR and BP variability and BRS. Balogh et a!. (1993) stated that 
antidepressants, especially antidepressants without strong cardiovascular effects, may 
also have a beneficial effect on the cardiovascular system through their therapeutic 
effect on depressive mood. 
Risk factors 
More recently interest has grown in another type of determinants: the higher 
prevalence of cardiovascular risk factors in depressed patients. Cigarette smoking is 
the most salient lifestyle risk factor in depressed patients (Glassman eta!., 1990; 
Glassman, 1993; Breslau eta!., 1998). Hayward (1995) concluded in his review that 
the frequency of cigarette smoking in depressed patient is about 50%, while this 
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percentage ranges between 20-30% in the general population. Additionally, he stated 
that the frequency of smoking is particularly high in depressed inpatients. The 
relationship between depression and cholesterol is much more complex and 
confusing. Up until the 1980s it was assumed that there would be a positive 
relationship between depression and cholesterol (Oxenkrug et al., 1983; Wardle, 
1995). Later on, studies appeared that found that depressive disorder and depressive 
symptoms were related to lower levels of total and HDL cholesterol (Morgan et al., 
1993; Horsten eta!., 1997; Maes eta!., 1997; Chen et al., 2001). Furthermore, 
depression may be related to other risk factors such as physical inactivity and 
overweight (Ariyo, 2000), but research on this issue is scarce. Detailed insight in the 
effect of cardiovascular risk factors on autonomic regulation in healthy subjects may 
contribute to the understanding of the relevance of these factors for autonomic 
dysfunctions in depressive disorder. 
Cigarette smoking is suggested to enhance HR and BP levels, increase BP 
variability, decrease HF variability of HR, and reduce BRS (Hayano et a!., 1990; 
Niedermaier et al., 1993; Mancia et al., 1997; Gerhardt eta!., 1999; Ragueneau et al., 
1999). Higher total cholesterol and low density lipoprotein (LDL) cholesterol levels 
could be related to lower overall HR variability (I<:upari et al., 1993; Christensen et a!., 
1999). Several studies have paid attention to the effects of other well known 
cardiovascular risk factors, including physical inactivity and an increased body mass 
index, on autonomic cardiac functioning, but equivocal results were reported (I<upari 
et al., 1993; Molgaard et a!., 1994; Kageyama et a!., 1997; Fagard et al., 1999; Kardos 
A et al., 2001). In healthy subjects the effect of smoking on cardiovascular variability 
and baroreflex sensitivity needs to be further investigated, and the effect of lipid 
levels, levels of physical activity and overweight on these parameters should be 
studied more in detail. 
6 Aims of the studies and outline of this thesis 
6.1 Aims of the studies 
The studies of this thesis concern the spontaneous pattern of motor activity and 
autonomic cardiac functioning in major depressive disorder. The main purpose of the 
studies was to obtain insight in the psychomotor and autonomic cardiac dysfunction 
in depression by investigating the 24-hour pattern of motor activity and the 
autonomic (sympathetic and parasympathetic) regulation of the cardiovascular system 
in healthy subjects and depressed inpatients. The data of the patients were assessed 
during a psychotropic drug free period drug and after double blind treatment during 
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4 weeks with imipramine or fluvoxamine. It was hypothesised that clinical state and 
antidepressant treatment affect the 24-uur pattern of motor activity and autonomic 
regulation in depressed patients. Furthermore, personality traits were theorised to 
contribute to variation in the 24-uur pattern of motor activity, and risk factors to 
variation in cardiovascular variability and baroreflex sensitivity. In addition, 
measurements of the spontaneous motor behavior and parasympathetic regulation in 
depressed patients were explored for their usefuloess to clarify the cholinergic 
dysfunction in major depressive disorder. 
The specific aims of the studies were the following: 
1) To extract the time trend in the daily pattern of motor activity in healthy subjects 
and to examine the effect of personality on this pattern. 
2) To evaluate the effect of risk factors on autonomic cardiac functioning in healthy 
subjects. 
3) To establish alterations in the 24~motor activity and autonomic cardiac 
functioning in medication free depressed patients, in comparison to healthy 
subjects, and to determine the relevance of specific clinical features for and the 
relationship between these functions. 
4) To compare the effect of treatment with a conventional tricyclic antidepressant 
(TCA) and a modern selective serotonin reuptake inhibitor (SSRI) on the 24~ 
hour pattern of motor activity in depressed patients and to explore the 
contribution of the improvement of clinical state to the changes after treatment. 
5) To compare the effect of treatment with a TCA and a SSRI on autonomic 
cardiac functioning in depressed patients, and to unravel the effects of 
pharmacological actions and improved depressive mood on the alterations in 
autonomic regulation observed after treatment. 
6.2 Outline of this thesis 
In chapter 2, a study to the 24-hour pattern of motor activity in the natural 
environment of healthy subjects is presented. The shape of the daily pattern of motor 
activity was modelled by random regression analysis and we examined whether the 
temperament dimensions of the Tridimensional Personality Questionnaire (TPQ), 
age and gender were related to overall levels of motor activity and the shape of the 
diurnal pattern. 
Chapter 3 deals with the influence of cardiovascular risk factors on the 
autonomic modulation of the cardiovascular system in healthy subjects. Cigarette 
smoking, lipid levels, body mass index, habitual physical activity, age and gender were 
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investigated as determinants of mean heart rate and blood pressure, cardiovascular 
variability and baroreflex sensitivity. To obtain large intraindividual variation, the 
cardiovascular measurements were performed during supine rest and head-up tilt. 
The fourth chapter presents a detailed study to the psychomotor and 
autonomic cardiac dysfunction in major depressive disorder. Unmeclicated severely 
depressed inpatients and healthy control subjects were compared regarding their 24-
hour motor activity and autonomic regulation. Within the patient group the relevance 
of specific clinical features (anxiety, agitation, psychomotor retardation, and psychotic 
features) and the relationship between motor activity and cardiovascular parameters 
were explored. 
In chapter 5 the effect of the tricyclic antidepressant imipramine and the 
selective serotonin reuptake inhibitor fluvoxamine on the 24-hour pattern of motor 
activity in major depressive disorder is described. Mean motor activity levels, 
fragmentation of motor activity, and immobility were studied during a psychotropic 
drugfree period and after a double blind treatment of 4 weeks under control of 
plasma levels. The contribution of changes in severity of depression, psychomotor 
retardation and agitation to alterations in the motor activity parameters were 
discussed. 
Chapter 6 reports about the autonomic regulation of the cardiovascular 
system in depressed patients before and after treatment with imipramine or 
fluvoxamine. We investigated the effect of orthostatic challenge on cardiovascular 
parameters in each treatment group and tried to unravel the pharmacological effect 
and the influence of improved depressive mood on changes in cardiovascular 
parameters after treatment. 
In the last chapter the main findings of the studies of this thesis are 
summarised, discussed, and integrated. A critical appraisal of the applied 
methodology is given, and suggestions for future research in this field are provided. 
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1 Abstract 
The effects of personality dimensions, age, and gender on 24-hour motor activity 
patterns were studied in 101 healthy subjects between 20-70 years. We measnred 
motor activity by wrist-actigraphy and personality dimensions by the Tridimensional 
Personality Questionnaire (TPQ) of Cloninger. Random Regression Models were 
used to estimate the effects of personality dimensions, age, and gender on the dinrnal 
pattern of motor activity. Harm Avoidance as well as Reward Dependence influenced 
the overall level of motor activity, independent of age and gender. Subjects high on 
Harm Avoidance showed lower activity levels than subjects low on Harm Avoidance, 
whereas subjects high on Reward Dependence had higher overall levels of motor 
activity than subjects low on Reward Dependence. Older subjects were found to be 
less active than younger subjects, but the activity level did not differ between males 
and females. 
2 Introduction 
Several biologically based personality theories have hypothesized relationships 
between personality characteristics and neurophysiological or neuroendocrine 
parameters (e.g. Eysenck, 1967; Zuckerman et al., 1980; Cloninger, 1987). These 
theories have so far neglected to put forward a direct association bet\Veen personality 
dimensions and locomotor activity. However, King (1986) theorised that overt 
spontaneous motor activity and personality styles, like extroversion and histrionic 
personality traits, would interrelate. More specifically, it was predicted that individuals 
with histrionic or extroverted traits would show enhanced motor activity to 
incentives. The theorised relationship between histrionic traits and motor activity 
level was demonstrated in patients with a panic disorder, though no relationship was 
found between extroversion and motor activity level (King et al., 1988). Positive 
results also have been found with children. For example, more energy, less inhibition, 
more attention seeking, more dominance, more engagement in social play, greater 
assertiveness and less compliance were related to higher ambulatory measured levels 
of motor activity among 3- and 4-year-olds (Buss et al., 1980). Even in younger 
children (2.5 years), ratings of "negative peer interaction" and "excitability" were 
found to be positively correlated with motor activity levels, whereas ratings of 
"seeking help with object blocks" were negatively correlated (Halverson and 
Waldrop, 1973). These findings underline the potential relevance of personality 
dimensions and individual differences for levels of overt motor activity. 
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In this study, we examined in a large group of healthy subjects whether 
personality traits are related to the overall level of motor activity independent of the 
effects of age and gender. Cloninger's Tridimensional Personality Questionnaire 
(TPQ; 1987) was used to assess personality traits. Cloninger (1987) developed a 
neurobiological learning model with three genetically independent temperament 
dimensions: Novelty Seeking, Harm Avoidance, Reward Dependence. In contrast to 
other multidimensional personality models (e.g. Eysenck's), Cloninger's model 
assumes that the observed phenotypic structure of personality may differ from the 
underlying biogenetic structure because variations in behavior result from the 
interaction between environmental and genetic influences (Cloninger 1987, 1991, 
1998, 1999). The TPQ was based on a synthesis of information derived from family 
studies, studies of longitudinal development, and psychometric studies of personality 
structure, as well as neuropharmacological and neuroanatomical studies of behavioral 
conditions and learning in men and animals. Subsequent research using the TPQ 
showed that one subscale (i.e. Persistence) of the Reward Dependence dimension 
was relatively independent of the three postulated temperament dimensions, and 
consequendy was assumed to be an additional genetically independent temperament 
dimension (Cloninger, 1994; Stallings et al., 1996). Genetic analysis demonstrated that 
54% to 61% of the stable variation of the four TPQ dimensions could be ascribed to 
heritability and that the dimensions had litde or no genetic correlations with one 
other (Cloninger, 1994). 
The TPQ dimensions have predictable patterns of interaction with specific 
classes of environmental stimuli (Cloninger, 1987). Novelty Seeking is the tendency 
toward excitement in response to novel stimuli or cues signalling potential rewards or 
relief from punishment. This tendency leads to frequent exploratory activity in 
pursuit of potential rewards, as well as active avoidance of monotony and potential 
punishment. Individuals high on Novelty Seeking are excitable, exploratory, curious, 
enthusiastic, and impulsive, whereas individuals low on Novelty Seeking are 
indifferent, uninquiring, unenthusiastic, stoical, and tolerant of monotony (Cloninger, 
1987, 1994, 1998, 1999). Harm Avoidance is a tendency to respond intensely to 
signals of aversive stimuli. Presumably, individuals high in Harm Avoidance learn to 
inhibit behavior to avoid punishment, novelty, and nonreward; they tend to be 
cautious, fearful, tense, apprehensive, and passive, whereas individuals low on this 
dimension tend to be carefree, relaxed, daring, courageous, and composed. Reward 
Dependence is the tendency to respond intensely to signals of reward (particularly 
verbal signals of social approval and sentiment). Individuals high on Reward 
Dependence tend to maintain or resist extinction of behavior that has previously 
been associated with reward or relief from punishment. They are eager to help and 
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please others, tender-hearted, dedicated, warmly sympathetic, and sensitive to verbal 
signals of social reinforcement, whereas those low on Reward Dependence are 
practical, tough-minded, cold, and socially insensitive. Finally, Persistence is the 
tendency to persevere in behavior despite frustration and fatigue. High scorers on 
Persistence are industrious, hard-working, persistent, and stable, whereas low scorers 
are inactive, indolent, unreliable, and unstable. 
If Cloninger's theory about specific relationships between temperament 
dimensions and the activation, inhibition, and maintenance of behavior is true, then 
we expect the TPQ dimensions to be related to individual differences in spontaneous 
patterns of motor activity. Because Novelty Seeking is postulated to be linked to 
exploratory activity and Harm Avoidance to the inhibition of behavior, we expected 
that high scorers on Novelty Seeking should exhibit higher levels of motor activity, 
whereas high scorers on Harm Avoidance should exhibit lower levels of motor 
activity. Additionally, low scorers on Persistence are thought to be inactive and 
indolent, suggesting that Persistence should be positively related to motor activity 
levels. There was no theoretical or rational ground to eXpect in advance an effect of 
Reward Dependence on motor activity level. 
King et al. (1988) emphasized that in studies investigating the relationship 
between personality traits and behavior, behavior needs to be measured over multiple 
time points and in many situations because situationally and temporally limited 
measures of behavior often show low correlations with personality traits. 
Accordingly, in this study, wrist-actigraphy was used to monitor motor activity during 
three days and nights in a natural environment. Wrist-actigraphy is an unobtrusive, 
objective method for assessing 24-hour patterns of spontaneous motor activity and 
has been demonstrated to measure motor activity in a valid and reliable way 
(Patterson et al., 1993; Tryon, 1991; Middelkoop et al., 1997a). Because previous 
studies demonstrated an effect of age and gender on wrist-actigraphy data 
(Lieberman et al., 1987; Witting et al., 1989; Van Hilten et al., 1993; Brown et al., 
1990), we also studied the effects of age and gender on the pattern of motor activity. 
3 Method 
3.1 Subjects 
From November, 1995, through March, 1997,101 subjects between 20-70 years of 
age participated in the study. The study population consisted of students (n=23), 
housewives (n=16), individuals who were employed (n=58), and subjects who were 
retired (n=4). Exclusion criteria were: a history of mental illness, sleep disorders, 
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current medical illness, medication use interfering with the activity pattern, recent 
circadian shifts, and working during evening hours and night-time. Recordings of two 
female participants were excluded from the data analysis because of illness during the 
recording period. The recordings of hvo other female participants were lost due to 
technical problems. The remaining study population consisted of 51 males (mean age: 
40.1 years, range: 20-66) and 46 females (mean age: 40,9 years, range: 20-67). 
Recruitment was aimed at an equal division of men and women in three beforehand-
defined age groups (between 20-35 years, between 36-50 years and between 51-70 
years). The first age group comprised 39 subjects, the second 30, and the third 28. 
The Medical Ethics Committee of the University Hospital Rotterdam-Dijkzigt 
approved the study, and subjects were not paid for their participation. 
3.2 Personality Questionnaire 
Within one week after the recording period, the Dutch version of the Tridimensional 
Personality Questionnaire (TPQ) (Cloninger, 1987; Dutch version: Van Den Brink et 
al., 1993) was completed. Two subjects returned incomplete questionnaires (missing 
items > 2), therefore the data of these subjects were not used in the analysis. The 
TPQ is a 1 00-item, true/ false questionnaire, including 34 items for Novelty Seeking, 
34 items for Harm Avoidance, 31 items for Reward Dependence, 9 items for 
Persistence, and 2 items for general information about the manner in which the 
questionnaire was completed. As previously discussed, Persistence was originally a 
sub scale of Reward Dependence, but empirical evidence indicated that separation 
from Reward Dependence was reqnired (Cloninger, 1994; Stallings et al., 1996). Prior 
research demonstrated that the internal consistency estimates for the dimensions 
were moderate to good (a is between 0.65 and 0.85), and the test-retest reliability 
estimates moderately high (r is between 0.70 and 0.79) (Cloninger, 1994). The test-
retest reliability was based on an interval of 6 months. 
3.3 Wrist-actigraphy 
To assess spontaneous 24-hour motor activity, subjects wore a wrist-actigraph 
continuously during 4 days and nights, either from Monday morning until Friday 
morning or from Tuesday morning until Saturday morning in their natural 
environment. The standard procedure was to measure motor activity from Monday 
morning until Friday morning, but for practical reasons 33% of the subjects wore the 
actigraph from Tuesday morning till Saturday morning. Day- and night-time motor 
activity was always measured on weekdays, but the motor activity on Friday night 
might have differed from other weekdays. However, post-hoc analyses revealed no 
systematic differences between the activity pattern of Friday night and the other 
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evenings. The nondominant wrist was chosen as the recording site, because 
recordings of the nondominant wrist are assumed to be more reflective of 
movements of the total trunk and less of movements involved in performing specific 
tasks such as writing (McPardand eta!., 1975; Middelkoop et al., 1997a). The subjects 
maintained their habitual24--hour pattern of activities at home and outside and were 
only allowed to take off the actigraph during bathing. The actigraph (Gaehwiler 
Electronic; size 51 x 36.5 x 21 mm) contained a monoaxial piezoelectric acceleration 
sensor and counted the number of suprathreshold movements of the wrist(> 0.1 g 
acceleration) per 30-s epochs. The analogue sensor signal was sampled at a frequency 
of 8Hz and subsequendy flltered by a band-pass fllter of 0.25-3.0 Hz. 
The first day and night of the recording period was used to acclimate 
subjects to wearing the actigraph. Therefore, wrist-actigraphy recordings of the last 
three days and nights were used for data analysis. According to Middelkoop and 
Sadeh (1997b), three days are necessary to obtain reliable motor activity data because 
of interday variations. A clock-time-based analysis was applied to compute, for each 
day, half-hour motor activity counts from 6 a.m. until6.00 a.m the next morning. 
Thereafter, half-hour motor activity counts were averaged for the recording days, and 
subsequently, these mean half-hour activity counts were averaged for several periods 
of the day. 
The 24--hour interval (from 6 a.m.-6 a.m.) was divided in eight periods, 
reckoning with findings of earlier studies and the assumed activity pattern of the 
study population. The first period, from 6 a.m. until 7 a.m., was chosen because in 
the studies of Lieberman et a!. (1989) and Renfrew et a!. (1987), older subjects were 
more active than younger subjects during this period. The second period, from 7 a.m. 
until 9 a.m., was assumed to reflect the period of getting up and travelling to work. 
The third period, from 9 a.m. until noon, represented the morning, and the fourth 
period, from noon until4:30 p.m., the afternoon. The fifth period, from 4:30p.m. 
until 6:30p.m., was supposed to be the period during which subjects returned home. 
The sixth period, from 6:30p.m. untilll p.m., reflected the evening. Finally the 
seventh period, from 11 p.m. until2:30 a.m., was assumed to represent for most 
subjects the period during which they went to bed and fell asleep; the last period, 
from 2:30a.m. until 6 a.m., represented the late night. 
3.4 Statistical Analysis 
Pearson product-moment correlations were computed to investigate the relationships 
among the four personality dimensions, and between age and each personality 
dimension. To test differences between males and females on the personality 
dimensions, we used t-tests for independent samples. 
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To estimate the effects of personality, age and gender on the diurnal pattern 
of motor activity, Random Regression Models (RRMs) for continuous data were 
used. The analysis of motor activity data was performed with the program Proc 
Mixed of the statistical package, Statistical Analysis Systems (SAS for Windows, 
release 6.12). RRMs estimate individual effects instead of effects for the total study 
population (Bock, 1983; Gibbons et al., 1993). The random regression approach uses 
data from individuals augmented by information from the total study population to 
estimate for each subject the personal trend across time. RRMs are characterised by 
the following model equation: "Y=fJo+fJ,X,+ ... +/lkXk+bo+b,Z,+ ... +bmZm +c;'', 
where Xt, ... ,Xk are group indicators and Zt, ... ,Zk are subject indicators. In 
RRMs, the intercept and time effects are allowed to differ for individuals, and 
therefore are called random terms. RRMs have advantages above the usually applied 
MANOVAs for repeated measurements. In RRMs, data are used efficiently, resulting 
in a more adequate estimation of the time trend. RRMs can cope with missing values 
because the estimation of an individual time trend is based on non-missing data for 
that individual. This implies that missing values are assumed to be missing at random 
(Rubin, 1987), and subjects may have data for different time points. In contrast to the 
classical ANOV A for repeated measurements, R.Rlvfs allow more general and realistic 
error structw:es. In this study we assumed an "unstructured" error structure, which 
allows both correlations between measurements and variances of measurements to 
differ (Gibbons et al., 1993; Verbeke and Molenberghs, 1997). In other words, 
variances and covariances may differ between repeated measurements. It should be 
noted that patterns of 24-hour motor activity have seldom been analysed by statistical 
models for repeated measurements and, as far as we know, never by Random 
Regression Models. Diurnal patterns in healthy subjects and patient groups have 
often been analysed per hour, per period of the day, per daytime and night-time, and 
per total day. The disadvantage of separate analyses is that the time trend itself cannot 
be identified. 
The motor activity data were characterised by skewed distributions of 
mean half-hour motor activity counts, large differences between mean motor activity 
counts, and large variability within each mean motor activity count (mean, SD, range: 
period 1: 459, 888, 8-6457; period 2: 1840, 1109, 117-5569; period 3: 1752, 903, 226-
5551; period 4: 1819, 921, 226-5747; period 5: 1093, 1093, 166-5572; period 6: 1597, 
812, 193-3815; period 7: 550, 435, 14-1935; period 8: 101, 111, 11-715). Due to these 
characteristics, the model did not fit well (-2 REML Log Likelihood>> 5000). A 
logw transformation was performed on the mean half-hour motor activity counts 
resulting in normality of data (mean, SD, range: period 1: 2.2, 0.36, 0.93-3.81; period 
2: 3.1, 0.37, 2.1-3.8; period 3: 3.2, 0.23, 2.4-3.7; period 4: 3.2, 0.24, 2.4-3.8; period 5: 
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3.3, 0.27, 2.2~3.8; period 6: 3.1, 0.27, 2.3~3.6; period 7: 2.6, 0.46, 1.2~3.3; period 8: 1.8, 
0.36, 1.05~2.85). The use of the transformed motor activity counts in the RRMs 
improved the model fit (~2 REML Log Likelihood< 600). The time variable was 
constructed by taking the middle of each predefined period of the day, wbich resulted 
in the following fixed time points for the data series: 1, 2.5, 5, 8.75, 12.00, 15.25, 
17.25 and 20.75 hrs. 
Analyses were conducted in two steps: 
Step 1 
The effect of time on the diurnal pattern of motor activity was stndied. The model 
estimating the time trend was built by adding fixed time effects of increasing order 
one by one until they were nonsignificant, and by adding random time effects of 
increasing order one by one until their variance components were negative (Brown 
and Prescott, 1999). 
Step 2 
We evaluated the main effects of personality dimensions, age, and gender on the 
motor activity pattern. The main effect terms were added simultaneously to the RRM 
for the time trend. The effects of the personality dimensions were stndied in separate 
analyses to simplify the description and to improve the understanding of the RRMs. 
4 Results 
4.1 Correlations Between Personality Dimensions, Age and Gender 
Novelty Seeking showed significant, negative correlations with Harm Avoidance (!=~ 
0.22, p<0.05) and Reward Dependence (r=~0.21; p<O.OS). Other correlations 
between the personality dimensions were nonsignificant (all r's<0.14; p's>0.19). 
Females showed significandy higher scores than males on Harm Avoidance 
(mean=13.1, sd=5.6 and mean=10.5, sd=5.0 respectively, p<0.01) and Reward 
Dependence (mean=14.1, sd=3.8 and mean=11.4, sd=3.8 respectively, p<0.05), but 
no significant gender differences were found for Novelty Seeking or Persistence. Age 
was significandy negatively correlated with Novelty Seeking (r=~0.32, p<0.05) and 
with Persistence (r=~0.22, p<0.01), indicating that older subjects have lower scores 
on these personality dimensions than younger subjects. 
4.2 Time trends in the motor activity data 
Figure 1 shows an example of a 24~hour actigram. The diurnal pattern, based on 
mean half~hour motor activity counts for the whole stndy population, is presented in 
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6:00p.m. 6:00a.m. 6:00p.m. 
Figure 1 Raw data of a 24-hour motor activity recording of a 22-year-old male. The 
x-axis represents the clock time (beg1nning and ending at 6 p.m.) and they-axis the 
number of counts per 30-sec epoch. 
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Figure 2 Observed and estimated diurnal pattern of motor activity for the whole 
study population. The diurnal pattern was estimated based on the following equation: 
mean half-hour motor activity counts = 0.83 + (1.8xtime) + (-0.5xtime') + 
(0.06xtime3) + (-0.004xtime4) + (lxlO'xtime') + (-lx106xtime'). 
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figure 2. On visual inspection, the diurnal pattern is characterised by a large increase 
in motor activity level from the first period (6-7 a.m.) to the second period of the day 
(7-9 a.m.), followed by slightly decreased motor activity levels in the next two periods 
(9 a.m.-4:30p.m.), a peak of motor activity in the period from 4:30p.m. until 6:30 
p.m. and a gradual decline in motor activity during the evening and the night. We 
found that the 24--hour pattern of motor activity could be modelled by six fixed time 
effects (time, time", time3, time', timeS and time6) and three random effects (intercept, 
time, time2). Thus, the estimated pattern was characterised by a linear time trend, in 
addition to 5 points of inflexion (figure 2). Dependent on the strength of the higher 
order time effects, the points of inflexion were more or less pronounced in the 
estimated pattern. The RRM for the time trend was used as reference model in the 
analyses of the main effects of personality, age and gender. 
Table 1 Significant effects of time, :Harm Avoidance (HA), Reward Dependence (RD) and age 
on the motor activity pattern. 
RR..'V! for the RRM for the RR.J'V! for the 
time effect effects of time, HA, effects of time, RD, 
age and gender age and gender 
variable df p df p df p 
Intercept 96 7.1 <.001 92 8.6 <.001 91 5.7 <.001 
Time 96 13.3 <.001 94 12.9 <.001 94 12.9 <.001 
Time2 96 -9.1 <.001 94 -8.9 <.001 94 -8.9 <.001 
Time3 96 6.5 <.001 94 6.3 <.001 94 6.3 <.001 
Time4 96 -4.6 <.001 94 -4.5 <.001 94 -4.5 <.001 
Time5 96 3.2 =.002 94 3.0 <.001 94 3.0 =.003 
Time6 96 -2.1 =.04 94 -2.0 =.05 94 -2.0 =.05 
Harm A voidance 469 -2.7 =.007 
Reward Dependence 469 3.5 <.001 
Age 469 -3.8 <.001 469 -3.8 <.001 
Gender 469 1.6 ns 469 -0.5 ns 
RM:M, Random Regression Model 
4.3 Estimated Effects of Personality 
Contrary to our prediction, the main effects of Novelty Seeking and Persistence were 
not significant, indicating that the overall level of motor activity was similar for 
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subjects with high scores and low scores on these personality dimensions. The main 
effect of Harm Avoidance on the motor activity pattern was significantly positive and 
that of Reward Dependence significantly negative (table 1). The effects were 
independent of age and gender. This finding indicates that overall levels of motor 
activity were low for individuals high on Harm Avoidance in comparison to 
individuals low on Harm Avoidance, and overall levels were high for individuals high 
on Reward Dependence in comparison to individuals low on Reward Dependence. 
4.4 Estimated Effects of Age and Gender 
A significant negative effect of age on the diurnal pattern of motor activity was found 
in all four RRMs (see also table 1), indicating that older subjects have lower overall 
levels of motor activity than younger subjects. In none of the RRMs did we find an 
effect of gender. 
5 Discussion 
In a healthy population of men and women between 20-70 years, we studied the 
effects of the TPQ personality dimensions: Novelty Seeking, Harm Avoidance, 
Reward Dependence and Persistence, and the effects of age and gender on the 
diurnal pattern of motor activity. On visual inspection, the diurnal pattern was 
characterised by a large increase in motor activity level during the beginning of the 
day, a gradual decline in motor activity during the evening and the night, and a peak 
in motor activity between 4:30p.m. and 6:30p.m. Two of the four TPQ dimensions 
were significantly related to the overall level of motor activity. We found that subjects 
high on Harm Avoidance showed lower overall levels of motor activity than subjects 
low on Harm Avoidance, whereas subjects high on Reward Dependence showed 
higher overall levels than subjects low on this dimension. Cloninger (1987) 
hypothesized that Harm Avoidance is linked to the inhibition of behavior to avoid 
punishment, novelty, and nonreward. Therefore, we expected in advance that 
subjects high on Harm Avoidance would have lower levels of motor activity. In 
accordance with our study, Buss et a!. (1980) found in children a negative relationship 
between "inhibition" and motor activity levels. Reward Dependence is theorised to 
reflect the tendency to respond intensively to signals of reward (particularly verbal 
signals of social approval and sentiment) and to maintain or resist extinction of 
behavior that has previously been associated with rewards or relief from punishment 
(Cloninger, 1987). In agreement with our findings, Buss et a!. (1980) found that 
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children who were high on attention seeking and more engaged in social play also 
showed higher levels of motor activity. 
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Personality theories vary much in their description and naming of personality 
dimensions, which makes it difficult to compare the findings of our study with 
previous studies. For instance, Novelty Seeking only partly overlaps with 
Zuckerman's dimension of impulsive sensation seeking (r=0.68) and Eysenk's 
exttaversion dimension (r=0.44) (Zuckerman and Cloninger, 1996). In patients witl1 a 
panic disorder, no relationship was found between mean motor activity levels and 
impulsivity (King et al., 1988). Because impulsivity is a part of Cloninger's Novelty 
Seeking, this finding is in agreement with our observation that Novelty Seeking had 
no effect on the level of motor activity. In Cloninger's model, the TPQ dimensions 
are suggested to have predictable patterns of interaction with specific classes of 
environmental stimuli. In this study we examined overall relationships with 
spontaneous motor activity patterns -without taking into account the interaction 
effects between TPQ dimensions and discrete environmental stimuli. It is possible 
that we did not obtain an effect for Novelty Seeking because specific situations 
involving excitement, novelty, and impulse provocation either did not arise or arose 
infrequently during routine daily activities. 
Older subjects demonstrated lower overall levels of motor activity than 
younger subjects. Renfrew et a!. (1987) also reported a decrease in the motor activity 
level due to aging, but Lieberman et al. (1989) found an increase and Witting et a!. 
(1990), no change at all. Diurnal patterns of motor activity have not been studied in 
prospective longitudinal studies. Biological processes due to aging could be 
responsible for the changes in diurnal patterns, but these changes may also be 
ascribed to differences in the type of daily activities and the preference for leisure 
time activities. For instance, 57% of the oldest age group in this study were retired or 
housewives, which could have resulted in an alteration of the diurnal pattern of 
motor activity. In addition, Renfrew et a!. (1987) found that older subjects watched 
television for most of the evening, while younger subjects were engaged in other 
activities. Although subjects did not keep an activity diary in this study, similar 
differences in activity type may explain our fmding as well. Regardless of the origin of 
the differences between age groups, our data show that it is important to take age 
into account in studies of diurnal patterns of motor activity. 
Little data are available on 24-hour profiles of motor activity in healthy 
subjects. Renfrew et al. (1987) presented diurnal patterns of motor activity in males 
between 21-83 years, and Lieberman et al. (1989) in males and females between 19-
35 years and between 65-94 years. Although these studies differed from ours 
regarding the selected time points and monitoring devices, diurnal patterns in both 
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studies were also characterised by a large increase in motor activity in the early 
morning and a decline in motor activity during the evening and night. In the study of 
Renfrew et al. (1987), smooth diurnal patterns (without peaks) of motor activity were 
found, whereas in the Lieberman et al. (1989) study, diurnal patterns were 
characterised by one or two peaks dependent on age and gender. Possibly, 
interinclividual variations in the pattern of motor activity are most pronounced during 
the morning and afternoon. 
Several potential shortcomings of the present study should be acknowledged. 
We did not code season. Consequently, the potential influences of season on the 
motor activity pattern could not be evaluated. Furthermore, in future studies it may 
be relevant to take into account the modifying effects of specific situational 
requirements and triggers on the relationships between personality dimensions and 
24-hour patterns of motor activity. Activity logs, in addition to wrist-actigraphy, may 
also be helpful for interpreting the observed patterns of motor activity. 
6 Conclusions 
The diurnal pattern of motor activity was characterised by a large increase in motor 
activity in the early morning, a gradual decline in motor activity during the evening 
and the night, and one peak of motor activity between 4:30p.m. and 6:30p.m .. Both 
Harm Avoidance and Reward Dependence influenced the overall level of motor 
activity: subjects high on Harm Avoidance showed lower activity levels than subjects 
low on this dimension, and high scorers on Reward Dependence showed higher 
activity levels than low scorers. Age had a negative effect on the motor activity level, 
indicating that older subjects were overall less active than younger subjects. Overall, 
this study showed that spontaneous patterns of motor activity are related to core 
dimensions of personality. 
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1 Abstract 
Community studies showed that reduced cardiovascular variability may be a predictor 
of cardiovascular diseases. \Ve studied in normotensive subjects the effects of age, 
gender and several risk factors on cardiovascular variability and baroreflex sensitivity 
and focused on the importance of these factors as detenninants of interindividual 
variation. In 65 subjects (38.4 ± 11.2 years) we obtained coefficients of variation 
(CV) of heart rate (HR) and blood pressure (BP) duriog periods of rest and 
orthostatic challenge. In addition, log power values of HR and BP io the mid 
frequency (MF) band (0.07-0.14 Hz), log power values ofHR in the high frequency 
(HF) band (0.15-0.50 Hz) and a baroreflex sensitivity (BRS) index were assessed by 
spectral analysis. Overall HR variability, MF and HF variability of HR and BRS were 
decreased by age. Mean HR values were positively related to total and high density 
lipoproteio (HDL) cholesterol plasma levels, and negatively to levels of physical 
activity. In addition, mean BP values were iocreased by a higher body mass index 
(BMI). Cardiovascular variability and BRS were not affected by risk factors, with the 
exception of overall HR variability which was decreased io smokers and subjects with 
a higher BMI. Thus, age turned out to be an important determinant of HR variability 
and BRS, but not of BP variability. Risk factors played a role io the modulation of the 
cardiovascular system, but mainly through their effects on mean HR and BP levels. 
2 Introduction 
Spectral analysis of heart rate HR and blood pressure BP variability has been applied 
to study in detail the autonomic modulation of cardiovascular control mechanisms 
(Akselrod et al., 1985; Malliani et al., 1991; Saul et al., 1991; Tulen et al., 1994; Tulen 
et al., 1996a; Task Force, 1996). HR variability in the HF domain (0.15-0.50 Hz) is 
related to respiratory variations (respiratory sinus arrhythmia) and reflects vagal 
(parasympathetic) modulation. BP variability in the frequency domain around 0.1 Hz 
reflects alterations in peripheral vasomotor resistance due to baroreflex-rnediated 
sympathetic control. HR variability io this frequency domain represents changes io 
baroreflex response and similarly reflects sympathetic activity, although an influence 
of vagal activity has also been suggested (Pomeranz et al., 1985). Additional 
information about the autonomic control of the cardiovascular system can be 
obtained by studying the transfer functions between systolic blood pressure (SBP) 
and ioterbeat interval (IBI) time series to provide non-iovasive iodices of BRS (Saul 
et al., 1991; Parati et al., 2000). 
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Age has been reported to influence autonomic cardiac functioning. HR 
variability in the two described frequency domains and BRS were decreased by age 
(Lipsitz et al., 1990; Ryan et al., 1994; Laitinen et al., 1998; Kardos et al., 2001). Less 
is known about gender differences and their origin. Some studies suggested that 
healthy females have a lower BRS than males (e.g. Laitinen et al., 1998; Kardos et al., 
2001). 
Community based studies found that a reduced cardiovascular variability may 
be a predictor for cardiac events, cardiovascular mortality and the onset of 
hypertension (fsuji et al., 1996; Kikuya et al., 2000; Singh et al., 1998). Therefore, it is 
relevant to obtain knowledge about the role of cardiovascular risk factors in 
cardiovascular variability and BRS. For instance, the acute effects of cigarette 
smoking were enhanced HR and BP levels (Niedermaier et al., 1993; Man cia et al., 
1997; Gerhardt et al., 1999; Ragueneau et al., 1999), an increased BP variability 
(Man cia et al., 1997; Gerhardt et al., 1999), a decreased HF variability of HR 
(Niedermaier et al., 1993), and a decreased BRS (Mancia et al., 1997; Gerhardt et al., 
1999). Measurements taken after smoking cessation probably provide information 
about the long-term effects of smoking on the autonomic cardiac modulation. After 
an overnight of smoking cessation, smokers demonstrated in comparison to non-
smokers a decreased HR variability in the HF domain (Hayano et al., 1990), and an 
increased HR and BP variability in the lower frequency domain (Ragueneau et al., 
1999). In addition, higher total cholesterol and low density lipoprotein (LDL) 
cholesterol levels were suggested to be related to lower overall HR variability (I<:upari 
et al., 1993; Christensen et al., 1999). These relationships need to be further explored, 
especially because subjects with hypercholesterolaemia showed no differences in the 
autonomic neural regulation and BRS in comparison to healthy subjects (Koskinen et 
al., 1995). Furthermore, a decrease was found in HR variability in the HF domain in 
physically inactive subjects (Melgaard et al., 1994), and in subjects with a higher BMI 
(I<ageyama et al., 1997). However, other studies reported the lack of a relationship 
(I<:upari et al., 1993; Fagard et al., 1999). Only one study has focused on the 
relationship between risk factors and BRS (Kardos et al., 2001). The BRS was 
inversely related to smoking and BMI, but no relationship with physical activity was 
observed. 
The objective of this study was to investigate in healthy normotensive 
subjects 1) the effects of age and gender and 2) the effects of several risk factors 
(smoking, lipid levels, BMI and habitual physical activity) on mean HR and BP level, 
HR and BP variability, and BRS. The importance of these factors as determinants of 
interindividual variation was evaluated. We were especially interested in determinants 
of BP variability and BRS, because they have been less frequently addressed than 
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determinants of HR variability. Cardiovascular measurements were performed duriog 
supine rest and head-up tilt to obtain data with a large intraindividual variation. These 
conditions were chosen because orthostatic challenge is characterised by an increase 
in sympathetic activity and a decrease in parasympathetic activity resulting in clear 
alterations in mean HR and SBP, HR and BP variability and BRS (Tulen eta!., 1994; 
Tulen eta!., 1996). The effect of orthostatic challenge was studied in advance of the 
effects of age, gender and risk factors. 
3 Methods 
3.1 Subjects 
Sixty-five healthy normotensive subjects (32 males and 33 females) between 20-59 
years of age (38.4 ± 11.2) participated in the study. Health status was evaluated on 
the basis of medical history information and present state of the physical and mental 
condition. Specific inclusion criteria were: no cardiovascular disease, no metabolic or 
respiratory pathologies, no current medical treatment, and medication-free for at least 
three months prior to the study. Normotensive status was evaluated during supine 
rest and defmed as SBP < 140 mmHg and DBP < 90 mmHg. All participants gave 
written informed consent. The Medical Ethical Committee of the University Hospital 
Rotterdam Dijkzigt approved the study. 
3.2 Protocol 
Cardiovascular recordings were performed between 09.00-12.30 hours. On the 
morning of the cardiovascular recordings, subjects were allowed to have a light 
breakfast, but drinking coffee and smoking were not permitted. Blood sampling took 
place between 08.30-11.00 hours after an overnight fast on the experimental day itself 
or within one week after the experiment. The cardiovascular recording session 
consisted of 5 sequential experimental periods preceded by a stabilisation period of 
15 minutes. This study presents data from the first two experimental periods: supine 
rest (10 min) and orthostatic challenge (10 min). Orthostatic challenge was performed 
by a passive 60° head-up tilting. During the experiment, subjects were requested to 
relax, to move as little as possible, not to speak, to breath regularly and to stay awake. 
3.3 Recording and analysis of cardiovascular data 
Electrocardiogram (ECG), BP and respiration were continuously on-line digitised at a 
sample frequency of 1024Hz by a DI-200 data acquisition card (Dataq Instruments, 
Akron, Ohio, USA) and stored on a personal computer by Windows compatible data 
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Acquisition Software (\VinDaq 1.38, Dataq Instruments) for this acquisition card. 
The ECG was derived from a precordial lead, amplified by a polygraph (Nihon 
Kohden, Tokyo, Japan). BP was recorded with a servoplethysmomanometer for 
continuous noninvasive measurements of finger arterial BP, by use of the "volume 
clamp" technique ofPenaz (1976) (Finapres 2300 NIBP monitor; Ohmeda, 
Englewood, CO, USA). A cuff was fixed around the middle finger of the non-
dominant hand, which was kept at the level of the heart throughout the entire 
experiment to optimise the correspondence with intrabrachial pressure changes 
(Parati et al., 1989). Thoracic and abdominal respiration were measured separately by 
means of impedance plethysmographs (Nihon Kohden). For the recording of 
thoracic and abdominal respiration, adhesive disposable Ag/ AgCl electrodes (Red 
Dot; 3M Health Care, Borken, Germany) were placed on the lateral side of the chest 
at the level of the umbilicus and the nipples. 
Subsequendy, R-R intervals in the ECG were detected with an accuracy of 1 
millisecond and transposed to HR series. SBP and DBP were defined per R-R 
interval of the ECG with an accuracy 0.1 mmHg. For prolonged BP recordings, the 
Finapres device has a built in "lock-adjust" procedure for the automatic adjustment 
of the finger cuff pressure by means of a servosystem, which is activated in parallel 
with blood flow changes. This self-adjusting procedure was used every 2 to 5 minutes 
during the experimental session to prevent slow drifts and therefore unreliable 
recordings. Blood pressure pulses missed due to this procedure (2 to 4 each time) 
were estimated by interpolation between two preceding and two succeeding pulses, 
and addition of a small amount of noise (0.25 x SD) to the interpolated value in order 
to prevent excessive reduction in variability (Mulder, 1988). The experimental periods 
of 10 min were split up in 2 segments of 5 minutes and corrected for technical and 
physiological artefacts in the IBI, SBP, DBP and respiration time series. Isolated 
extra-systolic contractions within a time segment were corrected by a linear 
interpolation procedure. If more than 5% of the total number of IBis and 15% of the 
total number of BP pulses in a time segment needed correction, the period was 
excluded from further analyses. 
The last 5 minute time segment of each experimental condition was further 
analysed by spectral analysis. HR and BP time series of the 5 minute time segments 
were subjected to a discrete Fourier transformation, based on nonequidistant 
sampling of the R-wave incidences (Carspan program) (Mulder et al., 1988; Van 
Steenis et al., 1994), to yield power spectra of the rhythmic oscillations over a 
frequency range of 0.02 to 0.50 Hz, with a resolution of 0.01 Hz. For each 5 minute 
time segment the following cardiovascular parameters were calculated: mean HR, 
mean SBP and mean DBP, variation coefficients of HR, SBP and DBP (CVI, 
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coefficient of variation of IBI; CVS, coefficient of variation of SBP; CVD, coefficient 
of variation ofDBP), power of the MF band (0.07-0.14 Hz) ofHR and SBP, and 
power of the HF band (0.15-0.50 Hz) of HR. The MF band in this study is similar to 
the low frequency domain of 0.04 -0.15 Hz as defined by the Task Force guideline 
(1996). 
Spectral power for each selected frequency band was expressed in relative 
terms, that is as a fraction of the mean value of the considered signal (squared 
modulation index) (Van Dellen et al., 1985). If this measure is computed for the 
whole spectrum (0.01-0.50 Hz) it is directly comparable to the squared variation 
coefficient. The spectral power data were transformed to natural logarithmic values 
to obtain a normal distribution of data. Finally, per time segment the gain (or 
modulus) in the MF band between SBP and IBI time series was computed as an 
index ofBRS (Saul et al., 1991; Parati et al., 2000), based on frequency points with a 
coherence~ 0.35 (Saul et al., 1991; Parati et al., 2000; Robbe et al., 1987). 
In addition, per time segment samples of the respiratory signals were 
obtained at each incidence of the R-wave. Respiratory time series, mostly of the 
abdominal respiration signa~ were subjected to spectral analysis in the same way as 
the HR and BP time series. The power spectra of the respiratory time series were 
evaluated primarily to assess whether interindividual variation in cardiovascular 
variability was related in some way to variation in the respiratory frequency. Per time 
segment the dominant respiratory frequency in the power spectrum was obtained. 
3. 4 Risk factors 
Smoking, physical activity and body mass index 
Thirty-six participants were non-smokers and 29 were smokers. Smokers were asked 
to estimate their daily use of cigarettes. Ten persons smoked less than 10 cigarettes 
per day, 11 persons smoked between 10 and 20 cigarettes pet day, and 8 persons ~20 
cigarettes per day. In the statistical analysis we compared smokers (code=1) with 
non-smokers (code=O). The Baecke questionnaire (validated Dutch version) (Pols et 
al., 1995) was applied for the assessment of an index of habitual physical activity, 
which was based on activity related to work, sport and leisure time. Anthropometric 
measurements were done to obtain the weight and height for the calculation of the 
BMI (kg/m2). 
Lipid levels 
A blood sample (1 0 ml) was obtained by a venipuncture after an overnight fast. 
Serum total cholesterol concentration was determined enzymatically by the 
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Boehringer Mannheim method. The serum high density lipoprotein (HDL) 
cholesterol concentration was also detennined enzymatically by a colorimetric test 
follov.ring the same protocol as the determination of total cholesterol concentration. 
Before performing the colorimetric test, HDL cholesterol was separated by 
precipitating apoprotein B-containing lipoproteins from serum. Serum low density 
lipoprotein (LDL) cholesterol was precipitated by adding polyvinyl sulphate and 
subsequently the LDL cholesterol concentration was calculated from the difference 
between total cholesterol concentration and the cholesterol concentration in the 
supernatant after centrifugation. Finally, serum triglyceride concentration was 
determined by the enzymatic hydrolysis of triglycerides with subsequent 
determination of the liberated glycerol by colorimetry. The assay of plasma lipid and 
lipoproteins took place at the Clinical Chemical Laboratory of the University Hospital 
Rotterdam Dijkzigt. 
3.5 Statistical analysis 
Before analysing the effects of orthostatic challenge, age, gender, and risk factors on 
autonomic cardiac functioning, we evaluated whether there was multicollinearity of 
the risk factors. Multicollinearity refers to the situation in which determinants of a 
multiple regression analysis are too strongly intercorrelated, which may result in an 
incorrect estimation of regression coefficients and/ or incorrect corresponding 
standard errors (Gunst and Mason, 1980). Each risk factor was estimated by the 
other risk factors by multiple regression analyses. From the formula ofVIFI, it can be 
derived that multiple regression correlation coefficients are not allowed to exceed the 
value of 0.87 to avoid the risk of multicollinearity. In the case of multiple correlation 
coefficients higher than 0.87 one or more risk factors were left out of further 
statistical analyses. P values < 0.05 were regarded as significant. The analyses were 
performed by the statistical package ofSPSS (release 9.0). The effects of orthostatic 
challenge, age, gender, a..nd risk factors on the cardiovascular parameters and 
respiratory frequency were studied by random regression models (RRMs). In RRMs 
individual effects are estimated instead of effects for the total study population (Bock, 
1983; Gibbons et al., 1993). The random regression approach uses data from 
individuals augmented by information of the total study population to estimate for 
1 Gunst and 11ason (1980) stated that there is a high risk for multicollinearity when variance 
inflation factors (VIF) in multiple regression analyses exeed the value of 4. The formula of 
\liF (1 / (1 - ...jRf) indicates that a value of 4 is accompanied by ..JRf::;:; 0.75 (R is the correlation 
between the observed value of a determinant and the value estimated on the basis of the other 
determinants). Therefore the correlation between observed values and estimated values may 
not exceed the value o£0.87 (..jR[=.Ji05=0.87). 
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each subject the personal trend across time. Because in RRlvfs the intercept and the 
slope due to time are allowed to differ for individuals they are random terms. In this 
study the intercept was used as a random term in order to obtain optimal model fits. 
In comparison to the usually applied MANOVAs, in RRMs data are used efficiently 
resulting in a more adequate estimation of effects. RRlvfs can cope with missing 
values because the estimation of an individual time trend is based on non-missing 
data for a given individual. This implies that missing values are assumed to be missing 
at random (Rubin et al., 1987) and subjects may have data for different time points. 
Furthermore, R.Rlvfs allow more general and realistic error structures than the 
classical ANOV A for repeated measurements. In this study the type of error 
structure was 'unstructured', which implies that correlations between measurements 
may vary and variances of measurements are allowed to differ (Gibbons et al., 1993; 
Verbeke and Molenberghs, 1997). In other words, (co )variances may differ between 
repeated measurements. 
The procedure was as follows: 
Step 1) The main effect of orthostatic challenge was studied. 
Step 2) The RRMs of step 1 were extended by entering simultaneously the main 
effects of age and gender. 
Step 3) The RRMs in step 2 were extended by entering simultaneously the main 
effects of all risk factors. 
The model fit ofRRMs of step 2 were compared with these of step 1, and the model 
fit of RRMs of step 3 with these of step 2. A statistical improvement of the model fit 
implies that the data are significantly better estimated by the determinants. The 
improvement of the model fit was tested with chi square statistics by comparing the-
2 Log Likelihood values of the models, accounting for the difference in degrees of 
freedom. Effects in the RRMs were reported as unstandardised l3's and p values < 
0.05 (two-tailed) were regarded as significant. For the RRMs the program Proc Mixed 
of the statistical package Statistical Analysis Systems (SAS for Windows, release 6.12) 
was applied. 
4 Results 
4.1 Effect of orthostatic challenge (step 1) 
Table 1 shows the cardiovascular parameters and respiratory frequency during supine 
rest and passive head-up tilt. The RMMs for the effect of orthostatic challenge (table 
2) demonstrated a significant increase in mean HR (13 = 16.5, P < 0.001), SBP (13 = 
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3.5, p < 0.01), DBP (13 = 11.6, p < 0.001) (see also figures 2 and 3), CVS (13 = 0.5, p 
< 0.05) and MF power of SBP (13 = 0.9, p < 0.001). Significant decreases were 
observed in the HF power ofHR (13 = -1.1, p < 0.001) and the BRS index (13 = -5.1, 
p < 0.001). The alteration in the HF power of HR was not accompanied by a 
siguificant change in the CVI. There was no significant difference in respiratory 
frequency between supine rest and orthostatic challenge. 
Table 1 Characteristics of cardiovascular parameters and respiratory frequencya 
Supine rest Head-up tilt 
HR (beats/ min) 64.8 ± 7.8 81.3 ± 11.5 
CVI (%) 5.2 ± 2.4 5.1 ± 1.9 
MF log power HR 6.2 ± 1.0 6.3 ± 1.0 
HF log power HR 6.3 ± 1.1 5.3 ± 1.3 
SBP (mmHg) 116.2 ± 14.0 120.1 ± 13.8 
CVS (%) 4.5 ± 1.7 5.0 ± 1.6 
MF log power SBP 5.4 ± 0.8 6.2 ± 0.7 
DBP (mmHg) 60.4 ± 9.1 72.1 ± 8.9 
CVD (%) 4.6 ± 1.6 4.8 ± 1.2 
BRS (ms/mmHg) 11.4 ± 5.3 6.7 ± 3.9 
Resp. Freq. (Hz) 0.23 ± 0.07 0.23 ± 0.08 
"Data represent mean± SD. HR, heart rate; CVI, coefficient of variation of interbeat 
intervals; MF, mid frequency band (0.07-0.14 Hz); HF, high frequency band (0.15-
0.50 Hz); SBP, systolic blood pressure; CVS, coefficient of variation of SBP; DBP, 
diastolic blood pressure; CVD, coefficient of variation of DBP; BRS, baroreflex 
sensitivity; Resp. Freq., respiratory frequency. 
4.2 Effect of age and gender (step 2) 
The RRMs for the effect of orthostatic challenge were extended with the effect of age 
and gender (table 2). Age and gender were entered simultaneously. The effect of 
orthostatic challenge remained the same after adjusting for age and gender effects. 
The model fit of the RRMs for BP variability got worse, indicating that age and 
gender were no proper determinants in the applied models. The model fit of all other 
RRMs improved, although not always significantly. Age and gender turned out to 
have no effect on mean HR and BP level, but older subjects showed in comparison 
to younger subjects a decreased CVI (13 = -0.07, p < 0.001), MF power of HR (13 = 
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-0.03, p < 0.01), and HF power ofHR (J3 = -0.06, p < 0.01). The effect of age on the 
power spectrum is illustrated io figure 1. The BRS iodex was also decreased by age (J3 
= -0.2, p < 0.001). Respiratory frequency turned out to be higher io women than io 
men (J3 = 0.04, p < 0.05). 
Table 2 Random regression analyses of the effect of orthostatic challenge, age and gender on 
cardiovascular parameters and respiratory frequencya 
RRMs step 1 RRMs step 2 Improvement 
effect of effect of Model Fitb 
oc Age Gender (X2, d£=2) 
HR (beats/ min) 16.5*** -0.06 3.3 3.2 
CVI (%) -0.2 -0.07*** -0.2 7.2* 
MF log power HR 0.1 -0.03** -0.4 4.4 
HF log power HR -1.1*** -0.06*** 0.3 16.9*** 
SBP (mmHg) 3.5** 0.10 1.4 2.9 
cvs (%) 0.5* 
MF log power SBP 0.9*** 
DBP(mmHg) 11.6*** 0.1 1.5 2.5 
CVD (%) 0.2 
BRS (ms/mmHg) -5.1 *** -0.2*** 0.06 11.7** 
Resp. Freq. (Hz) 8*104 7*104 0.04* 12.0** 
a Effects presented as unstandarclised Ws. b RRlvls step 1 versus step 2 (only RRMs with an improved 
model fit are presented).*, p <0.05; **, p <0.01; ***, p <0.01. HR, heart rate; CVI, coefficient of 
variation of interbeat intervals; MF, mid frequency band (0.07-0.14 Hz); HF, high frequency band (0.15-
0.50 Hz); SBP, systolic blood pressure; CVS, coefficient of variation of SBP; DBP, diastolic blood 
pressure; CVD, coefficient of variation of DBP; BRS, baroreflex sensitivity; Resp. Freq., respiratory 
frequency. OC, orthostatic challenge. Gender code: men::::O, women::::1. 
4.3. Effect of risk factors (step 3) 
The characteristics of the risk factors of the healthy subjects are given io table 3. We 
observed high multiple correlation coefficients for total, HDL and LDL cholesterol 
levels (r = 0.98, p < 0.001, r = 0.85, p < 0.001 and r = 0.98, p < 0.001 respectively). 
This iodicates that each of these factors could almost be predicted io total by the 
other risk factors. To control for multicollinearity, LDL cholesterol was not used io 
the random regression models. 
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Figure 1 Example of the power spectrum of interbeat intervals (IBI) of a young subject (28 
years) (a) and a older subject (50 years) (b) during supine rest It is apparent that the HR 
variability in the older subject was lower than the HR variability in the younger subject, 
especially the variability of the HF band (0. 15-0.50 Hz). The spectral power was assessed by the 
squared modulation index (Van Dellen et al., 1985). 
The RRMs of step 2 were extended by entering simultaneously the effects of 
smoking, lipid levels, BMI and habitual physical activity (table 4). The inclusion of risk 
factors in the statistical models resulted in a highly significant improvement of 
the model fit for HR, SBP and DBP. There was no substantial alteration of the effect 
of orthostatic challenge, age and gender on the cardiovascular parameters. Total and 
HDL cholesterol levels had a positive effect on mean HR ([3 = 2.6, p <0.05 and f3 
6.4, p < 0.05 respectively), whereas the index for habitual physical activity (Baecke 
questionnaire) affected the mean HR negatively ([3 = -2.6, p < 0.05) (see figure 2). 
Furthermore, both SBP and DBP were increased in subjects with a higher BMI ([3 
1.7, p < 0.01 and f3 = 1.2, p < 0.01 respectively) (figure 3). 
The RRMs for CVI, BRS and respiratory frequency showed a nonsignificant 
improvement of their model fit. In these models the effect of orthostatic challenge, 
age and gender was similar to the effect observed in step 2. There was a significant 
effect of smoking and BMI on CVI; smokers showed a decreased CVI ([3 = -1.1, p < 
0.05) in comparison to non-smokers, and subjects with a higher BMI a decreased 
CVI in comparison to subjects with a lower BMI ([3 = -0.2, p < 0.05). These findings 
were restricted to overall HR variability and were not valid for HR variability in the 
MF and HF band. The model fit of the RRMs for BP variability parameters was 
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deteriorated, indicating that similar to age and gender the risk factors were no proper 
determinants of interindividual variation. 
Table 3 Characteristics of the risk factors 
Mean±SD Range 
Smoking (cigarettes per day) 5.8 ± 8.8 0-40 
Total cholesterol (mmol/1) 5.2 ± 1.1 3.5-8.3 
HDL cholesterol (mmol/1) 1.4 ± 0.4 0.4-2.5 
LDL cholesterol (mmol/1) 3.4 ± 1.0 1.6-6.4 
Triglyceride (mmol/1) 1.2 ± 0.6 0.4-3.1 
BMI (kg/m2) 23.9 ± 3.3 17.5-313 
Baecke score 8.1 ± 1.0 6.0-11.2 
LDL, low density lipoprotein cholesterol; I-IDL, high density lipoprotein cholesterol; 
BMI, body mass index; Baecke score, index habitual physical activity. 
5 Discussion 
This study showed that all HR variability parameters and the BRS index were 
decreased by age, but not affected by gender. In contrast, age and gender were no 
proper determinants ofBP variability. A positive relationship was observed between 
mean HR, and total and HDL cholesterol, and a negative relationship between mean 
HR and habitual physical activity. In addition, BMI had a positive effect on mean 
SBP and DBP. The risk factors were no relevant determinants of interindividual 
variation in cardiovascular variability parameters or BRS. However, a lower CVI was 
found in smokers and subjects with a higher BMI. 
The observed effect of orthostatic challenge on autonomic cardiac 
functioning is in line with earlier findings (fulen eta!., 1994; Tulen eta!., 1996a). In 
healthy subjects the MF power of the SBP was increased during orthostatic challenge 
due to the augmentation of sympathetic activity, and the HF power of the HR was 
decreased due to diminished vagal activity. The lack of an alteration in MF power of 
the HR in this study supports the suggestion that HR variability in this frequency 
band represents both sympathetic and vagal activity. 
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Figure 2 Estimated effects of total cholesterol (a), HDL cholesterol (b), and physical 
activity (c) on mean HR levels. ____ , supine rest; ___ , head~up tilt; HR., heart 
rate; HDL, high density lipoprotein. The HR was estimated by the following regression 
equation: estimated HR = 59.6 + (16.5*condition) + (2.6*total cholesterol) + 
(6.4*HDL cholesterol)- (2.6*Beacke index). Regression lines were calculated per 
experimental condition (supine rest=O, orthostatic challenge=l). Per risk factor the 
regression lines were calculated by filling in the minimum and maximum value of that 
specific risk factor and the mean values of the other two risk factors in the equation. 
Prior research also showed that HR variability in both frequency domains 
decreases by age (Lipsitz et al., 1990; Ryan et al., 1994; Laitinen et al., 1998; Kardos et 
al., 2001 ), probably due to changes in autonomic functioning and/ or to reduced 
compliance of the arterial walls resulting in less sensitivity of the baroreceptors. It 
was surprising that the addition of age and gender effects to the RRMs for BP 
variability parameters resulted in deteriorated model fits revealing that age and gender 
were not proper determinants of BP variability, at least not in the linear models we 
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Figure 3. Estimated effects ofBl\1.1 on mean SBP level (a), and mean DBP level (b). 
____ , supine rest; ___ , head-up tilt; B:rvll, body mass index; SBP, systolic 
blood pressure; DBP, diastolic blood pressure. The SBP and DBP were estimated by 
the following regression equations: estimated SBP= 96.8 + (3.5*test) + (1.7*Bl\1.1) and 
estimated DBP = 43.3 + (11.6*test) + (1.2*BMI). Regression lines were calculated per 
experimental condition (supine rest= 0, orthostatic challenge= 1) and by filling in the 
minimum and maximum Bivfi value. 
applied. We could not confirm the finding that females would demonstrate a lower BRS 
than males (Laitinen et al., 1998; Kardos et al., 2001). 
The inclusion of risk factors in the RMMs for the effect of orthostatic 
challenge, age and gender resulted in a highly significantly improved model fit for 
HR, SBP and DBP, and clear effects of one or more risk factors. Both smoking and 
BMI had a significant negative effect on CVI, but the risk factors did not contribute 
to interindividual variation in BP variability or BRS. Similar to our findings, Gerhardt 
et al. (1999) found unchanged mean HR, SBP and DBP values in heavy smokers after 
an overnight deprivation of smoking. We could not conf1m1 the decreased HR 
variability in the HF band reported by Hayano et al. (1990). The effect of smoking 
was controlled in the RRMs for the effect of age, gender and the other risk factors, 
but a minor point of this study was the limited number of heavy smokers. However, 
community studies (Kageyarna et al., 1997; Fagard et al., 1999) also reported small or 
no differences in autonomic control mechanisms betw'een smokers and non-smokers. 
Fagard et al. (1999) found in men, but not in women, that HR was inversely 
related to leisure-time physical activity, and HF power of HR positively to 
occupational activity. We also observed that higher level of habitual physical activity 
resulted in a decrement of the mean HR, but we could not detect an effect on HR or 
SBP variability. Physical training has been postulated to increase cardiac vagal 
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modulation and reduce HR levels, which may also result to a certain extent from 
decreased cardiac sympathetic activity. Thus, the influence of habitual physical 
activity on HR level may originate from a combination of sympathetic and 
parasympathetic, but this was not supported by our fmdings of HR variability in the 
MF and HF band. 
Both total and HDL cholesterol had a positive effect on mean HR values. 
Previous studies in healthy subjects have reported positive relationships between total 
cholesterol and LDL cholesterol, and HR (ICupari et al., 1993; Christensen et al., 
1999), but no or an inverse relationship between HDL cholesterol and HR was 
expected because HDL cholesterol is the 'healthy' cholesterol and protects against 
coronary heart disease. The positive relationship between triglyceride and HR 
reported by Christensen et al. (1999) was not confirmed by our findings. In addition, 
previous studies suggested that total and LDL cholesterol were related to a 
suppression of overall HR variability (Kupari et al., 1993; Christensen et al., 1999), 
but none of the lipid levels in this study turned out to be an important determinant of 
cardiovascular variability or BRS, On the other hand, the absence of an effect of lipid 
levels on BRS was in line with the study of Koskinen et al. (1995) in which the BRS 
of subjects with hypercholesterolaemia was compared with that of healthy subjects. 
Finally, BMI was found to be related to higher mean SBP and DBP levels, 
and a decreased CVI. The relationship between obesity and BP frequently has been 
documented, but no biological model for this relationship has been established 
(Kaufman et al., 1997). A higher BMI was also related to a decreased overall HR 
variability, but there was no effect of BMI on the HF power of HR. The latter result 
was in contrast to the study of Kageyama et al. (1997), but in line ,vith other 
community studies (I<:upari et al., 1993; Fagard et al., 1999). 
It is striking that so many equivocal findings have been reported about 
whether and which risk factors are responsible for interindividual differences in 
cardiovascular variability and BRS. An explanation could be the differences in 
methodology between studies and the use of less adequate statistical analysis 
techniques. We optimised our statistical analysis by applying random regression 
models instead of classical MAN OV As, controlling the effect of each risk factor for 
the effect of age, gender and the other risk factors, taking into account the risk of 
multicollinearity, and testing the improvement of model fits. This was all done to 
obtain a valid estimation of regression coefficients and to estimate properly the 
corresponding standard errors. 
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6 Conclusions 
In healthy normotensive subjects interindividual variation in HR variability and BRS 
decreased by age, but gender did not influence HR variability or BRS. Both age and 
gender were not proper determinants of BP variability. Mean HR levels were 
positively related to total and HDL cholesterol, and negatively to levels of physical 
activity. Mean BP levels were positively related to BMI. Furthermore, overall HR 
variability was decreased in smokers and subjects with a higher BMI, but risk factors 
had no significant effect on BRS. The interindividual variation in BP variability could 
not properly been determined by the risk factors. The fact that HR and BP levels 
were differentially affected by one or more risk factors reveals that risk factors do 
play a complex role in die modulation of the cardiovascular system. 
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1 Abstract 
The daily pattern of motor activity and the autonomic cardiovascular regulation were 
studied in major depression to quantify changes in psychomotor function and 
autonomic cardiac functioning. Additionally, relationships between motor activity 
parameters, cardiovascular measures and specific clinical features were examined. 
Wrist-actigraphy was used to monitor 24-hour motor activity for 67 unmedicated 
(unipolar) depressed inpatients and 64 control subjects. During supine rest, spectral 
analysis was applied to assess HR and SBP variability, a baroreflex sensitivity (BRS) 
index and the respiratory frequency, in addition to mean heart rate (HR) and blood 
pressure (BP) levels for the patient group and a second control group (N=51). The 
patients showed a lower motor activity level and a reduced fragmentation of motor 
activity during wake, and a higher motor activity level and a decreased immobility 
during sleep. The mean HR and DBP level and the respiratory frequency were higher 
in the patient group than in the control group, but no differences in HR and SBP 
variability or BRS were found. Furthermore, motor activity parameters and 
cardiovascular measures of the patients were related to agitation and retardation and 
overall, patients with lower motor activity levels demonstrated lower SBP levels. This 
study conftrms that the 24-hour pattern of motor activity is altered in unmedicated 
depressed inpatients, but limited evidence was found for an autonomic cardiac 
dysfunction. Within the patient group there were relationships between motor 
activity parameters, cardiovascular measures, and clinical features, but the underlying 
neurobiological pathways need to be further explored. 
2 Introduction 
Neurobiological processes in depressed patients are evaluated to obtain insight in the 
etiology of depression, to fmd biological predictors for successful treatment outcome 
and to examine (side) effects of treatments. Dysfunctions of these neurobiological 
processes are, amongst others, reflected in changes in psychomotor function and 
autonomic cardiac functioning Qoyce and Paykel, 1989). Parker (2000) classified 
depressive disorders on the basis of three clinical features: mood state features (e.g. 
anxiety), observable psychomotor disturbance, and psychotic disturbance. These 
clinical features were hypothesised to be generated by different neurobiological 
processes, which may explain treatment specificity of clinical subtypes of depressed 
patients. Parker's model implies that psychomotor function and autonomic cardiac 
functioning are probably related to the presence of specific clinical features. In 
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addition, Thayer et al. (1998) speculated that disturbances in both functions are also 
related with one another. 
One part of the psychomotor dysfunction is retardation that has been 
recognised as the central feature of depression (Wid1ocher, 1983). In retarded 
patients, motor and psychic activities are slowed down. Alterations in motor activity 
are, for instance, slowed speech, fixed facial expression, less spontaneous movements 
of the limbs and trunk, an impaired gait and stride. Reduced fluency of speech, loss 
of interest, and impaired memory and concentration are examples of changes in 
psychic activity. Disturbances in cholinergic mechanisms may play a role in 
retardation, because cholinergic stimulation results in the reduction of explorative 
behavior and the inhibitory behavioral effects of this stimulation are exaggerated in 
depressed patients Oanowsky et al., 1994). Also dopaminergic dysfunctions are 
assumed to be responsible for the psychomotor dysfunction (Sobin and Sackeim, 
1997), although this is not contradictory because these neurotransmitter systems are 
known to interact with motor functions Oanowsky et al., 1994). It is still debated 
whether agitation is also a symptom of the psychomotor dysfunction or mainly the 
result of anxiety (Dantchev and Wid1ocher, 1998). 
Prior research in which overt motor behavior was quantified by means of 
wrist-actigraphy (a method to monitor diurnal patterns of motor activity) 
demonstrated that depressive disorder may be related to decreased daytime motor 
activity levels and to alterations in the distribution of motor activity (Teicher, 1995). 
In depressed patients, motor activity levels were found to be positively associated 
with anxiety and hyperactivity rating scores (I<:upfer et al., 1974;Joffe et al., 1987), 
and negatively with clinical ratings of retardation Ooffe eta!., 1987; Royant-Parola et 
al., 1986; Raoux et al., 1994). Schatzberg and Rothschild (1992) concluded on the 
basis of several biological studies that the dopaminergic system is more active in 
psychotic depression than in non psychotic depression. Surprisingly, the relationship 
between psychotic features (delusions and hallucinations) and for instance motor 
activity levels has not been explored. 
Autonomic dysfunctions in depressive disorder, particularly the reduction of 
parasympathetic (vagal) activity, result in sleep disturbances, altered appetite, dry 
mouth, constipation and cardiac complaints. Cardiovascular variability has been 
studied to obtain more insight in the origin of cardiac complaints in depressed 
patients (e.g., Akselrod et al., 1981; Malliani eta!., 1991; Tulen et al., 1994, 1996a). 
The sympathetic nervous system regulates the cardiovascular system through the 
baroreflex control of peripheral vascular resistance, inducing spontaneous BP 
variations with a frequency of about 0.10 Hz (Mayer waves) and compensatory 
variations in the (HR) with the same frequency. Variations in the HR signal with 
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higher frequencies follow the variations in respiration (respiratory sinusarrythmia), 
and result from centrally mediated cardiac vagal (parasympathetic) activity. During 
the last years interest has grown in HR variability in depressive disorder, because 
clinical studies demonstrated that depressed patients had decreased HR variability, 
probably due to a reduced parasympathetic activity (Dalack and Roose, 1990; Rechlin 
et al., 1994b; Lehofer et al., 1997). The latter may explain the increased risk of 
cardiovascular disease observed in this patient group (Glassman, 1998). 
Within depressed patients, elevated HR levels may accompany agitation or 
com or bid anxiety (Stein et al., 1994). In addition, more anxiety was associated with 
lower HR variability (Rechlin et al., 1994b; Dalack and Roose, 1990; Tulen et al., 
1996a) and reduced baroreflex control (Watkins et al., 1999). Parker et al. (1995) 
hypothesised that psychotic patients in comparison to nonpsychotic patients were 
more likely to demonstrate disturbances in vegetative functions. Therefore, it seems 
plausible that cardiovascular control mechanisms are in some way related to 
psychotic features. In depressed patients the relationship between psychomotor 
function and autonomic cardiac functioning has not been studied. If there is a 
relationship between disturbances in psychomotor function and the autonomic 
modulation of the cardiovascular system, this would provide evidence for common 
neurobiological mechanisms, for instance cholinergic mechanisms, since they play a 
role in both dysfunctions. 
In unmedicated depressed patients, the number of detailed studies to 
disturbances in motor activity and cardiovascular control mechanisms is limited, and 
only small sample sizes have been examined. In this study, a large number of 
unmedicated, severely depressed (unipolar) inpatients were compared with healthy 
controls, regarding their pattern of motor activity and autonomic cardiac functioning. 
We used wrist-actigraphy to obtain patterns of motor activity. Information about 
autonomic cardiac functioning was derived from HR, BP and respiratory recordings 
during supine rest. Spectral analysis was applied to analyse HR and BP variability and 
to assess BRS. We also examined whether interindividual variations in the patient 
group were associated with different clinical features (anxiety, agitation, retardation, 
psychotic features) and explored the relationship between the motor activity 
parameters and cardiovascular measures in depressed patients. 
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3 Methods 
3.1 Subjects 
Sixty-seven patients between 32 and 65 years of age, who met the DSM-IV criteria 
(APA, 1994) for a major depressive disorder (subtype unipolar) participated in the 
study. The diagoosis was based on the depression items of the Schedule for Affective 
Disorders and Schizophrenia (SADS) (Endicott and Spitzer, 1978). Patients were 
admitted to the Depression Unit of the Department of Psychiatry of the University 
Hospital Rotterdam - Dijkzigt and were measured after a psychotropic drug free 
period of at least seven days. On the day of the cardiovascular measurement the 
patients were on average 12 days medication free. Included were patients Vlith an 
initial score of at least 13 on the 17 item Hamilton Rating Scale of Depression 
(HRSD) (Hamilton, 1967). The patient group had a mean HRSD score of 27.2 (SD = 
4.6) 
This article reports motor activity data of in total 58 patients (18 males, 40 
females; mean age = 52.1, SD = 8.9) and cardiovascular data of in total 54 patients 
(19 males, 35 females; mean age= 52.1, SD = 8.5). Motor activity data of9 patients 
were unsuitable for data analysis because of treatment with a dopaminergicum (1 
patient), technical failure (2 patients), shortened measurement period (4 patients) and 
an incomplete daily sleep-wake log (2 patients). Cardiovascular data of 13 patients 
were not included in the data analysis, because of cardiovascular diseases and/ or 
diabetes mellitus (12 patients) and too many artefacts (1 patient). 
Motor activity data of the patients were compared with data of 64 healthy 
subjects (33 males, 31 females; mean age= 48.5, SD = 9.9) (control group 1). The 
control subjects were recruited by means of advertisements. Health status of the 
control subjects was determined on the basis of medical history information, and 
present state of the physical and mental condition (based on an intake interview and a 
questionnaire). Specific exclusion criteria were: a personal history of mental illness, 
sleep disorders, current medical illness, diseases and drugs interfering with the activity 
pattern, and recent circadian shift and working during evening hours and night-time. 
Cardiovascular data of the patients were compared with data from another healthy 
group (25 males, 26 females; mean age= 45.7, SD = 8.0) (control group 2). The 
subjects were recruited and screened in the same way as control group 1. The 
assessment of health status was also similar as in control group 1. Specific exclusion 
criteria for this group were: no personal history of mental illness, no current medical 
illness, and no medication use during the three months prior to the measurements. 
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All participants gave written informed consent after the study protocol was 
fully explained. The Medical Ethical Committee of the University Hospital 
Rotterdam-Dijkzigt approved the study. 
3.2 Measures 
Clinical subgroups 
The patient group was divided in eight overlapping subgroups in the following way: 
1) patients with high and low anxiety, 2) agitated and nonagitated patients, 3) retarded 
and nonretarded patients, and 4) patients with and without psychotic features. The 
research diagnostic criteria (RDC) (Spitzer et al., 1978) as measured by the Schedule 
for Affective Disorders and Schizophrenia (SADS) (Endicott and Spitzer, 1978) were 
used to subdivide the patients, with the exception of the division in high and low 
anxiety patients. We calculated for each patient a total anxiety score that was based 
on SADS items (in total13) that refer to anxiety, agitation and sleep complaints. 
Patients \'!il:ith a score above the median were classified as high anxiety patients, and 
patients \'!il:ith a score below the median as low anxiety patients. 
Motor activity moniton.ng 
Wrist-actigraphy has been demonstrated to measure motor activity in a valid and 
reliable way (Patterson et al., 1993; Tryon, 1991; Middelkoop et al., 1997). Subjects 
wore an actigraph on their non-dominant wrist for three consecutive weekdays and 
nights, except during bathing. Patients were instructed to maintain their normal 
activity pattern on the ward, and controls their normal pattern at home and outside. 
The actigraph (Gaehwiler Electronic) contained a monoaxial piezoelectric 
acceleration sensor and counted the number of supra threshold movements of the 
wrist(> 0.1 g acceleration) for every 30-sec epoch. Subjects also recorded in a daily 
log the instances of actigraphy removal, the estimated time of sleep onset and 
estimated time of final awakening in the morning. The following motor activity 
parameters were obtained and averaged for the three recording days: 1) motor activity 
level (average number of counts per epoch, as percentage of the maximum number 
of counts possible) during wake and sleep, 2) fragmentation index of motor activity 
(number of groups of consecutive zero count epochs divided by the total number of 
zero count epochs) during wake and sleep, and 3) immobility index (proportion of 
zero count epochs, relative to the total number of epochs) during sleep. The 
fragmentation index expresses the extent to which rest periods are interrupted by 
activity, whereas the immobility index expresses the relative amount of rest. 
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Cardiovascular and respiratory measurements 
On the morning of the cardiovascular measurements, subjects were not allowed to 
drink coffee or smoke. After a stabilisation period of 15 minutes, the 
electrocardiogram (ECG) (precordial lead), BP (noninvasive, Finapres), and the 
respiration (impedance plethysmographs) were measured continuously during 10 
minute supine rest. ECG, BP and respiration were on-line digitised at a sample 
frequency of 1024 Hz and processed according to procedures described by Tulen et 
al. (1996a, 1996b). The last five minutes of the 10 minutes of supine rest were used 
for further analysis, with the restriction that no more than 5% of the total number of 
heartbeats and 15% of the total number of BP pulses needed correction. 
Spectral analysis was applied (Carspan program) to yield power spectra of the 
rhythmic oscillations over a frequency range of 0.02 to 0.50 Hz (Mulder et al., 1988b; 
Van Steenis et al., 1994). In addition to mean HR, SBP and DBP, the power of the 
MF band (0.07-0.14 Hz) ofHR and SBP, and the power of the HF band (0.15-0.50 
Hz) of HR were calculated. Spectral power for each selected frequency band was 
expressed in relative terms (squared modulation index) (Mulder et al., 1988). A 
natural logarithmic transformation was performed to the spectral power data to 
obtain normal distributed data. As an index ofBRS, the gain (or modulus) between 
SBP and interbeat interval (IBI) time series in the MF frequency range was calculated 
(Robbe et al., 1987; Parati et al., 2000). 
Per time segment also the dominant respiratory frequency in the power 
spectrum was determined. To ensure that in this study HR and SBP variability in the 
MF band were not influenced by respiratory linked variations, the HR and SBP 
variability measures and the BRS index of subjects with a dominant respiratory 
frequency< 0.15 Hz were not included in the statistical analysis. In total, 2 patients 
and 8 controls had a respiratory frequency < 0.15 Hz. 
3.3 Statistical analysis 
Multivariate linear regression analyses were applied to compare motor activity data 
and cardiovascular data between patients and controls. The effect of study group was 
evaluated, while controlling for the effects of age and gender. Within the patient 
group the effects of the clinical features on motor activity and cardiovascular data 
were studied simultaneously by multivariate linear regression models, while adjusting 
for age and gender. Subsequently, these regression models were extended in one step 
with the effects of the motor activity parameters, in order to study the relationship 
between motor activity data and cardiovascular data. To prevent multicollinearity (the 
situation in which determinants of a multiple regression analysis are too strongly 
intercorrelated), immobility was left out as determinant in the models (Gunst and 
Motor activity and autonomic cardiac functioning 
-73-
Mason, 1980). Effects in the regression analyses were reported as unstandardised l3's 
and P values of :0:0.10 (two-tailed) were regarded as significant. The statistical 
analyses were performed with SPSS for Windows (release 9.0). 
4 Results 
Unmedicated Depressed Patients versus Healthy Controls 
Depressed patients were less active during the day, but more active during the night 
than the controls (table 1). During wake the patient group also had a lower 
fragmentation index, and during sleep a lower immobility index than the control 
group. During supine rest, depression resulted in higher mean HR and DBP levels, 
and a higher respiratory frequency, but no alterations were observed for HR and SBP 
variability in the MF band, for HR variability in the HF band, or for the BRS index 
(table 2). 
Table 1 Motor activity in depressed patients and controls 
Patient Control Effect of 
group group 1 depression a 
N Mean SD N Mean SD B df p 
1v1otor activity level 
during wake 58 6.9 3.4 64 11.6 5.4 -4.8 3 <0.001 
Fragmentation of activity 
during wake 58 0.4 0.2 64 0.5 0.1 -0.06 3 <0.01 
Motor activity level 
during sleep 57 0.8 0.6 64 0.5 0.3 0.3 3 <0.001 
Fragmentation of activity 
during sleep 57 0.05 0.02 64 0.05 0.03 0.005 3 n.s. 
Immobility 
during sleep 57 0.91 0.06 64 0.93 0.03 -0.03 3 <0.01 
a Multivariate linear regression analysis to test the effect of study group (patient group-1, control 
group=O), while controlling for the effects of age and gender (see section 3.2 for explanation of 
parameters). 
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Division in clinical subgroups 
From the 58 patients included in the analysis of the motor activity data, 22 patients 
showed high anxiety, 14 patients agitation, 37 patients retardation and 14 patients 
psychotic features. In addition, from the 54 patients included in the cardiovascular 
data analysis, 20 patients demonstrated high anxiety, 12 patients agitation, 32 patients 
retardation, and 16 patients psychotic features. 
Table 2 Cardiovascular parameters in depressed patients and controls 
Patient Control Effect of 
group group 2 depression a 
N Mean SD N Mean SD B df p 
Heart rate (beats/ min) 54 76.8 12.0 51 65.5 7.9 11.8 3 <0.001 
Log power MF band HR 47 5.7 1.1 43 6.0 0.9 -0.02 3 n.s. 
Log Power HF band HR 47 5.6 1.4 43 6.0 1.0 -0.2 3 n.s. 
Systolic blood pressure 
(nunHg) 53 131.9 21.8 51 123.2 19.9 5.3 3 n.s. 
Log power MF baud SBP 46 5.5 0.9 43 5.4 0.8 0.1 3 n.s. 
Diastolic blood pressure 
(nunHg) 53 70.9 10.8 51 64.9 13.2 4.3 3 :>0.09 
BRS index (ms/mmHg) 45 7.4 4.8 42 9.7 4.5 -0.9 3 n.s. 
Respiratory frequency (Hz) 53 0.26 O.Q7 51 0.23 0.07 0.03 3 <0.05 
>\Multivariate linear regression analysis to test the effect of study group (patient group=1, control 
group=O), while controlling for the effects of age and gender (see section 3.2 for explanation of 
parameters). 
Dijferences in Relation to Clinical Features 
Agitation had a significantly positive effect on the motor activity level during wake 
(table 3a), in contrast to retardation, which had a significantly negative effect on 
motor activity level both during wake and sleep (table 3b). Thus, agitated patients 
showed increased motor activity levels only during wake, while retarded patients 
demonstrated decreased motor activity levels throughout the whole day. 
Furthermore, retarded patients showed less fragmentation of motor activity during 
wake. The presence of high anxiety and psychotic features did not contribute 
significantly to variations in the motor activity pattern between patients. 
Table 3a Differences in motor activity between depressed patients related to clinical features" 
An.'X"ious Agitated 
high low yes no 
(N=22) (N=36) (N=14) (N=44) 
Mean SD Mean SD Mean SD Mean SD 
Motor activity level during wake 7.7 3.7 6.4 3.1 8.4 b 3.5 6.4 3.2 
Fragmentation of activity during wake 0.41 0.10 0.37 0.14 0.40 0.09 0.38 0.14 
Motor activity level during sleep 0.93 0.57 0.65 0.62 0.95 0.59 0.69 0.62 
Fragmentation of activity during sleep 0.06 0.03 0.05 0.03 0.05 0.03 0.05 0.03 
Immobility during sleep 0.89 0.08 0.92 0.05 0.89 0.08 0.91 0.06 
• The effects of the clinical features (prescnce=l, absencc=O) were tested simultanously by multivariate linear ret,'1:ession analyse~, while controlling 
for the effects of age and gender (sec section 3.2 for explanation of parameters). 
b Significant main effect of agitaton (13=3.5, df""6, p<O.OS). 
Table 3b Differences in motor actiYity between depressed patients related to clinical feature~" 
Retarded Psychotic Features 
yes no yes no 
(N=37) (N=21) (N=14) (N=44) 
Mean SD Mean SD Mean SD Mean SD 
Motor activity level during wake 5.6 b 2.3 8.8 35 6.3 2.3 6.9 3.4 
Fragmentation of activity during wake 0.35' 0.12 0.45 0.11 0.36 0.11 0.39 0.13 
Motor activity level during sleep O.S9d 0.42 1.05 0.80 0.63 0.35 0.79 0.67 
Fragmentation of activity during sleep 0.05 0.03 0.06 O.D3 0.05 0.04 0.05 0.03 
Immobility during sleep 0.92 0.06 0.89 0.06 0.92 0.06 0.91 0.06 
• The effects of the clinical features (presence= 1, absenCe""O) were tested simultanously by multivariate linear regression analyses, \vhilc contwlling 
for the effects of age and gender (see section 3.2 for explanation of parameters). 
bSignificant main effect of retardation (~=-4.0, df=6, p<0.001). 
'Significant main effect of retardation (13=-0.10, df=6, p<0.01). 
d Significant main effect of retardation (13=-0.44, df=6, p<O.OS). 
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Regarding autonomic cardiac functioning during supine rest, agitation had a 
significandy positive effect on mean HR and SBP level (table 4a), whereas retardation 
had a significandy negative effect on both mean SBP and DBP level (table 4b). These 
findings indicate that agitated patients had higher HR and SBP levels than 
nonagitated patients, and retarded patients had lower SBP and DBP levels than 
nonretarded patients. No differences were found for any cardiovascular measure or 
for respiratory frequency between patients with high and low anxiety and patients 
with and without psychotic features. The effects of agitation and retardation were 
controlled for the presence of the other clinical features and for age and gender. 
Relationship Motor Activity Measures and Cardiovascular Parameters in Patients 
In the patient group, variation in the mean SBP level was significandy explained by 
the motor activity level during wake ([3=2.5, df=10, p:>0.08), revealing that higher 
SBP levels during supine rest were observed in patients who were more active during 
the wake period. 
5 Discussion 
This study reports differences in motor activity levels, and fragmentation and 
immobility indices during the wake and sleep period between unmedicated, severely 
depressed inpatients and healthy control subjects. The patient group also showed 
higher mean HR and DBP levels, and a higher respiratory frequency in comparison 
to the control group. However, no significant differences were observed in HR and 
SBP variability and the BRS index. In the patient group, the clinical features agitation 
and retardation were related to motor activity and autonomic cardiac functioning. 
The alterations in mean HR and BP levels in agitated and retarded patients were not 
accompanied by differences in HR and SBP variability, or in the BRS index. None of 
the cardiovascular measures were related to the presence of high anxiety or psychotic 
features. Finally, less active patients were found to have lower SBP levels during 
supine rest. 
Although previous studies have examined motor activity patterns in 
unmedicated depressed patients (Wehr et al., 1980; Wolff eta!., 1985; Van Londen et 
a!., 1998), this is the first study in a large sample of unipolar depressed patients 
(n=58). In contrast, Wehr et al. (1980) studied 10 bipolar depressed patients, Wolff et 
a!. (1985) a mixed group of 25 bipolar and 5 unipolar depressed patients, and Van 
Londen et al. (1998) 9 bipolar, 2 psychotic, and 37 unipolar depressed patients. In 
congruence '\V.i.th our flndings, in these studies decreased motor activity levels and 
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reduced fragmentation of motor activity during daytime were observed. Van Londen 
et al. (1998) also found that depressed patients showed higher motor activity levels 
during the sleep period than the control group. A potential confounding factor in this 
stndy was the difference in stndy environment (hospital setting versus home 
environment) and as a consequence the difference in type of daily activities. Based on 
the fact that Van Lon den et al. (1998) found nearly the same results in a patient 
group comprising mainly outpatients, we assumed that stndy environment played a 
minor role. 
Retardation had the largest influence on the motor activity pattern in our 
unmedicated patient group. Ten of the 37 retarded patients of whom motor activity 
data were collected were also classified as agitated, but despite the common 
occurrence in a number of patients retardation and agitation had clear effects 
independent of one another. This stndy confirms the lack of a relationship between 
the motor activity pattern and anxiety in unmedicated depressed patients observed in 
previous stndies (l<:upfer et al., 1974; Raoux et al., 1994). No relationship was also 
observed with the presence of psychotic featnres. Twelve (86%) of the 14 patients 
with psychotic features were retarded (57%) or retarded and agitated at the same time 
(29%), whereas 29 (66%) of the 44 patients without psychotic features showed 
retardation (43%), agitation (9%) or a combination of these featnres (14%). Parker et 
al. (1999) reported that agitation, but not retardation was more likely to be present in 
psychotic depression than in nonpsychotic depression, but that psychomotor 
disturbances were more severe in psychotic than nonpsychotic depression. Possibly 
retardation and agitation obscured the effects of the psychotic features themselves. 
Rechlin et al. (1994b) observed in 16 unmedicated depressed patients 
increased HR levels and less HR variability in the HF range. In this stndy severe 
depression was accompanied by higher HR levels, but no evidence was found for 
differences in HR variability. Similar fmdings were reported by Lehofer et al. (1997) 
and Moser et al. (1998) in 23, respectively 26 unmedicated depressed patients. 
Lehofer et al. (1997) postnlated that the elevated HR level in depressed patients 
possibly derives from an increased 'autonomous' HR (=the HR present when there is 
no control of the autonomic nervous system at all) instead of a reduced 
parasympathetic activity. Additional support for the lack of distnrbances in 
cardiovascular variability in unmedicated depressed patients was found in the stndies 
ofTulen et al. (1996a) and Yeragani (1991). It should be emphasised that all 
discussed stndies controlled for the effects of age and gender, and examined patients 
after a medication free period of at least 7 days. On average our patients had a higher 
respiratory frequency than the controls, which may have influenced both MF and HF 
variability. Because we controlled for the possible effects of slow breathing on MF 
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variability, it is unlikely that differences in respiratory frequency are responsible for 
the lack of an effect of depressive disorder on HR and SBP variability. Before clear 
statements can be made about whether or not depression is related to alterations in 
HR and SBP variability, the influence of other factors such as duration of depressive 
disorder, history of treatment with antidepressants, and relationships with specific 
clinical features need to be explored. 
Epidemiological studies demonstrated that anxiety may be related to an 
increase in the risk of cardiovascular disease, and clinical studies suggest that anxiety 
disorders are related to reduced HR variability (Gorman and Sloan, 2000). Therefore, 
the presence of anxiety in depressed patients possibly plays a role in the increased 
mortality and morbidity of cardiovascular disease in depression (Watkins et al., 1999). 
Prior research demonstrated that in unmedicated depressed patients anxiety was 
related to lower HR variability in the HF range (fulen et al., 1996b) and an impaired 
baroreflex control of the heart (Watkins et al., 1999). In this study the role of anxiety 
in the higher risk of cardiovascular disease in depression could not be confirmed. 
Although Parker et al. (1995) found vegetative dysfunctions in psychotic depression, 
in this study none of the cardiovascular measures differed between patients with and 
without psychotic features. In contrast, agitated patients showed higher mean HR 
and SBP levels than nonagitated patients, and retarded patients demonstrated lower 
mean SBP and DBP levels than nonretarded patients. The fact that motor activity 
and autonomic cardiac functioning, especially reduced HR variability, may be related 
to one another, has been suggested before (Thayer et al., 1998; Watkins et al., 1999), 
but this is the first study that presents data on this issue. In line with the finding that 
agitation and retardation are related to motor activity levels and mean BP levels, we 
found for the whole depressed group that lower levels of motor activity were 
associated with lower mean SBP levels. At present it is too early to speculate about 
the existence of common neurobiological pathways underlying both functions, since 
both sets of parameters reflect peripheral as well as central neurobiological processes 
in depression. 
6. Summary 
Unmedicated depressed inpatients showed an altered diurnal pattern of motor activity 
and increased mean HR and DBP levels, but no changes in cardiovascular variability 
or BRS. In the patient group motor activity parameters and cardiovascular measures 
were related to the presence of retardation and agitation and overall, patients with 
lower motor activity levels during wake demonstrated lower BP levels during supine 
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rest. Our results may contribute to further understanding of the neurobiological 
processes involved in (subtypes of) depression, and additionally may enlarge our 
knowledge of treatment specificity of these clinical subtypes. 
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1 Abstract 
The psychomotor dysfunction in depression is related to alterations in the diurnal 
pattern of motor activity. After antidepressant treatment the motor activity level may 
he changed due to the improvement of depressive mood or pharmacological actions. 
The purpose of this study was to evaluate in 52 depressed inpatients the effects of 
imipramine (tricyclic antidepressant- TCA) and fluvoxarnine (selective serotonin 
reuptake inhibitor - SSRJ) on the 24-hour motor activity pattern. Motor activity was 
monitored by wrist-actigraphy during a medication free period and after 4 weeks of 
treatment. Clinical improvement was not different after imipramine or fluvoxamine 
treatment: the Hamilton depression score decreased significantly in patients treated 
\Vlth imipramine, as well as in patients treated \Vlth fluvoxamine; the clinical 
retardation score also reduced significantly in both treatment groups. However, after 
treatment patients treated with imipramine showed significantly higher motor activity 
levels during the wake period in comparison to the medication free period, and more 
fragmentation of motor activity during sleep. Treatment with fluvoxamine did not 
result in alterations in the 24-hour pattern of motor activity. The improvement of 
depressive mood and retardation seems to play a minor role in the change of the 
pattern of motor activity after imipramine. 
2 Introduction 
Psychomotor dysfunction is an important clinical feature of major depressive 
disorder, which may be reflected in alterations of the spontaneous 24-hour pattern of 
motor activity (Dantchev and Widlocher, 1998). Unmedicated depressed patients 
showed, in comparison to healthy controls, decreased motor activity levels and less 
fragmentation of motor activity during daytime and, in addition, less immobility 
during nighttime (Wehr et al., 1980; Wolff et al., 1985; Van London et al., 1998; 
Volkers et al., 2000). Only a limited number of studies have evaluated the effects of 
antidepressant treatment on the pattern of motor activity. After a combined 
treatment with TCAs and benzodiazepines, depressed patients demonstrated higher 
daytime motor activity levels (Raoux et al., 1994), and less periods of immobility 
during day- and nighttime (Raoux et al., 1994; Royant-Parola et al., 1986; Benoit et al., 
1985). In general, changes in the motor activity pattern after antidepressant treatment 
have been assumed to be caused by the improvement of depressive mood (Raoux et 
al., 1994; Royant-Parola et al., 1986; Kupfer et al., 1974;Joffe et al., 1987). 
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On the basis of studies in rats we expected that antidepressants may also 
have pharmacological effects on overt motor behavior. J anowsky and colleagues 
Oanowsky and Risch, 1987; Janowsky et al., 1994; Overstreet et al., 1995) have 
investigated the role of cholinergic mechanisms in affective disorders. Depressed 
patients showed exaggerated (behavioral, physiological and sleep) responses to 
cholinergic agents in comparison to control subjects, therefore rats were bred with 
increased cholinergic sensitivity. Important characteristics of these rats were their 
reduced activity and increased immobility during the forced swimming test. 
Overstreet et al. (1995) mentioned that the exaggerated immobility was counteracted 
by the chronic treatment of imipramine, desipramine (fCA). and sertraline (SSRI). 
West and Weiss (1998) found an increase in struggling behavior in rats developed for 
low activity in the forced swimming test after prolonged administration of 
imipramine and desipramine, but not after fluoxetine (SSRI). The studies in rats 
suggested that the TCAs imipramine and desipramine may have a stimulating effect 
on overt motor behavior. The effects of the SSRis sertraline and fluoxetine were 
conflicting. 
In humans, the effects of TCAs and SSRis on psychomotor functioning 
were compared mainly in healthy subjects after a single dose or after dose 
administration of several days, and have focused on the performance on laboratory 
psychomotor tasks (Fairweather et al., 1996; Hawley et al., 1997). TCAs, but not 
SSRis, resulted in an impairment of the psychomotor performance (e.g. slower 
reaction times). There is one clinical study (Stanley et al., 1999) that examined 
differences in spontaneous 24-hour: motor activity between unipolar depressed 
outpatients treated with a TCA or a SSRI. After 10 days, depressed patients treated 
with fluoxetine (SSRI) showed higher motor activity levels than patients treated with 
dothiepin (fCA). This was explained by the sedative side effects ofTCAs. The 
effects of antidepressant treatment on motor activity in depressed patients seems to 
be different from the effects in rats, but the rats received antidepressants for a longer 
period. It is assumed that over time tolerance develops to the sedative effects of 
antidepressants (O'Hanlon and Freeman, 1995). 
In this study, we examined the changes in clinical state and the motor activity 
pattern in 52 severely depressed inpatients after a double blind, randomised treatment 
with either imipramine or fluvoxamine (SSRI). The motor activity pattern was 
monitored by wrist-actigraphy during a psychotropic drug free period and after 4 
weeks of treatment at therapeutic plasma levels of the drugs. Based on the findings in 
rats Oanowsky et al., 1994; Overstreet et al., 1995; West and Weiss, 1998), we 
expected that the motor activity increased after imipramine, but there was not 
enough theoretical ground to have expectations about the effect of fluvoxamine. In 
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addition, the change in clinical state was evaluated in the two treatment groups, in 
order to determine the importance of clinical improvement to changes in the 24-hour 
motor activity pattern. 
3 Experimental procedures 
3.1 Subjects 
Participants were 52 depressed patients (20 males, 32 females; mean age 52.5 ± 8. 7 
years), who were admitted to the Depression Unit of the Department of Psychiatry 
of the University Hospital Rotterdam Dijkzigt and participated in a clinical study to 
the effectiveness of imipramine versus fluvoxam.ine. Inclusion criteria were a major 
depressive disorder (unipolar subtype) according to the DSM~IV criteria, 
accompanied by an initial score of at least > 13 on the 17 ~item Hamilton Rating Scale 
of Depression (HRSD) (Hamilton, 1967). The diagnosis was based on clinical 
observation and the depression items of the Schedule for Affective Disorders and 
Schizophrenia (SADS) (Endicott and Spitzer, 1978). Specific exclusion criteria were: 
1) the presence of a contraindication for imipramine or fluvoxamine, 2) a history of 
an adequate treatment (therapeutic plasma levels) during 4 weeks with amitriptyline, 
desipramine, nortriptyline, imipramine, or clomipramine, or the presence of an acute 
indication for electroconvulsive therapy (ECT), and 3) a response of more than 50% 
on the initial HRSD score to placebo medication. The placebo medication was 
administered to all patients during 4 days before onset of treatment. The study was 
approved by the Medical Ethical Committee of the University Hospital Rotterdam 
Dijkzigt. All patients gave written informed consent before the start of the study after 
the study protocol was fully explained. 
3.2 Design and procedure 
After admission all psychotropic drugs were discontinued In total45 patients used 
antidepressants of which 12 patients (23.1 %) TCAs, 14 patients (26. 9%) SSRis, 3 
patients (5.8%) lithium, 2 patients (3.8%) monoamine oxidase inhibitors (MAO Is), 
and 5 patients (9.6%) other antidepressants. Antipsychotics were taken by 6 patients 
(11.5%) and benzodiazepines by 31 patients (59.6%). After a psychotropic drug free 
period of at least 7 days, the patients were randomly assigned to a double blind 
treatment with either imipramine or fluvoxamine. The dose was adjusted each week 
on the basis of plasma levels in order to obtain optimal doses that corresponded to 
therapeutic plasma levels for imipramine (imipramine+ desipramine) of 200~300 
f.lg/1 and for fluvoxamine of 150~200 f.Lg/1. After four weeks of treatment with 
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optimal doses, the treatment effectiveness was determined by the HRSD and the 
Clinical Global Improvement Scale (CGIS) (Guy, 1976). During the treatment period 
no psychopharmaca were allowed besides the study medication. 
During the psychotropic drug free period and after 4 weeks of treatment at 
adequate plasma levels, the motor activity pattern was monitored by wrist-actigraphy 
during four consecutive weekdays and nights. At the start of the baseline 
measurement the duration of the medication free period was on average 10.8 days. 
The flrst day and night of the recording period were used to acclimatise the patients 
to wearing the actigraph. The patients were instructed to maintain their normal 
activity pattern on the ward and to take off the actigraph only during bathing. 
Furthermore, the instances of actigraph removal, the estimated time of sleep onset 
and estimated time of fmal awakening in the morning were recorded in a daily log. 
Preferably the patients completed the daily log themselves, but if necessary they were 
assisted by the researcher or nursing staff. 
3.3 Clinical ratings 
Besides the HRSD, the validated Dutch version of the Salpetriere Retardation Rating 
Scale (SRRS) (Widlocher, 1983; Weme et al., 1996) was filled in to measure 
psychomotor retardation during the medication free period and after 4 weeks of 
treatment at therapeutic plasma levels. The SRRS comprises 14 items that are related 
to motility (3 items), speech (3 items), objective cognitive activity (2 items), and 
subjective appreciation of cognitive activity (6 items). The score on the HRSD item 
for agitation was used as indicator for agitation. The two senior psychiatrists of the 
ward filled in all clinical scales. 
3.4 Motor activity monitoring 
Wrist-actigraphy is a reliable and valid method to monitor 24--hour motor activity 
patterns (Patterson et al., 1993; Tryon, 1991; Middelkoop et al., 1997a). The actigraph 
(Gaehwiler Electronics) (size 51 x 36.5 x 21 mm) contained a monoaxial piezoelectric 
acceleration sensor and counted the number of suprathreshold movements of the 
wrist (>0.1 g acceleration) for every 30-sec epoch. The analogne sensor signal was 
sampled at a frequency of 8Hz and subsequently illtered by a band-pass fllter of 
0.25-3.0 Hz. The non-dominant hand was chosen as recording site, because it reflects 
movements of the total trunk and less movements involved in specific tasks such as 
writing (l\'!cPartland et al., 1975; Middelkoop et al, 1997a). Because the fttst day and 
night of the recording period were used to acclimatise patients to wearing the 
actigraph, the data of this day were not used for analysis. Three recording days are 
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required to obtain reliable motor activity data, because of interday variations in motor 
activity within subjects (Middelkoop and Sadeh, 1997b). 
A clock-time based analysis was applied to compute, for each day, half-hour 
motor activity counts from 6.00 hrs in the morning until 6.00 hrs the next morning. 
The half-hour motor activity counts were averaged for the recording days. In 
addition, the following global motor activity parameters were assessed and averaged 
for the recording days: 1) motor activity level (average number of counts per epoch, 
as percentage of the maximum number of counts possible (= 253)) during wake and 
sleep, 2) fragmentation index of motor activity (number of groups of consecutive 
zero count epochs divided by the total number of zero count epochs) during wake 
and sleep, and 3) inunobility index (proportion of zero count epochs divided by the 
total number of epochs) during sleep. The wake period was defined as the time 
between final awakening in the morning and sleep onset in the evening minus the 
duration of daytime napping, and the sleep period as the time between sleep onset in 
the evening and final awakening in the morning. 
3.5 Statistical analysis 
General regression analyses were applied for the comparison of clinical scores and 
global motor activity parameters between the two treatment groups during the 
medication free period. We controlled for possible age and gender differences 
between the treatment groups. Random regression models (RRMs) for continuous 
data were applied to study changes in clinical scores and the pattern of motor activity 
after treatment with imipramine and fluvoxamine. Analyses were performed 
separately for the two treatment groups and the treatment effects were controlled for 
the effects of age and gender. RRMs estimate individual effects instead of effects for 
the total study population (Bock, 1983; Gibbons et al., 1993). The random regression 
approach uses data from individuals augmented by information from the total study 
population to estimate for each subject the personal trend across time. In RRMs, the 
intercept and time effects are allowed to differ for individuals, and are therefore 
called random terms. In this study the intercept was a random term. The advantage 
of this analysis technique above the usually applied MANOVAs for repeated 
measurements is an efficiendy use of data, because RR.lvis can cope with missing 
values. The estimation of an individual time trend is based on non-missing data for 
that individual. This implies that missing values are assumed to be missing at random 
(Verbeke and Molenberghs, 1987), and subjects may have data for different time 
points. RRMs allow more general and realistic error structures. In this study we 
assumed an 'unstructured' error structure, which allows both correlations between 
measurements and variances of measurements to differ (Bock, 1983; Verbeke and 
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Molenberghs, 1987). In other words, variances and covariances may differ between 
repeated measurements. 
The effects of the regression analyses were reported as unstandardised f:l's 
and p values < 0.05 (two-tailed) were assumed to be significant. The statistical 
analysis was performed with the program Proc l'vfixed of the statistical package 
Statistical Analysis Systems (SAS for Windows, release 6.12). Our study population 
was a subsample of the total patient group that participated in the drug trial. As the 
trial was still going on at the time of the data analysis, the data were presented as 
mean ± SD and no information was provided that could be related to individual 
subjects. Data were analysed independendy of the psychiatrists involved in the drug 
trial. 
4 Results 
4.1 Clinical improvement 
Twenty-five patients received imipramine and 27 patients fluvoxamine. The mean (± 
SD) dose for imipramine was 220.7 (± 93.4) mg and for fluvoxamine 201.0 (± 86.5) 
mg. In addition, the mean (± SD) plasma level for patients treated with imipramine 
Table 1 Clinical characteristics of patients treated with imipramine or fluvoxaminea 
Hamilton depression scale score 
Untreated 
After treatment 
SRRS score 
Untreated 
After treatment 
Hamilton agitation item score 
Untreated 
After treatment 
1m1pranune 
(n=25) 
27.7±5.1 
15.5 ± 8.0b 
24.7 ± 10.2 
13.6 ± 9.1b 
0.67 ± 0.82 
0.39 ± 0.72 
fluvoxamine 
(n=27) 
27.0 ± 5.4 
19.4 ± 9.7' 
25.6 ± 8.4 
17.4± 11.6b 
0.81 ± 0.92 
0.48 ± 0.85 
~Values given are mean± SD. bp < 0.001, 'P < 0.01, random regression analyses for the comparison 
of clinical scores before and after antidepressant treatment, while controlling for age and gender effects. 
SRRS, Salpetriere Retardation Rating Scale. 
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(imipramine + desipramine) was 275.4 (± 80.0) f.!g/1 and for patients treated with 
fluvoxamine 182.4 (± 41.8) f.!g/1. In total2 patients dropped out the study during 
treatment. As expected in view of the randomised design of the study, none of the 
clinical scores during the medication free period was significantly different between 
the treatment groups. After 4 weeks of treatment at therapeutic plasma levels, the 
patients treated with imipramine, as well as the patients treated with fluvoxamine, 
demonstrated a significant decrease of the HRSD score (13 = -12.1, p < 0.001 and l3 
= -7.6, p < 0.001 respectively) (table 1). Similar findings were observed for the SRRS 
scores; both after imipramine and fluvoxamine there was a reduction of the 
retardation score (13 = -11.1, p < 0.001 and 13 = -8.2, p < 0.01 respectively). The 
reduction of the agitation score was not significant in both treatment groups. 
4.2 Changes in motor activity pattern 
Figure 1 and 2 present the pattern of motor activity before and after imipramine or 
fluvoxamine treatment. There were no significant differences bet\.veen patients 
treated with imipramine and fluvoxamine concerning the global motor activity 
parameters during the medication free period (table 2). Patient treated with 
imipramine showed a significant increase in the mean motor activity level during 
wake (13 = 1.8, p < 0.001). The mean motor activity level during sleep was not 
significantly changed by the antidepressant treatments. Both treatment groups 
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Figure 1 Mean half hour motor activity counts for the 24-hour period (from 6.00 
hrs- 6.00 hrs) of depressed patients before and after treatment with imipramine. 
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Figure 2 Mean half hour motor activity counts for the 24-hour period (from 6.00 
hrs- 6.00 hrs) of depressed patients before and after treatment with fluvoxamine. 
showed no alteration in the fragmentation index during the wake period, but during 
the sleep period patients treated with imipramine showed a higher fragmentation 
index (J3 = 0.02, p < 0.05) in comparison to the medication free period. A higher 
fragmentation index indicates that periods without any motor activity were more 
often interrupted by activity. The immobility index during sleep was not altered by 
the two antidepressant treatments, indicating that there was no alteration in the 
relative amount of periods without motor activity. 
5 Discussion 
This study showed that, on average, there was a clinical improvement of depressive 
mood in the depressed inpatients after treatment at adequate plasma levels with 
imipramine as well as with fluvoxamine. Furthermore, based on clinical evaluations a 
reduction in retardation, but not in agitation, was observed in the two treatment 
groups. There were clear alterations in the motor activity pattern in patients treated 
with imipramine, but not in patients treated "With fluvoxamine, at least not after the 
treatment period we evaluated. After imipramine there was an increase in the mean 
motor activity level during wake and more fragmented motor activity during sleep. 
The treatment with imipramine (during 26 or 60 days) had a stimulating 
effect on reduced overt motor behavior in rats (Overstreet eta!., 1995; West and 
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Table 2 Global motor activity parameters of patients treated with imipramine or fluvoxaminea 
Motor activity during waked 
Untreated 
After treatment 
Motor activity during sleepd 
Untreated 
After treatment 
Fragmentation index during wake" 
Untreated 
After treatment 
Fragmentation index during sleepe 
Untreated 
After treatment 
Immobility index during sleep' 
Untreated 
After treatment 
imipramine 
(n=25) 
6.7 ± 3.2 
8.6 ± 3.Sb 
0.68 ± 0.59 
0.54 ± 0.25 
0.38 ± 0.13 
0.40 ± 0 13 
0.047 ± 0.018 
0.067 ± 0.033' 
0.92 ± 0.04 
0.91 ± 0.04 
fluvoxamine 
(n=27) 
7 3 ± 3.5 
7.4±3.7 
0.83 ± 0.68 
0.68 ± 0.42 
0.43 ± 0.11 
0.38 ± 0.12 
0.057 ± 0.037 
0.071 ± 0.043 
0.90 ± 0.06 
0.91 ± 0.06 
HValues given are mean± SD. bp < 0.001, cp < 0.05, random regression analyses for the comparison of 
the 24-hour pattern of motor activity before and after antidepressant treatment, while controlling for 
age and gender effects. dAverage number of counts per epoch, as percentage of the maximum number 
of counts possible. eN umber of groups of consecutive zero count epochs divided by the total number 
of zero count epochs. fProportion of zero count epochs divided by the total number of epochs. 
Weiss, 1998), therefore we expected an increase in motor activity in depressed 
patients after imipramine. The higher daytime motor activity in patients treated with 
imipramine was in agreement with our expectation. The lack of a change in motor 
activity levels after fluvoxamine was cousistent with the finding that the treatment of 
fluoxetine during 26 days did not result in alterations in reduced motor activity in rats 
(West and Weiss, 1998). The higher motor activity levels during daytime after 
imipramine were supported by the clinical study of Raoux et a!. (1994). They found in 
26 depressed inpatients (5 bipolar and 21 unipolar) that the daytime motor activity 
was increased after a combined treatment of a TCA (clomipramine, maprotiline, or 
trimipramine) and benzodiazepines. They ascribed the change in the motor activity 
pattern to the clinical improvement of the patients. Our results are in conflict with 
the results of Stanley eta!. (1999). They compared in 14 unipolar depressed 
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outpatients the effect on motor activity of a TCA (dothiepin) or a SSRI (fluoxetine). 
Patients who received fluoxetine were overall more active during daytime after 10 
days of treatment than patients that received dothiepin, especially between 6.00 and 
8.00 hrs. The lower motor activity levels in patients treated with dothiepin were 
suggested to originate from sedative side effects. In our opinion the treatment period 
in our study was long enough (on average 5 weeks when measurements were 
performed) to develop tolerance to sedation. Furthermore, their number of patients 
was limited and no pre-treatment measurements were taken into account. In contrast, 
we studied a large group of depressed patients, each patient was treated with clinically 
optimal doses due to the control of plasma levels, and the observed effects in our 
study were not obscured by comedication of other psychotropic drugs. A limitation 
of the evaluation after 4 weeks of adequate treatment was that a direct comparison 
between our findings and those of Stanley eta!. (1999) could not be made. SSRis are 
known to induce infrequently movement disorders such as agitation and akathisia (a 
form of motor restlessness) (Leo, 1996; Stahl, 1998). On group level we found no 
support for the presence of these phenomena after fluvoxamine, however we can not 
rule out that these phenomena occurred at the beginning of treatment. 
After imipramine also the motor activity during sleep was more fragmented, 
which was not accompanied by alterations in the motor activity level or the 
immobility index. The higher fragmentation index could refer to more nocturnal 
awakenings and/ or arousals during sleep. However, Thase (1998) stated that only the 
TCAs clomipramine, desipramine and protriptyline may have disruptive effects on 
sleep maintenance. Although SSRis induce insomnia and can increase the number of 
nocturnal awakenings (Thase, 1998; Stahl, 1998), the motor activity level, 
fragmentation of motor activity and the immobility during sleep were not changed 
after fluvoxamine. 
TCAs inhibit the reuptake of serotonin (5-HT) and norepinephrine, and in 
addition block the acethylcholinergic, a1 adrenergic, and histaminergic receptors. 
SSRis are known to block the reuptake pump of serotonin. Although there are 
several differences between the pharmacological proflles of imiprimanine and 
fluvoxarnine, one explanation for the effect of imipramine might be its 
anticholinergic and (nor)adrenergic properties. Future research should investigate the 
24-hour motor activity pattern in depressed patients after treatment with other TCAs 
and SSRis, and with newer antidepressants such as the selective noradrenaline 
reuptake inhibitors (SNRis). In the flrst place, to obtain more insight in the 
neurobiological mechanisms underlying the increase of motor activity after 
antidepressant treatment. Secondly, to flnd out whether the effects of imipramine and 
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fluvoxamine on the 24-how: motor activity were drug specific or can be generalised 
to other TCAs and SSRis. 
In both treatment groups there was a significant reduction in the severity of 
depression and retardation, indicating that the clinical effectiveness of both 
antidepressants was not different in this study. Although patients received 
antidepressant treatment during 4 weeks with optimal doses, there was a low 
percentage 29% of patients (in totallS) that showed a therapeutic response. Patients 
with an improvement of >50% of the initial HRSD score, or a moderate or markedly 
clinical improvement as measured by the CGIS were defined as responders. The 
percentage responders did not significantly differ between the treatment groups. 
Unfortunately, the nwnber of responders in the treatment groups was too small to 
study the effects of imipramine and fluvoxamine in responders and nonresponders 
separately. Thus, a contribution of the improvement of clinical state to the increase in 
daytime motor activity can not be ruled out, but it appears to play a minor role. This 
statement is supported by a previous study that showed no significant correlations 
between global motor activity parameters and the severity of depression in 66 
unmedicated depressed patients including the patients of this study ry olkers et al., 
2000). However, in these patients retardation was related to lower motor activity 
levels throughout the entire day, and agitation to higher motor activity levels dw:ing 
wake ry olkers et al., 2002a). Post~hoc general regression analyses of the presently 
used patient group showed that after treatment the HRSD scores in both treatment 
groups were not related to global motor activity parameters while controlling for age 
and gender effects, but interestingly this was also the case for the retardation and 
agitation scores. Furthermore, post-hoc random regression analyses indicated that the 
increase in motor activity after imipramine was not modified by changes in the 
HRSD, retardation or agitation scores. For this reason, the clinical relevance of our 
findings needs to be further explored, especially in relation to psychomotor 
retardation. Even after the treatment with imipramine the daytime motor activity 
levels in depressed patients were still lower than in healthy control subjects. To 
illustrate, the mean (± SD) motor activity during wake was 8.6 ± 3.5 in depressed 
patients treated with imipramine and 11.6 (± 5.4) in healthy subjects \Volkers et al., 
2002b). For this reason, patients should be followed during the entire hospital stay 
and after discharge to fmd out whether the effects of imipramine and fluvoxamine on 
motor activity are more pronounced after a longer treatment period and/ or in their 
natural environment. 
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6 Summary 
In depressed inpatients the treatment with imipramine resulted in an increase in 
motor activity during daytime and more fragmentation of motor activity during sleep. 
Patients treated with fluvoxamine demonstrated no alterations in the 24-hour pattern 
of motor activity. The clinical improvement in depressive mood and retardation 
seems to play a minor role in this finding. Future studies should explore the possible 
contribution of anticholinergic and (nor) adrenergic properties of imipramine to the 
change in motor activity level. 
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1 Abstract 
Diminished HR variability is considered to play a role in the relationship between 
depression and the increased risk of cardiovascular disease. The pharmacological 
effects of antidepressants and depressive mood itself may contribute to alterations in 
the autonomic cardiac functioning, but so far only a limited amount of data are 
available. Therefore, we studied the effects of two different types of antidepressant 
treatments (imipramine and fluvoxamine), in addition to the effect of depressive 
mood, on the cardiovascular system in depressed patients. Depressed inpatients were 
studied during a drug free period and after 4 weeks of adequate treatment of 
imipramine (n=17) or fluvoxamine (n=24). Heart rate (HR) variability, blood 
pressure (BP) variability, and a baroreflex sensitivity (BRS) index during supine rest 
and orthostatic challenge were analysed by means of spectral techniques to obtain 
non-invasive parameters of sympathetic and parasympathetic activity. Both 
imipramine and fluvoxamine reduced sympathetic and parasympathetic activity, 
although the effects of fluvoxamine were much less pronounced. Severity of 
depression was positively related to mean heart rate in the imipramine group, and to 
mean blood pressure in the fluvoxamine group. However, in both treatment groups, 
changes in the cardiovascular parameters after treatment were not influenced by 
changes in depressive mood. Our findings suggest that alterations in cardiovascular 
variability and baroreflex sensitivity in depressed patients after antidepressant 
treatment should be attributed to the pharmacological actions of antidepressants 
rather than to changes in depressive mood. 
2 Introduction 
Diminished HR variability is considered to be one of the biological mechanisms that 
play a role in the relationship between depression and the increased risk of morbidity 
and mortality of cardiovascular disease (Musselman eta!., 1998). Cardiovascular 
variability is frequendy analysed to provide estimates of sympathetic and 
parasympathetic regulation of the cardiovascular system (Akselrod et a!., 1985; 
Malliani eta!., 1991; Parati eta!., 1989, 2000). HR variability that is related to 
respiratory variations usually between 0.20-0.35 Hz (respiratory sinus arrhythmia) 
results from centrally mediated cardiac vagsl (parasympathetic) activity. BP variability 
in the frequency domain around 0.10 Hz (Mayer waves) reflects alterations in 
peripheral vasomotor resistance due to baroreflex-mediated sympathetic control. HR 
variability in this frequency domain represents changes in the baroreflex response and 
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similarly reflects sympathetic activity, although an influence of vagal activity has also 
been suggested. 
Tricyclic antidepressants (fCAs) are known for their cardiovascular side 
effects such as tachycardia, orthostatic hypotension, conduction delays, and cardiac 
arrhythmias (Littman et al., 1993). TCAs also induce decreased HR variability, 
indicating diminished vagal cardiac control due to the anticholinergic properties of 
TCAs (Yeragani et al., 1995; Tulen et al., 1996a). Selective serotonin reuptake 
inhibitors (SSRis) are considered to be devoid of strong pharmacological actions on 
the cardiovascular system, but their cardiovascular effects should not be overlooked. 
To illustrate, Lederbogen et al. (2001) found in depressed patients that paroxetine 
treatment with a high dose (40 mg) resulted in decreased HR variability, probably due 
to the mild anticholinergic properties of paroxetine. In addition, fluvoxamine 
treatment has the tendency to decrease the mean HR in depressed patients (Wakelin, 
1986; Hewer et al., 1995; Laird et al. 1993; Rechlin, 1994c). However, no effect on 
HR variability was found (Rechlin, 1994c). These flndings should be clarifled by 
studying the effect of fluvoxamine treatment both on HR and BP variability and on 
BRS by means of spectral analysis. Shores et al. (2001) found recently a suppression 
of sympathetic activity in healthy controls after a short-term treatment of sertraline. 
Therefore, the mean HR after fluvoxamine treatment could be decreased due to 
reduced cardiac sympathetic activity. 
The majority of studies in unmedicated depressed patients reported no 
alterations in cardiovascular variability or BRS (Y eragani et al., 1991; Rechlin, 1994c; 
Tulen eta!., 1996a; Lehofer et al., 1997; Moser et al., 1998). Nevertheless, in two 
studies (Lehofer et al., 1997; Moser et al., 1998) and in a previous study of our own 
!y olkers et al., 2002a) increased HR levels were observed in unmedicated depressed 
patients, implying the relevance of research on the influence of depressive mood on 
autonomic regulation. Besides their pharmacological effects, antidepressants may also 
affect the cardiovascular system through their therapeutic effect on mood state. 
Balogh et al. (1993) observed that the improvement of depressive mood due to 
antidepressant treatment had a beneficial effect on the autonomic modulation by 
increasing HR variability. This was especially the case after treatment with the SSRI 
fluoxetine and the dopamine/ noradrenaline reuptake inhibitor bupropion; both 
antidepressants that were assumed to have no strong cardiovascular effects. 
To obtain more insight in the contribution of antidepressant treatment to 
alterations in autonomic cardiac functioning in depressed patients, we studied the 
effects of a double blind treatment with imipramine or fluvoxamine on the 
autonomic regulation of the cardiovascular system in 52 depressed inpatients. During 
a medication free period and after 4 weeks of treatment at adequate plasma levels 
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cardiovascular measurements were performed during supine rest (SR) and orthostatic 
challenge (OC). HR and BP variability and BRS were assessed by means of spectral 
analysis. In each treatment group, also the overall effect of depressive mood on 
cardiovascular parameters was evaluated and the influence of the alteration in 
depressive mood state on the change of the cardiovascular parameters after 
treatment. 
3 Methods and Materials 
3.1 Patients 
Fifty-two depressed inpatients (20 men and 32 women; mean age 52.5 years, range 
32-65 years) with a major depressive disorder (unipolar subtype) according to DSM-
IV criteria participated in a clinical trial to the effectiveness of imipramine versus 
fluvoxamine. The Medical Ethical Committee of the hospital approved the study and 
all patients gave written informed consent Inclusion criteria were an initial score of 
>13 on the 17 item Hamilton Rating Scale of Depression (HRSD) (Hamilton, 1967). 
The diagnosis was based on clinical observation and the depression items of the 
Schedule for Affective Disorders and Schizophrenia (SADS) (Endicott et al., 1978). 
As exclusion criteria served: a history of an adequate treatment (therapeutic plasma 
levels) during 4 weeks with a TCA and a response of more than 50% on the initial 
HRSD score to placebo medication 4 days prior to active treatment. 
3.2 Design and Procedure 
After a psychotropic drug free period of at least 7 days (average duration 10.6 days), 
the patients were randomly assigned to a double blind treatment of imipramine or 
fluvoxamine and were treated during 4 weeks with optimal doses that corresponded 
to therapeutic plasma levels for imipramine (imipramine + desipramine) of 200-300 
J.Lg/1 and for fluvoxamine of 150-200 J.Lg/L No other psychotropic drugs were 
allowed. Two patients dropped out the study during treatment due to suicide and 
severe hypotension. Patients with cardiovascular disease and/ or diabetes mellitus 
(n = 11) were excluded afterwards from data analysis. Consequently, this study 
reports data of 41 patients (imipramine n = 17, fluvoxamine n = 24), of whom 35 
patients used psychotropic drugs before participating in the study; TCAs (9), SSRis 
(11), lithium (1), monoamine oxidase inhibitors (MAO Is) (2), other antidepressants 
(5), antipsychotics (6) and benzodiazepines (25). The mean (± SD) dose of 
imipramine was 221.7 (± 109.7) mg and the mean(± SD) plasma leve\281.8 (± 96.8) 
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flg/1. The mean (± SD) dose of fluvoxamine was 194.3 (± 84.8) mg and the mean (± 
SD) plasma level182.0 (± 42.5) f!g/1. 
Each week the HRSD was scored to ascertain severity of depression. The 
HRSD score of the medication free period and that assessed after 4 weeks of 
treatment at adequate plasma levels were used to evaluate changes in depressive 
symptomatology. The cardiovascular measurement was performed in the morning, 
after an overnight fast of smoking and coffee drinking, similarly during the 
medication free period and after treatment. 
3.3 Cardiovascular Measurement 
Electrocardiogram (ECG), BP and respiration were continuously sampled with 1024 
Hz during 10 min SR and 10 min OC (60° head-up tilting). The ECG was derived 
from a precordial lead, BP was recorded by a noninvasive measurement of flnger 
arterial BP (Finapres) (Penaz, 1976), and respiration was measured by means of an 
impedance plethysmograph. R-R intervals in the ECG were detected with an 
accuracy of 1 millisecond and transposed to interbeat interval (IBI) time series. 
Systolic and diastolic blood pressure (SBP and DBP) were defined per IBI with an 
accuracy 0.1 mmHg. In addition, at each incidence of the R-wave the value of the 
respiratory signal was obtained. The IBI, SBP, DBP and respiratory time series of the 
last 5 minutes of SR and OC were used for spectral analysis. 
The time series were subjected to a discrete Fourier transformation, based on 
nonequidistant sampling of the R-wave incidences (Carspan program) (Mulder et al., 
1988b; Van Steeuis et al., 1994), to yield power spectra of the rhythmic oscillations 
over a frequency range of 0.02 to 0.50 Hz. Per time segment we calculated the mean 
HR, SBP and DBP, variation coefficients of HR and SBP (CVI, coefficient of 
variation of IBI; CVS, coefficient of variation of SBP), mid frequency (MF, 0.07-0.14 
Hz) power ofHR and SBP, high frequency (HF, 0.15-0.50 Hz) power ofHR, and 
the dominant respiratory frequency. Spectral power for each selected frequency band 
was expressed in relative terms, that is as a fraction of the mean value of the 
considered signal (squared modulation index) (Van Dellen et al., 1985). If this 
measure is computed for the whole spectrum (0.01-0.50 Hz) it is directly comparable 
to the squared variation coefficient. The spectral power data were transformed to 
natural logarithmic values to obtain a normal distribution of data. The MF band used 
in this study is comparable with the low frequency domain of 0.04 -0.15 Hz as 
deflned by the Task Force guidelines (Task Force, 1996). Finally, per time segment 
the gain (or modulus) in the MF band between SBP and IBI time series was 
computed as an index ofBRS (Saul et al., 1991; Parati et al., 2000; Robbe et al., 1987). 
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3.4 Statistical analysis 
Random regression models (R.Rlvis) 1 for continuous measurements were applied to 
study the effect of posture (SR=1, OC=2) on the cardiovascular parameters before 
and after treatment, and the effect of antidepressant treatment (medication free=1, 
treatment=2) on the HRSD score and on the cardiovascular parameters duriog SR, as 
well as duriog OC. Subsequently, the HRSD score was included in the origioal RRMs 
to test the overall effect of severity of depression on the cardiovascular variables 
(cardiovascular data were combined for the drug free period and the period after 
treatment) duriog SR and OC. If both antidepressant treatment and the HRSD score 
had a significant effect on a specific cardiovascular parameter, the interaction term of 
these two determioants was entered in the extended RRMs to study the modifying 
effect of severity of depression on the effect of antidepressant treatment. The 
plausibility of extended RRMs was determined by compariog their model fit with the 
model fit of the origioal RRMs. The improvement of model fit was tested with chi-
square statistics by comparing -2 Log Likelihood values of the restricted and 
extended RRMs, accounting for differences in degrees of freedom. 
All analyses were performed separately for the two treatment groups. In the 
RRMs the effects of the determioants were always tested simultaneously and they 
were controlled for age and gender. Effects were reported as unstandardised f3's and 
p values < 0.05 (two-tailed) were regarded to be significant. The statistical analysis 
was performed with the program Prox Mixed of the statistical package Statistical 
Analysis Systems (SAS for Windows, release 6.12). 
1 Random regression models for continuous data estimate individual effects instead of effects for the 
total study population (Bock, 1983; Gibbons et al., 1993). The random regression approach uses data 
from individuals augmented by information from the total study population to estimate for each subject 
the personal trend across time. In RR.Ms, the intercept and time effects are allowed to differ for 
individuals, and are therefore called random terms. In this study the intercept was a random term. The 
advantage of this analysis technique above the usually applied :t"vl.ANOVAs for repeated measurements is 
an efficiently use of data, because RR.Ms can cope with missing values. The estimation of an individual 
time trend is based on non-missing data for that individual. This implies that missing values are assumed 
to be missing at random (Verbeke and Molenberghs, 1987), and subjects may have data for different 
time points. RR.Ms allow more general and realistic error structures. In this study we assumed an 
'unstructured' error structure, which allows both correlations between measurements and variances of 
measurements to differ (Gibbons et al., 1993; Verbeke and Molenberghs, 1987). In other words, 
variances and covariances may differ between repeated measurements. 
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4 Results 
4.1 Clinical state 
A significant reduction of severity of depression was found in patients treated with 
imipramine and fluvoxamine after 4 weeks of treatment at adequate plasma levels. 
The HRSD score in the imipramine group decreased from 26.7 (± 4.9) to 13.2 (± 9.8) 
(13=-13.4, p<0.001) and in the f!uvoxamine group from 26.2 (± 5.2) to 19.6 (± 9.3) 
(13=-6.7, p<0.001). 
4.2 Cardiovascular data 
4.2.1 Drug free period, effect of orthostatic challenge 
Before treatment orthostatic challenge resulted in both treatment groups in a 
significantly higher mean HR, mean DBP, MF power of SBP, and a significantly 
lower CVI, HF power of HR, and BRS (tables 1 and 2). Patients in the fluvoxamine 
group also showed a significantly lower MF power of HR in response to orthostatic 
challenge, and patients in the imipramine group a significantly increased respiratory 
frequency. Orthostatic hypotension was defined as a SBP reduction of > 15 mmHg in 
response to orthostatic challenge. During the drug free period orthostatic 
hypotension was observed in none of the patients in the imipramine group and in 3 
patients in the fluvoxamine group. 
4.2.2 Imipramine 
Cardiovascular effects 
Patients showed significantly higher mean HR levels during SR and OC after 
imipramine treatment in comparison to the medication free period (table 1). In 
addition, there was a significant decrease during SR and OC in the CVI, MF and HF 
power of HR, and MF power of SBP. The reduction of the BRS index was only 
significant during OC After treatment, OC resulted in the same significant changes 
of the cardiovascular parameters as before treatment, except that the decrease in JviF 
power of HR became significant after treatment and the significance of the increased 
respiratory frequency disappeared. Imipramine treatment induced orthostatic 
hypotension in one patient. 
Effect of depressive mood, in addition to cardiovascular effects 
The extended RRMs for HR had an improved model fit and showed that the HRSD 
score had overall a significant positive effect on mean HR (table 3). This implies that 
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Table 1 Cardiovascular parameters of patients treated ~th imipramine (n=17)a 
Supine rest Head-up tilt Effect of head~up tilt (~) 
HR (beats/ min) 
Untreated 72.3 (± 12.0) 92.3 (± 12.9) 20.0 (p<0.001) 
After treatment 86.6 (± 7.8) 106.1 (± 11.9) 19.4 (p<0.001) 
Effect of treatment (~) 15.2 (p<0.001) 14.8 (p<0.001) 
CVI (%) 
Untreated 4.8 (± 2.0) 3.5 (± 1.4) ~1.3 (p<0.01) 
After treatment 2.3 (± 1.1) 1.7 (± 0.6) ~0.6 (p<0.05) 
Effect of treatment (~) ~2.5 (p<0.001) ~1.8 (p<0.001) 
MF log power HR 
Untreated 5.8 (± 1.0) 5.6 (± 1.2) ~0.3 (p=ns) 
After treatment 4.4 (± 1.0) 3.0 (± 1.2) ~1.4 (p<0.001) 
Effect of treatment(~) ~1.5 (p<0.001) ~2.5 (p<0.001) 
HF log power HR 
Untreated 5.9 (± 1.5) 4.7 (± 1.5) ~1.2 (p<0.01) 
After treatment 4.2 (± 1.3) 3.0 (± 1.4) ~1.2 (p<0.05) 
Effect of treatment (~) ~1.7 (p<0.001) ~1.6 (p<0.001) 
SBP (mmHg) 
Untreated 122.8 (± 16.0) 127.3 (± 20.0) 2.4 (p=ns) 
After treatment 124.3 (± 14.4) 128.1 (± 19.7) 3.8 (p=ns) 
Effect of treatment(~) ~0.9 (p=ns) 1.6 (p=ns) 
cvs (%) 
Untreated 4.5 (± 1.6) 5.8 (± 2.0) 1.3 (p=ns) 
After treatment 3.5 (± 2.1) 4.7 (± 1.2) 1.1 (p<0.05) 
Effect of treatment (~) ~ 1.2 (p=ns) ~ 1.0 (p=ns) 
MF log power SBP 
Untreated 5.1 (± 0.7) 6.3 (± 0.8) 1.1 (p<0.05) 
After treatment 3.4 (± 1.1) 4.4 (± 0.7) 0.9 (p<0.5) 
Effect of treatment (~) ~1.8 (p<0.001) ~1.9 (p<0.001) 
DBP (mmHg) 
Untreated 68.3 (± 8.9) 80.5 (± 11.7) 11.5 (p<0.001) 
After treatment 68.0 (± 1 0.2) 79.2 (± 12.9) 11.2 (p<0.01) 
Effect of treatment (~) ~1.0 (p=ns) ~0.5 (p=m) 
BRS (ms/mmHg) 
Untreated 10.3 (± 5.6) 3.5 (± 2.2) ~6.7 (p<0.001) 
After treatment 8.4 (± 4.1) 2.2 (± 1.6) ~6.2 (p<0.001) 
Effect of treatment (~) ~2.3 (ns) ~1.7 (p<0.05) 
Resp. F<eq. (Hz) 
Untreated 0.25 (± 0.04) 0.28 (0.07) 0.03 (p<0.01) 
After treatment 0.27 (± 0.04) 0.25 (0.09) 0.02 (p=ns) 
Effect of treatment (~) 0.02 (p=ns) ~0.03 (p=ns) 
aVa.lues given are mean± SD. The effect of treatment and orthostatic challenge were studied by RRMs, while 
controlling for age and gender. HR., heart rate; CV, variation coefficient; MF, mid-frequency; HF, high-frequency; 
SBPand DBP, systolic and diastolic blood pressure; BRS, barorefle.'{ sensitivity; Resp. Freq., respiratory frequency. 
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Table 2 Cardiovascular parameters of patients treated with fluvoxamine (n=24)a 
Supine rest Head~up tilt Effect of head-up tilt (~) 
HR (beats/min) 
Untreated 78.0 (± 10.1) 96.9 (± 14.0) 19.0 (p<0.001) 
After treatment 75.7 (± 10.8) 91.7 (± 14.7) 16.0 (p<0.001) 
Effect of treatment (~) -2.2 (p=ns) -5.4 (p=ns) 
CVI (%) 
Untreated 4.8 (± 2.3) 3.6 (± 1.6) -1.3 (p<0.05) 
After treatment 3.4 (± 1.2) 3.0 (± 1.3) -0.4 (p=ns) 
Effect of treatment (~) -1.1 (p<0.05) -0.6 (p<ns) 
MF log power HR 
Untreated 5.8 (± 1.2) 5.1 (± 1.4) -0.7 (p<0.01) 
After treatment 5.3 (± 1.0) 4.7 (± 1.1) -0.6 (p<0.01) 
Effect of treatment (~) -0.5 (p<0.05) -0.4 (ns) 
I-IF log power HR 
Untreated 5.6 (± 1.3) 4.0 (± 1.2) -1.6 (p<0.001) 
After treatment 4.9 (± 1.0) 4.1 (± 1.0) -0.8 (p<0.01) 
Effect of treatment (~) -0.7 (p<0.01) 0.6 (p=ns) 
SBP (mmHg) 
Untreated 137.5 (± 25.8) 133.8 (± 20.6) 2.1 (p=ns) 
After treatment 136.0 (± 23.7) 136.9 (± 21.0) 1.6 (p=ns) 
Effect of treatment (~) -0.8 (p=ns) 0.5 (p=ns) 
cvs (%) 
Untreated 4.9 (± 1.5) 5.4 (± 1.4) 0.6 (p=ns) 
After treatment 4.8 (± 24) 4.2 (± 1.1) -0.6 (p=ns) 
Effect of treatment (~) -0.3 (p=ns) -1.2 (p<0.001) 
MF log power SBP 
Untreated 5.5 (± 0.8) 6.1 (± 0.9) 0.6 (p<0.01) 
After treatment 5.3 (± 1.0) 5.8 (± 0.9) 0.4 (p<0.05) 
Effect of treatment (~) -0.3 (p:>0.05) -0.4 (p<0.04) 
DBP (mmHg) 
Untreated 72.7 (± 13.0) 81.4 (± 10.9) 11.9 (p<0.001) 
After treatment 70.2 (± 10.1) 80.6 (± 9.7) 10.9 (p<0.001) 
Effect of treatment (~) -1.7 (p=ns) -1.3 (p=ns) 
BRS (ms/ mml-!g) 
Untreated 6.8 (± 3.9) 2.6 (± 1.6) -4.1 (p<0.001) 
After treatment 5.6 (± 3.5) 3.0 (± 2.0) -2.9 (p<0.001) 
Effect of treatment (~) -0.8 (p=ns) 0.04 (p=ns) 
Resp. Freq. (Hz) 
Untreated 0.26 (± 0.08) 0.28 (± 0.07) 0.02 (p=ns) 
After treatment 0.27 (± 0.07) 0.29 (± 0.08) 0.02 (p=ns) 
Effect of treatment(~) 0.009 (p=ns) O.Dl (p=ns) 
"Values given are mean± SD. The effect of treatment and orthostatic challenge were studied by R.RM:s, while 
controlling for age and gender. HR, heart rate; CV, variation coefficient; MF, mid~ frequency; I-IF, high-frequency; 
SBPand DBP, systolic and diastolic blood pressure; BR.S, baroreflex sensitivity; Resp. Freq., respiratory frequency. 
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severity of depression was positively related to a higher mean HR in the imipramine 
treatment group during SR and OC, when data were combined for the medication 
free period and the period after treatment. After entering the effect of the HRSD 
score, the effect of imipramine on mean HR became larger. The inclusion of the 
interaction term 'treatment effect and effect of HRSD score' in the RRM for HR 
resulted in improved model fits (SR, x'=197.8-193.3=4.5, df=l, p<O.OS and OC, 
X2=206.4-202.6=3.8, df=l, p<O.OS). However, the interaction term itself was not 
significant, indicating that increases in HR were not influenced by the alteration in 
severity of depression. The model fit of the extended RRMs for mean SBP and of the 
extended RRM for mean DBP during OC also improved, but the effect of the HRSD 
score was nonsignificant. The model fit of the extended RRMs for mean DBP during 
SR, HR and SBP variability parameters and BRS deteriorated. Thus, severity of 
depression was no proper determinant of these parameters. 
4.2.3 Fluvoxamine 
Cardiovascular effects 
There was no significant effect of fluvoxamine treatment on mean HR, SBP and 
DBP (table 2). However, during SR the patients demonstrated a significant decrease 
in CVI, .MF and HF power of HR, and MF power of SBP and during OC there was a 
significant decrease in CVS and MF power of SBP. After treatment, the same 
cardiovascular parameters showed a significant response to OC. Only the decrease in 
CVI was no longer significant. Orthostatic hypotension remained present in 1 patient 
after fluvoxamine treatment, but disappeared in the two other patients. 
Effect of depressive mood, in addition to cardiovascular effects 
Only the RRMs for mean SBP and DBP showed an improved model fit after 
including the HRSD score (table 3). The HRSD score had a positive effect on mean 
SBP during OC and on mean DBP during both SR and OC. This reveals that, 
overall, more severely depressed patients showed higher BP levels (data were 
combined for the medication free period and the period after treatment). The effect 
of fluvoxamine treatment on mean SBP and DBP remained nonsignificant. The 
model fit of the RRMs for mean HR, cardiovascular variability and BRS became 
worse after entering the HRSD score, implying that variation in these parameters 
could not be adequately explained by severity of depression. 
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Table 3 The effect of the HRSD score on the cardiovascular variables in patients treated with 
imipramine (n=17) and fluvoxamine (n=24)' 
imipramine fluvoxamine 
Supine rest Head-up tilt Supine rest Head-up tilt 
HR (beats/min) 
Effect of treatment (P) 22.7 (p<O.OO!) b 23.6 (p<O.OOI)' 
Effect of HRSD (B) 0.6 (p<0.05) 0.7 (p<0.05) 
SBP (mmHg) 
Effect of treatment CP) -5.4 (p=ns) 6.3 (p=ns) 3.5 (p=ns) 6.2 (p=ns) d 
Effect of HRSD (B) -0.4 (p=ns) 0.4 (p=ns) 0.6 (p=ns) 0.8 (p<0.05) 
DBP (minHg) 
Effect of treatment(~) 4.5 (p=ns) 1.2 (p=ns) " 2.4 (p=ns) f 
Effect of HRSD (B) 0.4 (p=ns) 0.4 (p<0.05) 0.5 (p<O.OI) 
• The effects of R.Rlvfs with a significantly or nonsignificantly improved model fit were presented .. lJl effects were 
controlled for age and gender. Significantly improved model fits: b X2:::::2Q3.3-197.8=5.5, df=1, p<O.OS, "X2=21 1.5-
206.4=5.1, df=l, p<O.OS, dx2=338.7-333.9=4.8, df=l, p<O.OS, • X2=324.5-319.7=4.8, df:::::t, p<O.OS, and rx2= 
283.0-275.3=7.7, df=1, p<O.Ol. HR., heart rate; SBP and DBP, systolic and diastolic blood pressure. 
5 Discussion 
The increase in mean FIR level after imipramine treatment is in line with previous 
studies in patients with major depression, panic disorders and generalised anxiety 
disorder (McLeod et al., 1992; Yeragani et al., 1992; Tulen et al., 1996a). Because 
there was no significant difference between respiratory frequency before and after 
treatment, we attributed the increase in mean HR and decrease in HR variability of 
the HF band to diminished parasympathetic (vagal) activity, due to the anticholinergic 
properties (blockade of muscarine, receptors) of imipramine. After imipramine 
treatment, the SBP variability in the MF band was also decreased; indicating reduced 
sympathetic tone, although there were no clear alterations of mean SBP and DBP 
levels. This phenomenon was also observed in the only previous study to the effect 
of imipramine treatment on BP variability in depressed patients (Tulen et al., 1996a). 
This suppression may be explained by the potency ofTCAs to block the 
noradrenaline reuptake in the central and sympathetic nervous system (Veith et al., 
1994). The lower HR variability in the MF band probably reflected both the 
inhibition of sympathetic activity and parasympathetic activity. The effect of 
imipramine on parasympathetic processes was supported by the decreased BRS. 
Orthostatic challenge resulted in similar significant changes in the cardiovascular 
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parameters during the medication free period and after treatment, with the exception 
of the changes in the MF variability of HR and the respiratory frequency. Although 
orthostatic hypotension is assumed to be the major side-effect ofTCAs, just one 
depressed patient developed orthostatic hypotension. 
The decrease in mean HR after fluvoxamine treatment was not significant, 
but during orthostatic challenge there was a tendency for the decrease to reach 
significance (p<0.08). This fioding is in agreement with that of other studies 
performed in depressed patients (Wakelin, 1986; Hewer et al., 1995; Laird et al. 1993; 
Rechlin, 1994c). It was striking that fluvoxamine treatment resulted in lower overall 
HR variability, MF and HF variability of HR, and MF variability of SBP during SR, 
and in lower overall SBP variability and MF variability of SBP during OC. This is the 
flrst study demonstrating an inhibition of sympathetic and parasympathetic activity 
after fluvoxamine treatment in depressed patients, although the inhibition of 
parasympathetic activity was only present during SR and all effects were much less 
pronounced than the effects of imipramine. The inhibition of sympathetic activity 
may explain the nonsignificantly reduced mean HR levels. Furthermore, the same 
cardiovascular parameters showed a significant response to orthostatic challenge 
before and after treatment, only the decrease in CVI was no longer significant. 
F!uvoxamine treatment had a beneficial effect on orthostatic hypotension in 2 
patients, because their orthostatic hypotension was no longer present after treatment. 
In contrast to the present study, Rechlin (1994c) found after 14 days in a smaller 
group of depressed patients (n = 8) no effect of fluvoxamine on time domain 
measures of HR variability. However, we treated patients for several weeks under 
control of plasma levels, we applied the technique of spectral analysis, and we took 
the influence of respiratory frequency into account. In addition, random regression 
models were applied to optimise the statistical analysis. We expected a decreased 
cardiac sympathetic activity after fluvoxamine treatment, because Shores et al. (2001) 
found in healthy controls that the plasma noradrenaline appearance rate was 
decreased after a short-term (3 days) treatment with the SSRI sertraline, reflecting 
suppression of sympathetic activity. They suggested that the agonist action of 
sertraline on 5-HTta receptors was involved in this suppression. However, Szabo et 
al. (1992) assumed that a 'non-specific' noracb:enaline reuptake mechanism was 
responsible for the reduction in renal nerve sympathetic activity, mean heart rate, and 
clearance of plasma noradrenaline after the administration of high doses of 
fluvoxamine in anaesthetised rabbits. The assumption was based on the observation 
that the serotonin reuptake was already maximally blocked at lower doses of 
fluvoxamine. 
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The patients in the present stndy were all severely depressed. On group level, 
both antidepressants induced a significant reduction of depressive mood. Severity of 
depression had a positive overall effect on mean HR in the imipramine group, but the 
increase in mean HR due to imipramine treatment was not mediated by changes in 
depressive mood. In the fluvoxamine group severity of depression had a positive 
overall effect on mean SBP during orthostatic challenge, and mean DBP during both 
supine rest and orthostatic challenge. Interestingly, severity of depression was no 
proper determinant of any of the variability parameters or BRS, at least not in the 
linear regression models we applied. The discrepancy between the effect of severity 
of depression on mean HR and on HR variability is to a certain extent supportive for 
the statement ofLehofer eta!. (1997) that depression is related to an elevated 
intrinsic HR level (=the HR present when there is no control of the autonomic 
nervous system at all) rather than to alterations in the autonomic cardiac modulation. 
We could not confirm the finding of Balogh et al. (1993) that improvement of 
depressive mood contributes to changes in cardiovascular parameters after 
antidepressant treatment. 
6 Conclusions 
Sympathetic and parasympathetic activity is reduced in depressed patients after 
imipramine and fluvoxamine treatment, although the effects of fluvoxamine were 
much less pronounced. In the imipramine group severity of depression was overall, 
positively related to mean HR levels and in the fluvoxamine group to mean BP levels. 
Depressive mood had no influence on changes in the cardiovascular parameters due 
to antidepressant treatment. The effect of fluvoxamine on autonomic cardiac activity 
needs to be further clarified and its clinical relevance should be stndied, especially in 
relation to the risk of cardiovascular disease in depression. Our findings suggests that 
in depressed patients alterations in cardiovascular variability and BRS after 
antidepressant treatment should be attributed to the pharmacological effects of the 
antidepressants rather than to changes in depressive mood itself. 
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1 Introduction 
This thesis addresses the spontaneous pattern of motor activity and autonomic 
cardiac functioning in healthy subjects and patients with a major depressive disorder. 
The general aim of the presented studies was to obtain insight in the psychomotor 
and autonomic cardiac dysfunction in major depression, and to establish the potential 
determinants. In addition, the relevance of the parameters of spontaneous motor 
behavior and parasympathetic activation as indirect (peripheral) indicators of the 
cholinergic dysfunction in depressed patients was explored. The patients were studied 
during a psychotropic drug free period and after double blind treatment with either 
the tricyclic antidepressant (TCA) imipramine or the selective serotonin reuptake 
inhibitor (SSRJ) fluvoxamine. Wrist-actigraphy was used to assess the 24-hour pattern 
of motor activity and spectral analysis was applied to obtain information about the 
autonomic (sympathetic and parasympathetic) regulation of the cardiovascular 
system. In this chapter the fmdings of the studies are summarised, discussed and 
integrated, the methods of the studies are critically reviewed and recommendations 
for future research are done. 
2 Motor activity in major depression 
2.1 Proflle of the 24-hour pattern of motor activity 
In the second chapter of this thesis the shape or (in statistical terms) the time trend 
of the daily pattern of motor activity was specified in 99 healthy control subjects 
between 20-70 years. The daily pattern was assessed by monitoring the 24-hour 
motor activity with a wrist-actigraph for 3 consecutive days and nights. On visual 
inspection, the pattern was characterised by a large increase of motor activity in the 
early morning, a peak of motor activity in the late afternoon, and a gradual decline 
dnring the evening and night. Random regression analyses demonstrated that the 
shape of the diurnal pattern could be modelled by a complex function of six time 
effects, indicating that the estimated pattern was characterised by a linear time trend 
and 5 points of inflexion. The increase in motor activity in the early morning and a 
decline in motor activity during the evening and night are in line with previous 
studies to the proflle of the 24-hour motor activity in healthy subjects (Renfrew et al., 
1987; Lieberman et al., 1989). Support for a complex time trend was found in a study 
of Brown eta!. (1990), who observed in 23 healthy subjects between 22 and 54 years, 
on the basis of co sin or analyses, that the waveform of the circadian rhythm of motor 
activity is not quite sinusoidal. 
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In chapter 4 the 24-hour pattern of motor activity was compared between 
healthy subjects and unmedicated depressed patients with a focus on alterations in 
mean motor activity levels, fragmentation of motor activity and immobility in 
patients. However, on visual inspection of figure 1 in chapter 2 and figures 1 and 2 in 
chapter 5 it is clear that there is an essential difference in the 24-hour proflle between 
healthy subjects and unmedicated depressed patients (see also Tulen et al., 2001). In 
contrast to the healthy subjects, the diurnal pattern of the unmedicated depressed 
patients was not characterised by a motor activity peak in the late afternoon. This 
difference in the 24-hour profile was confirmed by explorative statistical analyses that 
indicated that the time trend in unmedicated depressed patients may be less complex 
than in healthy subjects and that it can be estimated by a linear trend and 2 points of 
inflection. 
The patients were hospitalised and many patients attended the closed ward 
during the medication free period. They followed a structured day schedule with ftxed 
hours for eating, therapy, visiting, and in bed- and out-bed times. Thus, the 24-hour 
motor activity of the patients was measured in a rather controlled environment. In 
contrast, healthy subjects followed their normal activity regime at home, work and 
college. However, occupational activities were always performed during office hours. 
The difference in the proflle of the daily pattern supports the assumption that the 
motor activity peak in the afternoon was related to returning home from work or 
college. 
2.2 Differences between healthy subjects and unmedicated depressed patients 
In chapter 4 we compared the 24-hour pattern of motor activity between 64 healthy 
subjects (33 males and 31 females; mean age= 48.5) (control group 1) and 58 
unmedicated patients (18 males and 35 females; mean age= 52.1) with a major 
depressive disorder (subtype: unipolar). The mean (SD) score on the 17 item version 
of the Hamilton Rating Scale of Depression (HRSD) (Hamilton, 1967) was 27.2 (4.6), 
which indicates that the patients were severely depressed. We optimised the study 
design by measuring a large sample of patients, all suffering from one subtype of 
depression, by measuring the motor activity during three consecutive days and nights, 
by controlling for age and gender differences, and by restricting the measurements as 
far as possible to weekdays to rule out a weekend effect. In comparison to the healthy 
subjects, the patients had lower motor activity levels during the wake period and 
higher activity levels during the sleep period. In addition, during the wake period the 
patient group showed a reduced fragmentation of motor activity and during sleep a 
decreased immobility. The reduced motor activity level and fragmentation of motor 
activity during daytime are consistent with the findings in unmedicated depressed 
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patients reported by Wehr et al. (1980), Wolff et al. (1985) and Van Landen eta!. 
(1998). 
As discussed before, there was a difference in study environment between 
patients and healthy subjects (hospital settiog versus home environment). However, 
we questioned whether the depressed patients at the time of the baseline 
measurement would have been more active in their home environment than at the 
ward, in view of their severe depression. It is more likely that it is the other way 
around; the patients were more active at the ward than they would have been in their 
home environment, because from the first day of admission they were stimulated by 
the nursing staff to perform all kind of activities. Beacke et a!. (1982) considered that 
occupational activities, sport, and other physical activities during leisure time are the 
three components that determine habitual physical activity. In healthy subjects 
occupational activities may have had an important influence on the morning and 
evening motor activity, but according to the Baecke questionnaire all subj eels had 
daily occupations with low activity levels (e.g. clerical work, teaching, studying, 
housework, medical practise, and occupations with a university education). Van 
Landen et a!. (1998) found nearly the same patient data in a group of mainly 
depressed out-patients. This supports the assumption that major depressive disorder 
affects the 24-hour motor activity and indicates that the influence of study 
environment may play a minor role. 
Prior research in patients without antidepressant treatment (Royant-Parola et 
a!., 1986; Raoux et a!., 1994) and a previous study of our own using motor activity 
data of an unmedicated group depressed patients, including the patients examined in 
chapter 4 (y olkers et al., 2000), demonstrated that objective ratings of severity of 
depression is no determinant of the interindividual variation in motor activity 
parameters assessed by wrist-actigraphy. In chapter 4 the unmedicated depressed 
patient group was divided in subgroups with specific clinical features according to the 
research diagnostic criteria (RDC) (Spitzer eta!., 1978) as measured by the Schedule 
for Affective Disorder and Schizophrenia (SADS) (Endicott and Spitzer, 1978). The 
presence of high anxiety and psychotic features was not related to the motor activity 
parameters, but agitation and retardation were independent determinants of the mean 
motor activity level and fragmentation of motor activity. Agitation was positively 
related to motor activity levels during wake, whereas retardation negatively to motor 
activity levels during both wake and sleep. Furthermore, retardation was related to 
less fragmentation of motor activity during wake. The latter results confum the 
negative relationship between clinical ratiogs of retardation (Salpetriere Retardation 
Rating Scale (SRRS) ofWidlocher (1983) and daytime activity levels in depressed 
patients free of antidepressants reported by Van Landen et al. (1998). Raoux eta!. 
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(1994) also found this relationship but only in patients who later on showed a 
therapeutic response to antidepressant treatment and not in nonresponders. In 
contrast, the relationship between retardation and lower motor activity levels was not 
replicated by Royant-Parola eta!. (1986). The relationship between clinical ratings and 
motor activity parameters in unmedicated depressed patients is not well documented. 
Only Joffe et al. (1982) studied the 24-hour motor activity in relation to hyperactivity 
scores in depressed patients, but this was restricted to the period during 
antidepressant treatment and not before. They found a positive relationship between 
hyperactivity scores and daytime motor activity counts. 
Summarising, motor activity levels in unmedicated depressed patients are 
lower during wake and higher during sleep than in healthy subjects. The patients also 
showed a reduced fragmentation index during wake and a decreased immobility 
during sleep. Within the patient group agitation was positively related to levels of 
motor activity and retardation negatively. The motor activity parameters were not 
associated with the presence of high anxiety or psychotic features. 
2.3 Effect of imipramine and fluvoxamine on the 24-hour motor activity 
In chapter 5 the 24-hour motor activity was investigated in 52 depressed patients 
during a psychotropic free period and after 4 weeks of adequate double blind 
treatment with either the TCA imipramine (n=25) or the SSRI fluvoxamine (n=27). 
At the start of the baseline measurement the average duration of the medication free 
period was 11 days. In patients treated with imipramine, as well as fluvoxamine there 
was a significant decrease in severity of depression (HRSD score) and psychomotor 
retardation (SRRS score). but a nonsignificant decrease in agitation (score on the 
agitation item of the HRSD). In addition, the patients treated with imipramine 
showed an increased motor activity level during wake and a higher fragmentation 
index during sleep. The treatment with fluvoxamine did not result in alterations in the 
24-hour motor activity. Post-hoc analyses demonstrated that the increase in motor 
activity after imipramine was not modified by either changes in severity of depression 
or in retardation and agitation scores. 
So far, few studies have quantified the effects of antidepressants on the 24-
hour motor activity in depressed patients (Teicher, 1995). There are several older 
studies to the effect of lithium and amitriptyline treatment (Kupfer et al., 1974; Weiss 
et a!., 197 4; Kupfer et a!., 1975; Heninger and Kirstein, 1977) that showed that these 
antidepressant attenuated the increased motor activity levels of predominandy 
agitated depressed patients and elevated the motor activity levels of predominandy 
retarded depressed patients. Later studies demonstrated that depressed patients 
showed higher motor activity levels after a combined treatment with TCAs and 
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benzodiazepines (Raoux et al., 1994), and less periods of immobility during day- and 
nighttime (Raoux et al., 1994; Royant-Parola et al., 1986; Benoit et al., 1985). 
Moreover, the study of Joffe et al. (1987) reported that the treatment with 
carbamazepine in 19 depressed patients (15 bipolar, 3 unipolar, and 1 schizoaffective) 
tended to increase the total 24-hour motor activity level in responders, but not in 
nonresponders. Yet, there is one previous study that compared patients treated with a 
TCA with patients treated with a SSRl. Stanley et al (1999) reported that after 10 days 
patients treated with dothiepin (TCA) had lower motor activity levels than patients 
treated with fluoxetine (SSRI). The lower levels after dothiepin were explained by the 
sedative side effects of dothiepin. A shortcoming of this study was that no 
medication free baseline period was incorporated and that 10 days are relatively short 
to evaluate the effect of antidepressant treatment because after several weeks patients 
may develop tolerance to sedative side effects. 
Changes in the motor activity pattern have been considered to be related to 
the improvement of depressive mood (IZupfer et al., 197 4; Raoux et al., 1994; 
Royant-Parola et al., 1986; Joffe et al., 1987; Benoit et al., 1985). This is not in line 
with our findings that clinical ratings of depressive mood, retardation and agitation 
were no determinants of the increase in motor activity after imipramine. Previously, 
Joffe et al. (1987) also found no correlation between changes in the level of motor 
activity and alterations in the clinical ratings of motor hyperactivity, motor 
retardation, anxiety, excitement, and tension in therapeutic responders and 
nonresponders. Because the improvement of clinical state due to imipramine and 
fl.uvoxamine was not related to changes in the motor activity parameters, we 
proposed that the 24-hour motor activity was mainly influenced by the 
pharmacological action of the antidepressants. In rats prolonged treatment with 
antidepressants, especially with TCAs, was found to have a stimulating effect on 
overt motor behavior (Overstreet et al., 1995; West and Weiss, 1998). It was 
emphasised that imipramine has cholinergic and (nor)adrenergic properties, but 
fl.uvoxamine not The relevance of anticholinergic actions of antidepressants for the 
stimulation of decreased overt behavior is further discussed in section 4. 
2.4 Role of Harm Avoidance and Reward Dependence 
In chapter 2 we studied the effect of the temperament dimensions of the 
Tridimensional Personality Questionnaire (TPQ) of Cloninger (1987, 1993, 1994) on 
the diurnal pattern of motor activity in healthy subjects. Harm Avoidance and 
Reward Dependence influenced the overall level of motor activity, but did not affect 
the shape of the 24-hour pattern. Individuals with high scores on Harm Avoidance 
(the tendency to be fearful, tense, apprehensive, and passive) demonstrated lower 
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motor activity levels than individuals with low scores on this temperament trait. 
Individuals with high scores on Reward Dependence (the tendency to be eager and 
please others, tenderhearted, dedicated, warmly, dependent and sociable) had higher 
overall motor activity levels than subjects with low scores on Reward Dependence. 
Novelty Seeking and Persistence had no significant effect on the 24-hour motor 
activity. 
This is the first study that investigated in healthy adult subjects the 
relationship between personality and the spontaneous pattern of motor activity. 
Biological based personality theories have put forward relationships between 
neurophysiological and neuroendocrine parameters (Eysenck, 1967; Zuckerman et al., 
1980; Cloninger, 1987), but not with overt motor behavior. Because Harm Avoidance 
is hypothesised to be linked to the inhibition of behavior in order to avoid 
punishment, novelty and frustrative nonreward (Cloninger, 1987), higher scores on 
Harm Avoidance were expected in advance to be related to lower overall levels of 
motor activity. Cloninger (1994) stated that Reward Dependence is related to social 
behavior, such as seeking social contact and communicating with other people. The 
relationship between social behavior and higher motor activity levels was previously 
found by Buss et al. (1980) in young children. In this perspective, it is interesting to 
mention that prolonged SSRl treatment may have an effect on social behavior: 
paroxetine administration enhanced behavioral indices of affiliation behavior in 
healthy subjects (Knutson et al., 1998). However, this was not found after fluoxetine 
(Gelfm et al., 1998). Theoretically, fluvoxamine could have increased the motor 
activity level in the study of chapter 5 by improving social behavior, but the 
unchanged motor activity levels provided no support for this argumentation. 
The data of the healthy subjects are relevant for the interpretation of reduced 
daytime motor activity in depressed patients. Many studies demonstrated that Harm 
Avoidance scores are lower in depressed patients than in healthy subjects (Brown et 
al., 1992;Joffe et al., 1993; Hansenne et al., 1999; Marijnissen et al., 2001). In 
depressed patients there is no evidence that depressive mood is related to lower 
scores on Reward Dependence, but a recent study in healthy students showed that 
self-ratings of depression were negatively correlated with scores on Reward 
Dependence (Naito et al., 2000). Unfortunately, the personality data of the depressed 
patients of our study still need to be analysed. During the medication free period the 
motor activity levels in the patients were lower than in healthy subjects, but 
remarkably after .imipramine and fluvoxamine treatment the levels remained reduced. 
Although the lowered motor activity levels after treatment may be explained by the 
incomplete improvement of clinical state of 71% of the patients and the hospital 
environment, it seems reasonable to hypothesise that higher scores of Harm 
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Avoidance may contribute to lower basal motor activity in major depressive disorder. 
To obtain insight in this issue, it is recommended to follow depressed patient more 
frequently during their hospital stay and after discharge in their home environment. 
2.5 DefJnition of agitation and its relationship with retardation 
One reason for the lack of studies to the relationship between clinical ratings of 
agitation and objective measures of 24-hour motor activity in depressed patients is 
the absence of a clear definition of the phenomenon of agitation in major depressive 
disorder (Sobin and Sackeim, 1997; Lemke and Hesse, 1998; Lemke et al., 1999). 
Consequently, there are no rating scales available that specif1cally measures agitation, 
apart from the 18-item CORE questionnaire of Parker and Haclzi-Pavlovic (1996) for 
the psychomotor disturbance in depression which comprises an agitation subscale of 
5 items (facial apprehension, facial agitation, motor agitation, verbal stereotype, and 
stereotyped movements). As a resul~ global items of commonly used clinical scales 
such as the Hamilton Rating Scale of Depression (HRSD) are frequently applied to 
obtain an impression of agitation in depressed patients. Psychomotor agitation is 
characterised by several observable behavioral manifestations, but it is unknown 
which of these manifestations are reflected in a positive score on one single item 
(Sobin and Sackeim, 1997). 
Lemke et al. (1999) stated that retardation and agitation are not mutually 
exclusive phenomena and that they need to be measured as independently varying 
phenomena. Dantchev and Widlocher (1998) emphasised that mania instead of 
agitation is the opposite of retardation, and that retardation and agitation are two 
manifestations of a broader psychomotor dysfunction. The increase in activity, flight 
of ideas and distractibility observed in mania would be more the reverse of 
retardation than agitation, while agitation was postulated to be more the result of 
other causes, mainly anxiety. Our data support the idea that retardation and agitation 
are two distinct manifestations, because 10 of the 58 unmedicated depressed patients 
presented retardation and agitation simultaneously. Additionally, we found opposite 
effects of retardation and agitation on motor activity level during wake that were 
independent of each other. Furthermore, our results support the suggested 
relationship between agitation and anxiety because all patients with agitation (n=14) 
demonstrated high anxiety. Parker and Haclzi-Pavlovic (1996) have a contradictory 
hypothesis about the relationship between agitation and retardation. Factor analyses 
showed that the scores on the retardation and agitation sub scales of the CORE 
questionnaire were not related, but they concluded that this does not necessarily 
mean that agitation occurs independently of retardation in the clinical context. Based 
on clinical observation, it was suggested that agitation is probably superimposed on 
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retardation (dependent relationship). In onr sample of unmedicated depressed 
patients participating in the stndy of chapter 4 this seems not the case, because 4 of 
the 14 agitated patients were not classified as retarded. 
2.6 Method of wtist-actigraphy 
The wtist-actigraph is a valid and reliable method to monitor the spontaneous pattern 
of motor activity in a natural environment when motor activity is monitored for at 
least three consecutive day and nights (Tryon, 1991; Patterson eta!., 1993; 
Middelkoop eta!., 1997a; Middelkoop and Sadeh, 1997b). To increase the validity of 
the data in the presented stndies the total measurement period was extended to fonr 
days, of which the flrst day was used to acclimatise subjects to wearing the actigraph. 
Although the actigraphs were calibrated to produce the same output, in practise 
variation occurred in the measured motor activity counts between different devices. 
To minimise this difference we standardised the positioning protocol, used the same 
actigraph for repeated measurements within patients, and took care that all actigraphs 
were used with the same frequency. The wrist-actigraph that was used in our studies 
was comfortable to wear as wristv.ratch, and only a small number of patients and a 
few healthy subjects experienced wearing the wtist-actigraph as stressful and 
unpleasant. Some patients were paranoid about the real function of the actigraph; e.g. 
they thought they were spied on or reported that they felt electric stimuli that were 
induced by the actigraph. There are now advanced wrist-actigraphs (e.g. Actiwatch of 
Cambridge N enrotechnology) available that have a more compact size, weight less, 
have an increased internal memory capacity and are waterproof or water resistant. 
For practical and ethical reasons we measured the 24-hour motor activity in the 
depressed patients two times, before and after treatment, but the features of the new 
devices may offer the opportunity to monitor the 24-honr motor activity for a period 
of several weeks in these patients. 
Future studies to the spontaneous pattern in motor activity in depressed 
patients may also beneflt of the optimised bandpass filters of the new devices; for 
instance the Actiwtist has a bandpass filter of 3.0-11.0 Hz. Van Someren et a!. (1996) 
recommended that motor activity data will gain validity when the high pass filter of 
single axis wrist-actigraphs, like the one we used, is increased from 0.25 to 0.5 Hz and 
the lowpass filter from 3.0 to 11.0 Hz. A highpass filter > 0.05 was suggested to 
reduce the contribution of the gravitation force and prevent a positive bias for motor 
activity levels in subjects with a low frequency of movement accelerations. 
Furthermore, Van Someren et al. (1996) found that accelerations of wrist-movements 
are not limited to very low frequencies, but range between the 0.25 to 11.0 Hz. 
Discussion 
- 121 -
3 Autonomic cardiac functioning in major depression 
3.1 Differences between healthy subjects and unmedicated depressed patients 
In chapter 4, we also compared th_e autonomic regulation of the cardiovascular 
system during supine rest between 51 healthy subjects (25 males and 26 females; 
mean age 45. 7) (control group 2) and 54 unmedicated depressed patients (19 males 
and 35 females; mean age= 52.1). The technique of spectral analysis was applied to 
unravel sympathetic and parasympathetic processes of the cardiovascular regulation. 
On the day of the cardiovascular measurement, patients were on average medication 
free for 12 days. The patients demonstrated an increased mean heart rate (HR) and 
diastolic blood pressure (DBP), but no alterations were found with respect to HR 
power in the mid-frequency band (MF: 0.07-0.14 Hz) and high-frequency band (HF: 
0.15-0.50 Hz), systolic blood pressure (SBP) power in the MF band and baroreflex 
sensitivity (modulus). This study supported the suggestion that major depressive 
disorder is related to alterations in the cardiovascular system, but the parameters for 
cardiovascular variability and baroreflex sensitivity were not different indicating no 
alterations in sympathetic and parasympathetic processes. 
In the late 1980s and early 1990s Dalack and Roose (Roose et al., 1989; 
Dalack and Roose, 1990; Roose and Dalack, 1992;) proposed that HR variability in 
the HF range was decreased in depressed patients probably due to a reduced 
parasympathetic activity. A decreased HR variability may explain in part the increased 
risk of cardiovascular morbidity and mortality in major depressive disorder 
(Glassman and Shapiro, 1998; Musselman eta!., 1998). However, the majority of 
studies in unmedicated depressed patients have reported less evidence for alterations 
in HR and BP variability or baroreflex sensitivity (Rechlin et al., 1994b; Lehofer et al., 
1997; Moser et al., 1998; Tuien et al., 1996a; Yeragani, 1991). Similar to our results, 
these studies did report an increase in mean HR in depressed patients. Lehofer et al. 
(1997) suggested that the elevated mean HR levels might derive from an increased 
setpoint (a higher intrinsic HR), rather than from reduced parasympathetic activity. 
Cigarette smoking was found to be associated with increased mean HR and 
BP levels and BP variability, and decreased HF variability of HR and baroreflex 
sensitivity (Niedermaier et al., 1993; Mancia eta!., 1997; Gerhardt et al., 1999; 
Ragueneau et al., 1999; Hayano et a!., 1990). To avoid an acute effect of smoking, ali 
participants were instructed not to smoke on the morning of the cardiovascular 
measurement. The nursing staff took care that the patients did not forget this 
instruction or secredy smoked a cigarette. We do not expect a large bias of smoking 
status on the cardiovascular data of the patients, because the number of smokers 
among the depressed patients (42%) was nearly equal to that of the healthy control 
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group (about 45%) (see chapter 3). However, a confounding effect of smoking status 
can not be ruled out completely, because the percentage of subjects who smoked ;:o, 
20 cigarettes differed between patients (27%) and controls (12%). This difference was 
caused by the difficulty to recruit heavy smokers for the healthy control group, 
especially in the age category> 45 years. 
Although there were no differences between healthy subjects and 
unmedicated depressed patients in cardiovascular variability or baroreflex sensitivity 
on group level, within the patient group the presence of agitation was related to 
higher mean levels of HR and SBP and the presence of retardation to lower mean 
levels of SBP and DBP. Both agitation and retardation did not influence the HR and 
SBP power data or the baroreflex sensitivity index. The presence of high anxiety and 
psychotic symptoms was not related to any of the cardiovascular parameters. 
Previously, Thayer et al. (1998) and Watkins et al. (1999) suggested that psychomotor 
retardation, through decreased physical activity, may result in altered autonomic 
cardiac functioning, especially decreased HR variability. The relationship between 
retardation and reduced HR variability was not confirmed in our study. Stein et a!. 
(1994) concluded in their review that, in general, the mean HR is elevated in 
subgroups of depressed patients with symptoms of agitation or comorbid anxiety 
disorders, but not in retarded patients. They argued that the increased HR may 
originate from increased sympathetic activity and/ or decreased parasympathetic 
activity. However, we did not fmd that the increase in mean HR in the agitated 
patients was accompanied by changes in cardiovascular variability or altered 
baroreflex sensitivity, neither was high anxiety during the current episode of 
depression related to higher mean HR or changes in one of the other cardiovascular 
parameters. 
Further exploration of the data of this study by linear regression analyses 
indicated that also the score on the tension/ anxiety scale of the shortened Profile of 
Mood State (POMS) (Shacham, 1983; Wald and Mellenbergh, 1990) was not related 
to the cardiovascular parameters. The absence of a relationship between anxiety and 
cardiovascular parameters is in contrast with the study ofTulen eta!. (1996b), who 
demonstrated in unmedicated depressed patients that high scores on trait anxiety 
were related to an increased HR and a decreased HF power of HR. Like our results, 
Watkins eta!. (1999) and Moser eta!. (1998) found no relationship between state and 
trait anxiety and HF variability of HR in unmedicated depressed patients, but on the 
other hand Watkins eta!. (1999) observed a negative correlation between state 
anxiety scores and baroreflex sensitivity. It seems that the observed relationship 
between anxiety disorders, for example panic disorder, and increased MF variability 
ofHR and decreasedHR variability (Yeragani, 1995; Gorman and Sloan, 2000) may 
Discussion 
- 123-
not be simply generalised to a relationship between high anxiety (state and trait) 
scores and enhanced sympathetic activity and reduced parasympathetic activity in 
major depressive disorder. 
3.2 Effect of antidepressant treatment and depressive mood on autonomic regulation. 
In chapter 6 the effect of imipramine, fluvoxamine, and depressive mood on the 
autonomic regulation of the cardiovascular system was examined in 52 depressed 
patients (20 males and 32 females; mean age = 52.5 years) during a medication free 
period and after 4 weeks of double blind treatment at therapeutic plasma levels. 
Cardiovascular parameters were obtained during supine rest and orthostatic challenge 
(60% head-up tilt). After imipramine, patients showed higher mean HR levels and 
decreased overall HR variability (variation coefficient), MF and HF power of HR, MF 
power of SBP and baroreflex sensitivity. In the imipramine group, severity of 
depression was positively related to the mean HR (data were combined for the 
baseline and post-treatment period), but improvement of depressive mood was not 
related to changes in mean HR after treatment. There was no effect of fluvoxamine 
on mean HR, SBP and DBP. However, after fluvoxamine, patients did demonstrate a 
decreased overall HR and SBP variability, MF and HF power of HR, and MF power 
of SBP. In this treatment group severity of depression was positively related to mean 
BP levels. 
The increase in mean HR and decrease in HF variability of HR after TCAs 
are considered to be caused by the anticholinergic properties of this type of 
antidepressant Gakobsen et al., 1984; Yeragani et al., 1992; Rechlin et al., 1994a; 
Rechlin et a!., 1994b; T ulen et a!., 1996a). There were no significant changes in the 
mean SBP and DBP, but the decreased MF power of SBP suggested that imipramine 
also reduced sympathetic activity. This decrease of SBP power was also reported in 
the only previous study to the effect of imipramine on BP variability (Tulen et a!., 
1994). Veith et al. (1983) found in depressed patients after long-term treatment with 
several TCAs (imipramine, doxepin, and amitriptyline) increased plasma 
noradrenaline levels pointing to an activation of the sympathetic nervous system. 
However, in a later study it was found that desipramine, given for 2 days, resulted in a 
reduction of plasma noradrenaline levels in healthy subjects and depressed patients 
(Veith eta!., 1994). This was assumed to be compatible with a short-term inhibition 
of sympathetic activity. However, the initial inhibition was reversed in the patients 
after several weeks of treatment with an associated rise in plasma adrenaline, which 
was not caused by increased extravascular and vascular rates of noradrenaline, but 
attributed to a reduction of plasma clearance. In this view, it should be stressed that 
indices of sympathetic activity (for instance catecholamine levels, muscle sympathetic 
-124- Chapter 7 
nerve activity, and BP variability in the MF band) are not just mutually exclusive but 
need to be regarded as complementary (Tulen et al., 1994; Pagani and Malliani, 2000). 
Even cardiovascular parameters of sympathetic activity such as the MF variability of 
SBP and the Pre-ejection Period (PEP) provide distinct, but additional information 
about sympathetic activity. Recendy, Schacbinger et al. (2001) found evidence that 
SBP variability around the frequency of 0.10 Hz is a marker of central sympathetic 
activity and PEP of peripheral sympathetic activity. 
Based on the available studies, Roose et al. (1998) concluded that SSRis 
slighdy decrease the HR, do not routinely slow intracardiac conduction, do not affect 
supine or standing BP levels or induce orthostatic hypotension. However, our study 
showed that fluvoxarnine treatment diminished HR and SBP variability indicating a 
suppression of sympathetic and parasympathetic activity similar to imipramine, 
although the effects of fluvoxamine were much less pronounced. This is in contrast 
with the study ofRechlin (1994c) who reported after 14 days fluvoxamine treatment 
in a smaller group of depressed patients (n=8) no effect at all on HR variability. 
Similar to our results, a decreased HR variability was recendy reported in depressed 
patients and in patients with a panic disorder after treatment with the SSRI 
paroxetine (Yeragani et al., 1999; Lederbogen et al., 2001). However, the 
pharmacological profiles of fluvoxarnine and paroxetine are not quite similar, since 
paroxetine is known to have cholinergic properties. Future studies should explore the 
effect of fluvoxamine on autonomic cardiac functioning in patients after several 
months or even years, because the cardiovascular effects of fluvoxamine may become 
more prominent over time. 
After 4 weeks of antidepressant treatment, improvement of depressive mood 
had no favourable effect on the cardiovascular parameters. This is in contrast with 
the statement of Balogh eta!. (1993) that antidepressants, especially antidepressants 
without strong cardiovascular effects, have a beneficial effect on the cardiovascular 
system through their efficacy on depressive mood. The HRSD score decreased 
significandy in both treatment groups, but as discussed in chapter 6 only about 30% 
of the patients showed a therapeutic response. It is possible that the number of 
responders in our study was too small to detect a relationship between improvement 
of depressive mood and alterations in autonomic regulation. 
3.3 Role of risk factors 
A higher prevalence of one or more risk factors in depressed patients may contribute 
to alterations in the autonomic regulation, in addition to clinical state and 
antidepressant treatment. Research on the role of risk factors in the autonomic 
regulation of healthy subjects may provide more insight in the relevance of these 
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factor for autonomic cardiac dysfunctions in major depressive disorder. In chapter 3 
the effect of age, gender and risk factors on the autonomic modulation was studied in 
65 healthy subjects between 20-59 years of age. Mean HR, SBP and DBP, HR and 
SBP variability, and baroreflex sensitivity were measured during supine rest and 
orthostatic challenge (60% head-up tilt). Older subjects showed reduced overall HR 
variability, MF and HF power of HR as well as baroreflex sensitivity. Higher total and 
high density lipid (HDL) cholesterol levels and lower levels of habitual physical 
activity were related to a higher mean HR. Furthermore, the body mass index was 
positively related to mean SBP and DBP, and negatively to the overall HR variability. 
Smoking was also negatively related to overall HR variability. 
The decrease in HR variability and baroreflex sensitivity by age has been 
reported in previous studies (Lipsitz et al., 1990; Ryan et al., 1994; Laitinen et al., 
1998), but it was striking that model fit analyses indicated that age and gender were 
no suitable determinants of the overall SBP variability and the MF power of SBP. 
From a physiological point of view, it is difficult to explain why age is related to HR 
variability, but not to BP variability, while all these parameters play a role in the 
modulation of the cardiovascular system. One possibility is that the relationship 
between age and BP variability should be estimated by a more complex function, 
instead of the applied linear function. The risk factors influenced mean HR and BP 
levels, but they had only minor effects on cardiovascular variability and baroreflex 
sensitivity. Yet, there have been too many equivocal findings reported to make final 
statements about whether and which risk factors are related to cardiovascular 
variability and baroreflex sensitivity. 
The study of chapter 3 was performed based on the hypothesis that 
depression is related to an increased prevalence of cardiovascular risk factors, which 
may contribute to the increased risk of cardiovascular disease in major depression 
(Glassman and Shapiro, 1998; Musselman et al., 1998). Smoking is the most 
important risk factor for cardiovascular disease in major depressive disorder (Breslau 
et al., 1998; Glassman and Shapiro, 1998). There exist several theories regarding the 
role of smoking in major depression. The psychoactive effect of nicotine may elevate 
mood and the sense of well-being. Therefore depressed patients would self-medicate 
with cigarettes (Hayward, 1995; Breslau et al., 1998). Smoking may increase the 
vulnerability to major depression by influencing neurotransmitter systems involved in 
the development of depression. Furthermore, genetic factors may predispose to both 
conditions (Kendler et al., 1993). 
Depression may also be related to disturbances in the lipid metabolism 
(Wardle, 1995; Morgan et al., 1993; Horsten et al., 1997; Maes et al., 1997; Chen et al., 
2001). Information on the relationship between depression and alterations in the 
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body mass index and habitual physical activity is limited. However, Ariyo et al. (2000) 
found recently in a large community study that physical activity was inversely related 
to depression scores and that a higher body mass index was related to higher 
depression scores. 
Additional analyses revealed that the patient group studied in chapter 4 
consisted of 38 nonsmokers and 28 smokers (the smoking status of 1 patient was 
unknown). Four patients smoked less than 10 cigarettes per day, 6 patients between 
10 and 20 cigarettes per day and 18 patients 2 20 cigarettes per day. The smoking rate 
of 42% was somewhat lower than the 50% suggested by Hayward (1995), but higher 
than the 20-30% observed in the general population. In our patient group, the mean 
values of total cholesterol (5.1 mmol/1), HDL cholesterol (1.4 mmol/1), low density 
cholesterol (LDL) (3.4 mmol/1), and triclyceride (1.3 mmol/1) were in the normal 
range and showed much similarity with the mean values of healthy subjects included 
in the study of chapter 3. The mean value of the body mass index in our patient 
groups was 27.5 kg/m2, which is above the criterium of2 0.25 kg/m2 for moderate 
overweight (\IV'HO, 1995), while that of the healthy subjects was 23.9 (kg/m2). In 
contrast, we found in a pilot study that the habitual physical activity of the last year 
did not differ between depressed patients and healthy subjects. 
To conclude, risk factors influence mean HR and BP levels in healthy 
subjects, but their effect on HR and BP variability and baroreflex sensitivity is 
limited. Preliminary data suggest that the smoking rate and body mass index were 
increased in the depressed patient group of our studies. 
3.4 Respiration 
HR and SBP power data were obtained during spontaneous breathing, although the 
subjects were asked to breathe regularly and not to speak. The unmedicated 
depressed patients showed, on average, a significantly higher respiratory frequency 
than the healthy subjects. Higher respiratory frequencies and smaller tidal volume 
(depth of breathing) were found to reduce the HF power of HR (Brown et al., 1993). 
This finding resulted in the recommendation to control the breathing frequency, for 
instance by a metronome, in order to improve the interpretation of spectral data 
obtained in experimental settings. 
In our earlier studies, depressed patients experienced controlled breathing as 
difficult and uncomfortable leading to increase mean HR and BP levels. Furthermore, 
controlled breathing in this patient group is hampered by the presence of a 
hyperventilation-like pattern in some of the patients. Recently, Bloomfield et al. 
(2001) wrote a critical note on the study of Brown et al. (1993). They demonstrated 
that metronome-guided breathing in comparison to spontaneous breathing induced 
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only a small decrease in HF power of HR. This decrease appeared to be extremely 
small in comparison to the large difference in HF power of HR they found between 
healthy subjects and cardiac patients. Furthermore, within these groups HF power 
was relatively constant across the range of typical breathing frequencies. Therefore, 
Bloomfield et al. (2001) argned the need of controlled breathing, because it also 
introduces other biases in the cardiovascular measurement. 
Time-frequency analysis of cardiovascular variability may elucidate the 
relationship between respiration and HR variations ryan Steenis and Tulen, 1996; 
Novak and Novak, 1993a, 1993b). This analysis presents the power of a signal in time 
and frequency simultaneously (Cohen, 1995). An advantage of this type of analysis 
above the spectral analysis is that it does not assume stationary signals and that is can 
describe transient and sustained changes in frequency and amplitude over time. 
Recendy, Van Steenis et al. (submitted) developed a new technique that provides 
simultaneously the instantaneous amplitude and frequency of a signal in time within a 
narrow frequency band, for instance the HF band. This technique may be used to 
make a comparison between the time-frequency data of the respiratory and HR 
signal, and may allow us to make statements about the extent to which changes in the 
respiratory frequency and depth are followed by alterations in frequency and 
amplitude of the HR signal. 
4 Cholinergic dysfunction in depressed patients 
Since J anowsky and colleagues proposed the cholinergic hypothesis of depression 
(Janowsky et al., 1972), considerable evidence has accumulated supporting a role of 
the cholinergic system in the etiology of depression (J anowsky et al., 1994; J anowsky 
and Overstreet, 1995). Increased central cholinergic activity and/or cholinergic 
hypersensitivity through an increased number of postsynaptic receptors or activation 
of the intracellular second-messenger system may be responsible for depressed mood, 
behavioral inhibition (e.g. reduced spontaneous motor activity) and changes in the 
REM sleep observed in depressed patients. As a consequence of the very rapid 
metabolism of acetylcholine and the absence of traceable metabolites, it is difficult to 
measure central cholinergic fnoctions direcdy. Central cholinergic agents have an 
effect on many physiological variables, including polysomnographic, psychomotor, 
cardiovascular, papillary, neuroendocrine, neurohormonal, thermoregulatory, salivary 
and sweat parameters (Dilsaver, 1986; Akselrod et al., 1985; Janowsky et al., 1994; 
Janowsky and Overstreet, 1995). Because of their sensitivity to cholinergic 
~ 128 ~ Chapter 7 
manipulations, these parameters may be appropriate (peripheral) markers of the 
central cholinergic function. 
In humans, the reduction of motor behavior induced by central cholinergic 
agonists and cholinesterase inhibitors is very similar to psychomotor retardation in 
depressed patients Oanowsky et al., 1994). In this respect, the reduced level of 
spontaneous motor activity during daytime in unmedicated depressed patients as 
described in chapter 4 may reflect a cholinergic dysfunction. Yet, it is unknown which 
parts of the brain are involved in the cholinergic dysfunction in depressed patients. 
Alterations in psychomotor activity in major depression can originate from various 
central cholinergic systems. In fact, the cholinergic neurons in the neostratum are 
interneurons that control normal motor function in interaction with nigrostriatal 
doparoine and striatal GABAergic neurons (Hyman and Nesder, 1993; Chau et al., 
2001). In addition, cholinergic neurons in the basal forebrain have projections to 
limbic structures such as the hippocampus and amygdala, which are amongst others 
important for motivation (Hyman and Nestler, 1993; Chau et al., 2001). Finally, the 
reticular activating system has a distinct cholinergic component that is involved in 
behavioral arousal (Dilsaver, 1986). 
In chapter 5 we suggested that the anticholinergic and/ or (nor)adrenergic 
properties of imipramine were responsible for the increase in daytime motor activity 
after treatment. A large number of studies demonstrated that acute and chronic 
administration of anticholinergic drugs can cause behavioral activation in rats 
Oanowsky et al., 1972; Overstreet et al., 1995; Daws and Overstreet, 1999). As far as 
we know the effects of central anticholinergic agents on spontaneous motor behavior 
in humans have not been evaluated. It is also plausible that imipramine increases 
motor activity in depressed patients through a direct or indirect effect on other 
neurotransmitter systems. To illustrate, behavioral inhibition by the cholinergic 
agonist physostigmine was found to be rapidly reversed by stimulation of the central 
noradrenergic and dopaminergic system a anowsky et al., 1994). The fact that 
exaggerated immobility in cholinergic hypersensitive rats could be reduced by both 
the TCAs imipraroine and desipramine, and the SSRI sertraline points to the 
possibility of an interaction between muscarinic and aminergic post-receptors in the 
G protein function or in other aspects of the cellular second pathway (Daws and 
Overstreet, 1999). If this would be the underlying mechanism of increased motor 
activity after antidepressant treatment, the treatment period with fluvoxamine may 
have been too short to establish an effect. To elucidate these mechanisms the 
measurement of the 24~hour pattern of motor activity in depressed patients before, 
during and after prolonged administration of a central anticholinergic, a TCA, a SSRI, 
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a selective noradrenaline reuptake inhibitor (SNRI) and placebo should be 
performed. 
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Acetylcholine is an important neurotransmitter of the parasympathetic 
system (Powley, 1999). Blockade of the parasympathetic activity to the sinus node of 
the heart by acute challenges of muscarinic antagonists and vagotomy resulted in the 
abolishment of the HF variation of the HR (Akselrod eta!., 1981,1985; Pomeranz et 
a!., 1985; Malliani eta!., 1991). Therefore, HR power in the high frequency band 
(0.15-0.50 Hz) is considered to be an index of parasympathetic activity (Parati eta!., 
1995; Task Force, 1996), but may also be an indirect marker of cholinergic activity in 
major depression. The study of chapter 4 showed that the HR power in the HF band 
was not different between unmedicated depressed patients and healthy subjects. If 
HF power is a marker for cholinergic activity indeed, this flnding is not supportive 
for a cholinergic dysfunction in major depression. However, the role of the 
cholinergic system in parasympathetic cardiac control is complex, because an 
increased HF power of HR was found after low-doses of cholinergic antagonists 
probably due to central activation (Montano et al., 1998). For this reason, HR 
variability in the HF band cannot be considered to be a simple indicator of 
cholinergic activity. 
In chapter 6 we reported that after treatment 'With imipramine, a reduction in 
HF power of HR occurred in the depressed patient group. Anticholinergic effects of 
imipramine were considered to be responsible for this effect. Fluvoxamine is 
assumed to be free of cholinergic actions, but nevertheless the patients demonstrated 
a decreased HF power of HR after fluvoxamine. Future studied should focus on the 
origin of this effect. 
Dilsaver (1986) emphasised that combining peripheral markers of central 
cholinergic mechanisms would provide more insight in the cholinergic dysfunction in 
major depression. Some evidence was found in chapter 4 for a relationship between 
the psychomotor function and autonomic cardiac functioning in depressed patients. 
Overall, the unmedicated depressed patients with lower motor activity levels 
demonstrated higher SBP levels. Based on this fmding no statements could be made 
about the existence of common neurobiological pathways. Challenge studies in 
healthy subjects investigating simultaneously the effect of cholinergic agents on the 
24-hour motor activity and autonomic cardiac functioning may further clarify the 
relationship between motor activity and cardiovascular parameters in depression. 
They may also provide additional information about how central and peripheral 
cholinergic processes influence these parameters. 
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5 Conclusions 
Based on the studies of this thesis, the following conclusions were drawn: 
1) The 24-hour pattern of motor activity in healthy subjects is characterised by a 
complex time trend. The overall level of motor activity is related to Harm 
Avoidance and Reward Dependence, but the time trend is not affected by these 
personality traits. 
2) Risk factors have an effect on mean heart rate and blood pressure during supine 
rest and orthostatic challenge in healthy subjects. The influence of these factors 
on heart rate and blood pressure variability and baroreflex sensitivity is restricted 
to a decreased overall heart rate variability in smokers and subjects with a higher 
body mass index. 
3) There are differences in the 24-hour pattern of motor activity and the autonomic 
regulation of the cardiovascular system between unmedicated depressed patients 
and healthy subjects. Agitation is related to increased heart rate and blood 
pressure levels and retardation to decreased blood pressure levels in these 
patients. There is also a positive relationship between motor activity and blood 
pressure. 
4) Imipramine treatment in depressed patients results in higher motor activity levels 
during wake and more fragmentation of motor activity during sleep. Fluvoxa-
mine treatment does not affect the 24-hour motor activity level. The effect of 
imipramine may be caused by its pharmacological action, rather than by clinical 
improvement. 
5) Sympathetic and parasympathetic activity is reduced in depressed patients after 
imipramine and fluvoxamine treatment, although the reduction after fluvoxamine 
is much less pronounced. Heart rate and blood pressure levels are positively 
related to severity of depression, but improvement of depressive mood does not 
modify changes in these cardiovascular parameters after antidepressant 
treatment. 
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24-HOUR MOTOR ACTIVI1Y AND AUTONOMIC CARDIAC 
FUNCTIONING IN MAJOR DEPRESSIVE DISORDER 
Major depressive disorder is an affective disorder and its life time prevalence in the 
Dutch population is about 15 %. It is a psychiatric disorder with a large disease 
burden. There are three important factors that are considered to contribute, alone or 
by interaction, to the development of this psychiatric disorder: genetic factors, 
psychosocial, and neurobiological factors. The major hypotheses about the 
neurobiological basis of major depression are the original monoamine hypothesis and 
the more recent hypothalamic-pituitary-adrenal (HP A) axis hyperactivity hypothesis. 
Depression is also proposed to be a manifestation of hypersensitivity of the 
cholinergic system, but the cholinergic dysfunction in depressed patients has not 
been extensively studied. Depressed patients can be treated effectively by 
antidepressants such as tricyclic antidepressants (fCAs) and selective serotonin 
reuptake inhibitors (SSRis ). TCAs and SSRis have a different pharmacological profile 
and their efficacy is suggested to be different in hospitalised patients. 
One important feature of major depressive disorder is the psychomotor 
dysfunction, which is characterised by psychomotor retardation and/ or agitation. 
Retardation is reflected in the slowing down of physical and psychic activity and 
manifestations of agitation are for instance being unable to sit still, pacing, and 
handwringing. Dysfunctions in the central dopaminergic system are involved in 
psychomotor disturbances in depressed patients, but cholinergic hypersensitivity may 
also be one of the underlying factors. The psychomotor disturbance is likely to be 
reflected in the spontaneous pattern of motor activity. Previous studies reported that 
depressed patients were less active during the day than healthy persons and that they 
had an altered distribution of motor activity throughout the day. Personality, age, and 
gender may be determinants of the diurnal pattern of motor activity in the general 
population, whereas in depressed patients the clinical state and antidepressant 
treatment are two additional factors that may influence 24-hour motor activity. 
Furthermore, a relationship between major depression and abnormalities in the 
autonomic regulation of the cardiovascular system has been suggested. The 
autonomic cardiac dysfunction, in particular diminished parasympathetic activity 
resulting in decreased heart rate (HR) variability, has been hypothesised to be one of 
the biological factors involved in the increased risk of cardiovascular disease in 
depressed patients. Alterations in the autonomic :regulation in major depression may 
be related to clinical state, antidepressant treatment and the higher prevalence of risk 
factors. 
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The general aim of the studies of this thesis was to obtain insight in the 
psychomotor and autonomic cardiac dysfunctions in major depressive disorder and 
to evaluate the potential determinants of these dysfunctions. The 24-hour pattern of 
motor activity and the autonomic regulation of the cardiovascular system were 
evaluated in healthy subjects and unipolar depressed inpatients of the depression 
ward of the University Hospital Rotterdam- Dijkzigt. All patients participated in a 
clinical trial to the efficacy of antidepressant treatment and electroconvulsive therapy 
(ECT) in therapy-resistant depression. In this thesis, we used the patient data 
obtained during the psychotropic drug free period and after treatment with either the 
TCA imipramine or the SSRI fluvoxamine. The 24-hour pattern of motor activity 
was assessed by wrist-actigraphy, and spectral analysis of cardiovascular variability 
was applied to obtain information about the autonomic (sympathetic and 
parasympathetic) regulation of the cardiovascular system. 
In chapter 2 the effect of personality, age and gender on the overall level of motor 
activity and the shape of the diurnal pattern was studied in 99 healthy subjects 
between 20-70 years of age. The Tridimensional Personality Questionnaire (TPQ) of 
Cloninger was applied to assess four temperament traits (Novelty Seeking, Harm 
Avoidance, Reward Dependence and Persistence). On visual inspection, the 24-hour 
pattern of motor activity of healthy subjects was characterised by an increase in 
motor activity in the early morning, a peak of motor activity in the late afternoon, and 
a gradual decline of motor activity during the evening and night. The shape of the 
diurnal pattern or, in statistical terms, the time trend was estimated by six time terms. 
The overall level of motor activity was found to decrease by age, indicating that older 
subjects were overall less active than younger subjects, but age had no effect on the 
shape of the diurnal pattern. The 24-hour pattern of motor activity did not differ 
betw'een males and females. Furthermore, Harm Avoidance was negatively related to 
overall levels of motor activity, and Reward Dependence positively. Similar to age, 
Harm Avoidance and Reward Dependence did not modify the time trend. 
Summarising: This study showed that the diurnal pattern of motor activity 
has a complex time trend in healthy subjects. Dimensions of temperament and age 
were determinants of the overall level of motor activity in healthy subjects, but the 
shape of the diurnal pattern of motor activity was not influenced by these factors. 
In chapter 3 the role of age, gender and risk factors (smoking, plasma lipid levels, 
body mass index and habitual physical activity) in the autonomic regulation was 
investigated in 65 healthy subjects between 20-59 years of age. Mean HR, mean 
systolic and diastolic blood pressure (SBP and DBP), HR and SBP variability, and 
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baroreflex sensitivity were measured during supine rest and orthostatic challenge 
(60% head-up tilt). The baroreflex is a negative feedback mechanism to maintain the 
arterial blood pressure in a normal range. Orthostatic challenge induced an increase 
in mean HR and DBP, mid-frequency band (MF: 0.07-0.14 Hz) power of SBP, and a 
decrease in high-frequency band (HF: 0.15-0.50 Hz) power ofHR and baroreflex 
sensitivity. The overall HR variability (variation coefficient), MF and HF variability of 
HR, and the baroreflex sensitivity were decreased by age. Furthermore, a higher mean 
HR was related to higher total and high density lipid (HDL) cholesterol levels and to 
lower levels of habitual physical activity. Mean SBP and DBP were positively related 
to the body mass index and the overall HR variability was negatively related to both 
smoking and the body mass index. 
Concluding, this study demonstrated, in agreement with the literature, that 
orthostatic challenge is characterised by an augmentation of sympathetic activity and 
a reduction of parasympathetic (vagal) activity. Subjects with a higher age showed 
lower HF power of HR and decreased baroreflex sensitivity, suggesting that older 
subjects have a reduced parasympathetic activity. In healthy subjects the effect of risk 
factors on cardiovascular variability and baroreflex sensitivity may be limited. 
However, the fact that HR and BP levels were differentially affected by one or more 
risk factors reveals that these factors do play a complex role in the modulation of the 
cardiovascular system. 
In chapter 4 the spontaneous pattern of motor activity and the autonomic cardiac 
functioning during supine rest was studied in 67 unmedicated severely depressed 
inpatients between 35 and 65 years of age. The data of the patients were compared 
with data of two healthy control groups. Within the patient group, the relevance of 
specific clinical features (high levels of anxiety, agitation, retardation and psychotic 
features) was explored in relation to 24-hour motor activity and autonomic 
regulation, and the mutual relationship between motor activity parameters and 
cardiovascular parameters was evaluated. 
In comparison to healthy subjects, the patients demonstrated a lower motor 
activity level during wake and a higher motor activity level during sleep. During the 
wake period, the patients also had a lower fragmentation of motor activity, indicating 
that rest periods were less frequendy interrupted by motor activity. During sleep they 
showed a reduced immobility, which suggests a decrease in the relative amount of 
rest. Within the patient group, the presence of agitation was positively related to 
motor activity during wake, and the presence of retardation negatively to motor 
activity throughout the entire day and to fragmentation of motor activity during 
wake. Furthermore, depression was related to higher mean HR and DBP levels, but 
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not to HR and SBP variability or baroreflex sensitivity. Agitated depressed patients 
showed higher mean HR and SBP levels than nonagitated patients, whereas retarded 
patients demonstrated lower mean SBP and DBP levels than nonretarded patients. 
The motor activity level during wake was another determinant of the mean SBP. 
These fmdings contribute to our understanding of the neurobiological basis 
of (subtypes of) depression. However, the relationship between disturbances in 
psychomotor activity and autonomic regulation, and the underlying pathway need to 
be further clarified. Major depressive disorder is related to changes in the 24-hour 
motor activity and the autonomic regulation of the cardiovascular system, but the 
latter changes were restricted to mean HR and BP levels. Within the patient group, 
both motor activity and cardiovascular parameters were influenced by the presence of 
agitation and retardation. Furthermore, we found an association bet\veen motor 
activity during wake and the mean SBP. 
Chapter 5 describes how we investigated the effect of antidepressant treatruent on 
the diurnal pattern of motor activity in 52 depressed patients (20 males, 32 females; 
mean age= 52.5 years). Patients were studied during a psychotropic drng free period 
of at least 7 days and after 4 weeks of treatruent with either imipramine or 
fluvoxamine at therapeutic plasma levels of the drugs. On average, there was a clinical 
improvement of depressive mood and retardation in patients treated with 
imipramine, as well as in patients treated v.rith fluvoxamine. After imipramine, the 
mean motor activity during wake and the fragmentation of motor activity during 
sleep were increased. Fluvoxarnine treatruent did not affect any of the wrist-
actigraphy parameters. Post-hoc statistical analyses showed that the increase in motor 
activity after imipramine was not modified by changes in severity of depression or 
clinical scores of retardation and agitation. It was remarkable that in the imipramine 
group the motor activity levels during wake were still much lower after treatruent 
than the activity levels of the healthy subjects described in chapter 2. One explanation 
for this fmding may be the clinical setting in which the patients were measured. 
To summarise, adequate treatment with imipramine, but not \.Vi.th 
fluvoxamine, resulted in an increased daytime motor activity. Improvement of the 
clinical state was not related to this change in motor activity, therefore differences in 
the pharmacological proflle between imipramine and fluvoxarnine could be 
responsible for this effect. Imipramine has anticholinergic and (nor)adrenergic 
properties, whereas fluvoxamine has not. The clinical relevance for the effect of 
imipramine on motor activity should be investigated in future studies, especially in 
relation to psychomotor retardation. 
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In chapter 6 we evaluated the effect of antidepressant treatment on autonomic 
cardiac functioning during supine rest and orthostatic challenge in 52 depressed 
patients (20 males, 32 females; mean age = 52.5 years). Cardiovascular measurements 
were done during a psychotropic drug free period (average duration 11 days) and 
after 4 weeks of treatment with either imipramine or fluvoxamine at therapeutic 
plasma levels of both compounds. After imipramine, patients showed an elevated 
mean HR level and a diminished overall HR variability (variation coefficient), MF and 
HF power of HR, MF power of SBP and a reduced baroreflex sensitivity. In contrast, 
patients treated with fluvoxamine demonstrated no significant alterations in mean 
HR or BP. However, after fluvoxamine all HR variability parameters and MF 
variability of SBP were decreased during supine rest. During orthostatic challenge the 
overall as well as MF variability of SBP was decreased. On group level, the response 
pattern to orthostatic challenge only showed minor changes in each group after 
treatment. However, in the imipramine group 1 patient developed orthostatic 
hypotension during treatment, while in the fluvoxamine group orthostatic 
hypotension disappeared in 2 patients. Finally, in the imipramine group severity of 
depression was positively related to mean HR (when data of the baseline and post~ 
treatment period were combined), but improvement of depressive mood did not 
modify the change in mean HR level after treatment. In the fluvoxamine group 
severity of depression was positively related to mean SBP and DBP. 
The conclusion of this study was that both imipramine and fluvoxamine 
reduced sympathetic and parasympathetic activity in depressed patients, although the 
effects of fluvoxamine were much less pronounced. Depressive mood was positively 
related to mean HR and BP, but not to any of the parameters of cardiovascular 
variability or baroreflex sensitivity. The alterations in the autonomic regulation after 
treatment could be attributed to the pharmacological actions of the drugs and were 
not explained by improvement of depressive mood. 
Chapter 7 presents the final conclusions of this thesis. Major depressive disorder is 
related to alterations in the spontaneous pattern of motor activity and in autonomic 
cardiac functioning, although the last one was restricted to mean HR and BP. Clinical 
state in depressed patients affects the 24~hour motor activity and autonomic 
regulation. However, pharmacological effects rather than improvement of clinical 
state were responsible for changes in the motor activity and cardiovascular 
parameters after treatment with imipramine or fluvoxamine. In healthy subjects a 
relationship was found between personality traits and overall levels of motor activity. 
This may be relevant for the interpretation of the motor activity data of depressed 
patients, because these patients probably have a lower Harm Avoidance score than 
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the general population. Some risk factors (higher lipid levels, less habitual physical 
activity and a higher body mass index) had clear effects on mean HR and BP, but we 
observed minor effects of risk factors on HR and SBP variability and baroreflex 
sensitivity in healthy subjects. The contribution of risk factors to autonomic cardiac 
functioning in depressed patients needs to be further investigated, especially because 
of the higher prevalence of risk factors in this patient group. 
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24-UURS MOTORISCHE ACTIVITEIT EN AUTONOME 
CARDIALE FUNCTIE IN DEPRESSIEVE STOORNISSEN 
Depressie is een stemmingsstoornis waarvan de 'life-time' prevalentie in Nederland 
ongeveer 15% bedraagt, hetgeen betekent dat ongeveer 1 op de 7 mensen op een 
bepaald tijdstip in bet !even lijdt aan een depressieve stoomis. Drie belangtijke 
factoren worden verondersteld, aileen of in samenwerking met elkaar, bij te dragen 
aan het ontstaan van deze psychiatrische ziekte. Dit zijn genetische factoren, 
psychosociale factoren en neurobiologische factoren. De twee meest gangbare 
hypothesen over de neurobiologische basis van depressieve stoomissen zijn de 
oorspronkelijke monoaminen hypothese en de ten opzichte hiervan meet recente 
hypothese over de hyperactiviteit van de hypothalamus-hypofyse-bijnier (liP A)-as. 
Depressie wordt daarnaast verondersteld het resultaat te kunnen zijn van een 
overgevoeligheid van bet cholinerge zenuwstelsel (met acetylcholine als een van de 
belangtijkste neurotransmitters), maar de cholinerge disfunctie in depressieve 
patienten is niet uitvoerig onderzocht. Depressieve patienten kunnen succesvol 
behandeld worden met antidepressiva zoals de tricyclische antidepressiva (ICAs) en 
de selectieve serotonine heropname remmers (SSRis). TCAs en SSRis hebben 
verschillende farmacologische eigenschappen en de effectiviteit van beide 
antidepressiva is mogelijk verschillend bij patienten die zijn opgenomen in de kliniek. 
Een belangrijk kenmerk van depressieve stoomissen is de psychomotorische 
disfunctie, waarbij een onderscheid gemaakt kan worden tussen psychomotorische 
retardatie (vertraging) en agitatie (motorische onrust). Retardatie heeft betrekking op 
de vertraging van zowellichamelijke als geestelijke activiteiten, terwijl agitatie zich 
bijvoorbeeld uit in niet stil kunnen zitten, op en neer !open, en han den wringen. 
Aangenomen wordt dat disfuncties van het centrale dopami.nerge zenuwstelsel een 
rol spelen bij de veranderingen in de psychomotoriek van depressieve patienten, maar 
de eerder genoemde overgevoeligheid van bet cholinerge zenuwstelsel is mogelijk 
ook een van de onderliggende factoren. De verstoring in de psychomotoriek komt 
ook naar voren in het 24-uurs patroon van motorische activiteit; depressieve 
patienten zijn minder actief overdag en hebben een veranderde verdeling van 
motorische activiteit over de dag been. Een mogelijke determinant (bepalende factor) 
van het spontane motorisch activiteiten patroon bij gezonde personen is 
persoonlijkheid. Bij depressieve patienten zijn bet klinisch toestandsbeeld (b.v. ernst 
van de depressie) en de behandeling met antidepressiva twee aanvullende factoren die 
de 24~uurs motorische activiteit mogelijk beinvloeden. Het is bekend dat depressieve 
stoornissen mogelijk ook samenhangen met verstoringen in de autonome regula tie 
van het cardiovasculaire systeem, of met andere woorden, de controle over het hart-
- 160 - Samenvatting 
en vaatstelsel door het autonome zenuwstelsel, dat kan onderverdeeld worden in een 
sympathisch en parasympathisch gedeelte. De autonome cardiale disfunctie is een van 
de biologische factoren die verondersteld worden verantwoordelijk te zijn voor het 
verhoogde risico op hart- en vaatziekten bij depressieve patienten. In het bijzonder 
zou het gaan om een venninderde act:iviteit van het parasympathische zenuwstelsel 
resulterend in een verlaagde hartslagvariabiliteit (variabiliteit van de tijdsintervallen 
tussen opeenvolgende hartslagen). V eranderingen in de autonome regula tie van het 
cardiovasculaire systeem bij depressieve pat:ienten hangen mogelijk samen met het 
klinisch toestandsbeeld of met het vaker voorkomen van risicofactoren voor hart- en 
vaatziekten (zoals roken) in deze patientengroep. 
Het algemene doe! van de onderzoeken beschreven in dit proefschrift was 
om meer inzicht te krijgen in de psychomotorische en autonome cardiale disfunct:ies 
bij depressieve patienten en de mogelijke determinanten van deze disfuncties. 
Daartoe werd het 24-uurs patroon van motorische act:iviteit en de autonome regula tie 
van het cardiovasculai.re systeem onderzocht bij gezonde personen en bij patienten 
met een unipolaire depressieve stoornis. De patienten waren opgenomen op de 
afdeling Psychiatrie van het Erasmus Medisch Centrum Rotterdam- Dijkzigt. Aile 
patienten waren deelnemers aan een klinische studie naar de effectiviteit van de 
behandeling met antidepressiva en electroconvulsieve therapie (ECT) bij 
therapieresistente depressies. In dit proefschrift hebben we gebruik gemaakt van 
patientgegevens die werden verzameld tijdens een medicatie vrije periode (voor 
aanvang van de behandeling) en na dubbelblinde behandeling met de antidepressiva 
imipramine ( een TCA) of fluvoxamine ( een SSRI). Met behulp van een pols-
actometer ( een soort polshorloge met een versnellingssensor) werd gedurende drie 
dagen en nachten het spontane patroon van motorische activiteit geregistreerd. 
Hartslag, bloeddruk en ademhaling werden gemeten in het psychofysiologisch 
laboratorium van de afdeling Psychiatrie en vervolgens werd de techniek van 
spectraalanalyse toegepast om informatie te verkrijgen over de autonome regula tie 
van het cardiovasculaire systeem. 
In hoofdstuk 2 werd bij 99 gezonde personen tussen de 20 en 70 jaar het globale 
niveau van motorische activiteit en het beloop van het 24-uurs patroon bepaald. 
We bestudeerden het effect van persoonlijkheid, leeftijd en geslacht een effect op dit 
patroon. De gegevens van de gezonde personen dienden als nonngegevens waarmee 
de gegevens van de patienten vergeleken konden worden. De Tridimensional 
Personality Questionnaire (TPQ) van Cloninger werd afgenomen om vier dimensies 
van temperament te bepalen (Novelty Seeking, Harm Avoidance, Reward 
Dependence, en Persistence). De motorische activiteit van de gezonde person en 
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uitgezet tegen de tijd laat zien dat er een toename van motorische activiteit aanwezig 
was in de vroege ochtend, een piek in de motorische activiteit aan het einde van de 
middag, en een geleidelijke daling van bet motorische activiteiten niveau tijdens de 
avond en nacht. Het beloop over de 24-uurs periode bleek geschat te kunnen worden 
met zes verschillende tijdsfuncties. We vonden dat bet globale niveau van motorische 
activiteit afnam bij een hogere leeftijd; oudere personen waren over het algemeen 
minder actief dan jongere person en, maar leeftij d had geen effect op bet beloop van 
het dagelijkse patroon. Het 24-uurs patroon van motorische activiteit verschilde niet 
tussen mannen en vrouwen. Daamaast bleek er een positieve relatie te bestaan tussen 
de Harm Avoidance score en het globale niveau van motorische activiteit en een 
negatieve relatie tussen de Reward Dependence score en dit niveau. Net als leeftijd, 
hadden Harm Avoidance en Reward Dependence geen effect op bet beloop van bet 
24-uurs patroon. 
Samenvattend: Het dagelijks patroon van motorische activiteit van gezonde 
personen kan beschreven worden met behulp van een complexe tijdsfunctie. 
Persoonlijkheidsdimensies en leeftijd bepaalden bet globale niveau van motorische 
activiteit, maar zij waren geen determinanten van het beloop over de dag. 
Hoofdstuk 3 beschrijft bet onderzoek bij 65 gezonde personen tussen de 20 en 59 
jaar naar de rol van leeftijd, geslacht en risicofactoren (roken, cholestero~ 
overgewicht, en dagelijkse hoeveelheid lichamelijke activiteit) bij de autonome 
regula tie van bet cardiovasculaire systeem. De gemiddelde hartslag, systolische en 
diastolische bloeddruk, de hartslag- en systolische bloeddrukvariabiliteit, en de 
baroreflex gevoeligheid werden bepaald tijdens rust (in lighouding) en een orthostase 
test (60% passief rechtopstaand). De orthostase test leidde tot een toename van de 
gemiddelde hartslag en diastolische bloeddruk, een toename van de systolische 
bloeddrukvariatie in de midden frequentie band (1\iF: 0.07-0.14 Hz), en een afname 
van de hartslagvariatie in the hoge frequentie band (HF: 0.15-0.50 Hz). De globale 
hartslagvariabiliteit (variatie coefficient), de MF en HF hartslagvariabiliteit en de 
baroreflex gevoeligheidsindex waren lager bij personen met een hogere leeftijd. 
Behalve een effect van leeftijd, ontdekten we dat de gemiddelde hartslag boger was 
bij personen met hogere totaal en HDL (high density lipide) cholesterol waarden en 
bij personen met een geringere hoeveelheid dagelijkse lichamelijke activiteit. Ook 
kwam naar voren dat hogere systolische en diastolische bloeddruk waarden 
gerelateerd waren aan een hogere body mass index ( een maat voor overgewicht), en 
dat verlaagde globale hartslagvariabiliteit zowel samenhing met roken als met een 
hogere body mass index. 
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De conclusie van bovenstaand onderzoek was dat de orthostase test 
resulteerde in een toegenomen sympathische activiteit en verminderde 
parasympathische (vagale) activiteit. Dit is in overeenkoms met de bestaande 
literatuur. Oudere personen vertoonden een lagere HF hartslagvariabiliteit en een 
verminderde baroreflex gevoeligheid. Dit suggereert dat ouder worden gepaard gaat 
met een afname van parasympathische activiteit. Bij gezonde person en is het effect 
van risico factoren op cardiovasculaire variabiliteit en baroreflex gevoeligheid 
mogelijk beperkt. Het feit dat enkele van de risicofactoren een (verschillend) effect 
hadden op de gemiddelde hartslag en bloeddruk, maakt duidelijk dat deze factoren 
een complexe rol spelen bij de regulatie van het cardiovasculaire systeem. 
In hoofdstuk 4 werden het spontane patroon van motorische activiteit en de 
autonome cardiale functie tijdens rust (in lighouding) onderzocht bij 67 medicatie 
vrije patienten met een ernstige depressieve stoornis tussen de 35 en 65 jaar. De 
gegevens van de patienten werden vergeleken met de gegevens afkomstig van t\Vee 
gezonde controlegroepen. Binnen de patientengroep werd het belang van specifieke 
klinische kenmerken (hoog angstniveau, agitatie, retardatie en psychotische 
kenmerken) voor de 24-uurs motorische activiteit en de autonome regulatie 
onderzocht. Eveneens werd de onderlinge relatie tussen de parameters voor 
motorische activiteit en de cardiovasculaire variabelen vastgesteld. In vergelijking tot 
gezonde personen vertoonden de patienten een lager niveau van motorisch activiteit 
tijdens wakker-zijn en een hoger niveau van motorische activiteit tijdens de slaap. 
Tijdens de waakperiode was ook de fragmentatie van de motorische activiteit 
verminderd, wat inhoudt dat rustperiodes minder vaak werden afgewisseld met 
motorische activiteit, terwijl er tijdens de slaap minder immobiliteit was, hetgeen 
betekent dat bier mogelijk sprake was van een afname van de relatieve hoeveelheid 
rust. Binnen de groep patienten was de aanwezigheid van agitatie gerelateerd aan 
meer motorische activiteit tijdens de waakperiode, en de aanwezigheid van retardatie 
aan minder motorische activiteit gedurende de gehele dag en aan minder fragmentatie 
van motorische activiteit overdag. 
De depressieve stoomis werd gekenmerkt door een hogere gemiddelde 
hartslag en diastolische bloeddruk, maar niet door veranderingen in hartslag- en 
systolische bloeddrukvariabiliteit of in baroreflex gevoeligheid. Geagiteerde 
depressieve patienten hadden gemiddeld een hogere hartslag en systolische bloeddruk 
dan niet geagiteerde patienten, terwijl patienten met retardatie gemiddeld een lagere 
systolische en diastolische bloeddruk hadden dan patienten zonder retardatie. 
Daarnaast bleek bij de patienten het niveau van motorische activiteit tijdens de 
waakperiode positief gerelateerd te zijn aan de gemiddelde systolische bloeddruk. 
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Bovenstaande bevindingen dragen bij tot het begrip van de neurobiologische 
basis van ( subtypen van) depressieve stoomissen. We von den enig bewijs voor een 
verband tussen de verstoringen in de psychomotorische act:iviteit en de autonome 
regula tie, maar het onderliggende mechanisme moet nog verder verhelderd worden. 
Depressieve stoornissen hangen samen met veranderingen in de 24-uuts motorische 
activiteit en de autonome regulat:ie van het catcliovasculaire systeem, maar deze 
veranderingen komen aileen naar voren in de gemiddelde hartslag en bloeddruk 
niveaus. De aanwezigheid van agitatie en retardatie bepalen zowel de parameters voor 
motorische activiteit als de carcliovasculaire variabelen. Eveneens bestond er een 
verband tussen motorische activiteit tijdens de waakperiode en de gemiddelde 
systolische bloeddruk. 
Hoofdstuk 5 beschrijft hoe het effect van de behandeling met antidepressiva op het 
dagelijkse patroon van motorische activiteit is nagegaan bij 52 depressieve patienten 
(20 mannen, 32 vrouwen; gemiddelde leeftijd = 52,5 jaar). De patienten werden in 
eerste instantie onderzocht tijdens een periode van tenminste 7 dagen waarin zij geen 
psychofarmaca gebruikten en een tweede keer na een behandeling van 4 weken met 
imipramine of fluvoxamine terwijl zij therapeutisch effectieve doseringen gebruikten 
van de desbetreffende antidepressiva. Op groepsniveau was er een klinische 
verbetering van de depressieve stemming en van de mate van retardatie zowel bij de 
patienten die behandeld waten met imipramine als met fluvoxamine. Na imipramine 
was het glohale motorische activiteiten niveau tijdens de waakperiode toegenomen 
evenals de fragmentatie van motorische activiteit tijdens de slaap. Na fluvoxamine 
werd geen enkele verandering waargenomen in de parameters voor motorische 
act:iviteit. Aanvullende statistische analyses toonden aan dat de toename van 
motorische activiteit na imipramine niet a:fh.ing van de verbetetde depressieve 
stemming of van veranderingen in de klinische scores voor agitatie en retardatie. Het 
was opvallend dat na behandeling met imipramine overdag het motorische 
activiteiten niveau nog steeds veellaget was dan dat van gezonde personen (zie 
hoofdstuk 2). Dit zou te maken kunnen hebben met de klinische setting waarin de 
patienten verbleven. 
Samenvattend: een adequate behandeling met imipramine, maar niet met 
fluvoxamine resulteerde in een toename van de motorische act:iviteit overdag. 
Aangezien verbeteringen in het klinisch toestandsheeld niet gerelateerd waren aan de 
verandering in motorische activiteit, zouden farmacologische verschillen tussen 
imipramine en fluvoxamine verantwoordelijk kunnen zijn voor dit effect. Imipramine 
heeft bijvoorbeeld anticholinerge en (nor)adrenerge eigenschappen, terwijl 
fluvoxamine deze niet heeft. De klinische relevant:ie van het effect van imipramine op 
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de motorische activiteit bij depressieve patienten met psychomotorische retardatie is 
een onderv.rerp voor toekomstig onderzoek. 
In hoofdstuk 6 bestudeerden we het effect van de behandeling met antidepressiva op 
de autonome regulatie tijdens rust (in lighouding) en tijdens een orthostase test bij 
dezelfde groep depressieve patienten als in hoofdstuk 5. Carcliovasculaire metingen 
werden verricht tijdens een periode waarin geen psychofarmaca werden gebruikt 
(gemiddelde duur van deze periode was 11 dagen) en na een adequate behandeling 
van 4 weken met imipramine of fluvoxamine. Na behandeling met imipramine werd 
bij de patienten een verhoogde gemiddelde hartslag gevonden, en een afname van de 
globale hartslagvariabiliteit, de hartslagvariatie in de MF en HF band, de 
bloeddrukvariatie in de MF band en de baroreflex gevoeligheid. Na behandeling met 
fluvoxamine werden geen significante veranderingen in de gemiddelde harts lag en 
bloeddruk aangetoond. Wij vonden echter wel een verlaging van alle parameters voor 
hartslagvariabiliteit en van de MF bloeddrukvariabiliteit tijdens rust en van de globale 
en MF bloeddrukvariabiliteit tijdens de orthostase test. Op groepsniveau namen we 
na beide behandelingen slechts kleine veranderingen waar bij het reactiepatroon op 
orthostatische inspanning. In de imipramine-groep ontwikkelde 1 patient 
orthostatische hypotensie gedurende de behandeling, tetwijl in de fluvoxamine-groep 
orthostatische hypotensie bij 2 patienten niet !anger aanwezig was na behandeling. 
Tenslotte werd in de imipramine-groep een positief verband gevonden tussen de 
ernst van de depressie en de gemiddelde hartslag (wanneer de data van de baseline 
periode werden gecombineerd met de data verzameld na behandeling). Er was geen 
verband tussen de verbetering van de depressieve stemming en veranderingen in de 
carcliovasculaire variabelen. 
De conclusie van dit onderzoek was dat zowel imipramine als fluvoxamine 
de sympathische en parasympathische activiteit verminderden bij depressieve 
patienten, hoewel het effect van fluvoxamine vee! minder duidelijk was dan het effect 
van imipramine. Patienten clie meer depressief waren hadden een hogere hartslag en 
bloeddruk, maar de parameters voor carcliovasculaire variabiliteit en de baroreflex 
gevoeligheid waren niet gerelateerd aan de mate van depressiviteit. V eranderingen in 
de autonome regulatie bij het gebruik van antidepressiva kunnen worden 
toegeschreven aan farmacologische effecten, en niet zozeer aan verbeteringen van de 
depressieve stemming 
In hoofdstuk 7 komen de eindconclusies van clit proefschrift aan bod. Een 
depressieve stoornis hangt samen met veranderingen in het spontane patroon van 
motorische activiteit en de autonome cardiale functie, waa.rbij de autonome disfunctie 
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beperkt is tot veranderingen in de gemiddelde hartslag en bloeddruk. Het klinisch 
toestandsbeeld heeft een effect op de 24-uurs motorische activiteit en de autonome 
regula tie, maar farmacologische effecten en niet de verbetering van het klinische 
toestandsbeeld lijken verantwoordelijk te zijn voor veranderingen bij depressieve 
patienten na behandeling met imipramine en fluvoxarnine. Bij gezonde person en 
bepaalden Harm Avoidance en Reward Dependence, beide climensies van 
temperament, mede het globale niveau van de 24-uurs motorische activiteit. Deze 
bevinding zou van belang kunnen zijn bij de interpretatie van de gegevens over 
motorische activiteit van de patienten, aangezien depressieve patienten een lagere 
Harm Avoidance score hebben dan niet depressieve personen. Enkele risicofactoren 
(hogere cholesterol waarden, minder dagelijkse lichamelijke activiteit en een hogere 
body mass index) bingen sarnen met een hogere gemiddelde hartslag en bloeddruk bij 
gezonde personen, maar de effecten op carcliovasculaire variabiliteit en baroreflex 
gevoeligheid waren gering. Het is belangrijk dat in toekomstig onderzoek de rol van 
risicofactoren in de autonome carcliale functie bij depressieve patienten nader wordt 
onderzocht, met name omdat risicofactoren meer voorkomen in deze 
patientengroep. 

Dankwoord 

Dankwoord • 169 . 
De klus is geklaard! Opgelucht schrijf ik deze laatste pagina's. Vee! mensen hebben 
direct of indirect bijgedragen aan dit proefschrift. Zonder hen was het in ieder geval 
niet zover gekomen. 
Allereerst wil ik de patienten van de afdeling Dp2 van het Dijkzigt 
Ziekenhuis en de controle personen bedanken voor hun deelname aan mijn 
onderzoek. Ik hoop dat het proefschrift op enigerlei wijze kan bijdragen aan een 
verbetering van de behandeling van patienten met een depressieve stoornis. 
De hulp en inzet van de verpleegkundigen van de afdeling Dp2 waren 
onmisbaar bij dit onderzoek. Zij zorgden er o.a. voor dat de patienten hun dagboek 
invulden, de actometer omhielden (en niet in de fruitrnand of koelkast stop ten), en 
niet rookten of koffie dronken voor aanvang van de psychofysiologische metiog. 
De medewerkers van de afdeling Klinische Chemie wil ik bedanken voor de 
lipide bepalingen die zij hebben verricht. 
Walter van den Broek en Jan Bruijn, beste Walter en Jan, vanafhet begin tot 
aan de afronding van het proefschrift hebben jullie mij gesteund en hadden jullie 
vertrouwen in mij. Door jullie enthousiasme en gedrevenheid heb ik vee! valide en 
betrouwbare gegevens kunnen verzamelen. Daamaast gaven jullie mij als co-auteurs 
waardevolle adviezen bij het schrijven van de artikelen. Bedankt voor de fijne 
samenwerking van bijna 6 jaar. 
Siska Verploegh, beste Siska, jouw adrninistratieve talenten, praktische 
ins telling en punctualiteit waren van groot belang. Daarnaast nam je zeer deskundig 
bloed af en assisteerde indien nodig bij de metiogen. Dank je voor al je werk en 
collegialiteit. 
Professor Verhoeven, beste Willem, jij bent pas vorig jaar mijn promotor 
geworden vanuit de afdeling Psychiatrie. Ik heb het zeer gewaardeerd dat je je zo snel 
hebt ingelezen in het onderwerp van mijn proefschrift. Ik heb de vruchten mogen 
plukken van jouw wetenschappelijk inzicht, discipline en betrokkenheid. Van weinig 
naar veel begeleiding, dat was wennen, maar de snelheid van het schrijfproces nam 
hierdoor toe. Bedankt voor de goede begeleiding en de tijd die je hiervoor hebt 
vrijgemaakt. 
Professor Passchier, beste Jan, je bent als promotor vanuit de afdeling 
Medische Psychologie & Psychotherapie voortdurend betrokken geweest bij mijn 
onderzoek. J e hield belangstellend en nauwlettend de voortgang van het onderzoek in 
de gaten en voorzag mijn manuscripten van opbouwende kritiek. We zaten niet altijd 
op een lijn, maar naar mijn mening zijn we steeds weer tot elkaar gekomen. Ik wil ik 
je hartelijk bedanken voor je inzet en jouw bijdrage aan mijn academische groei. 
Professor Pepplinkhuizen, beste Lolke, jij hebt mij lange tijd begeleid als 
promotor vanuit de afdeling Psychiattie. Ik wil je bedanken voor jouw aandeel in het 
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tot stand komen van dit proefschrift. Ik hoop dat je het uiteindelijke resultaat met 
belangstelling zallezen. 
Doctor Tulen, beste Joke, jij hebt als dagelijkse begeleidster samen met mij 
hard gewerkt om dit resultaat te bereiken. V oorop stond dat het een goed 
proefschrift moest worden. Als copromoter is het mede aan jou om te beoordelen of 
dit inderdaad gelukt is. Ik heb vee! geleerd van jouw expertise op het gebied van de 
Psychofysiologie en ik heb bewonderiog voor jouw nauwgezetheid. We hebben elkaar 
steeds beter leren kennen en raakten op elkaar ingespeeld. Ik wil je oprecht bedanken 
voor alles wat je me hebt meegegeven. Ik kijk terug op een goede en leerzame 
periode. 
Professor Hengeveld, Professor Kerkhof en Professor van Doom en wil ik 
dank betuigen voor het plaatsnemen in de kleine promotiecommissie. Beste Lorenz, 
destijds was jij een van mijn stagebegeleiders. Ik ben verheugd dat je nu lid bent van 
mijn promotiecommissie. Beste Michie!, dank je voor het zorgvuldig doorlezen en 
beoordelen van de verschillende stukken het laatste jaar. Professor Kahn, Professor 
Wolters en Doctor Duivenvoorden wil ik bedanken voor hun acceptatie om 
opponent te zijn tijdens mijn verdediging. Beste Hugo, je hebt me vee! geleerd over 
statistische technieken en modelleren. We hebben heel wat boeiende uren 
doorgebracht (met thee en indien voorradig gebak). 
Op mijn boekenplank staat een lange rij met onderzoeksverslagen en 
literatuurstudies van studenten en co-assistenten. Beste Marlies Wegewijs - de Jong, 
Marieke Gieteling, Ben Baggerrnan, Kathelijne Koorengevel, Koen van der Kooy, 
Natasja van Bommel, Siska Kortekaas, Harry Bordhoe, Winston Leeflang, Andre 
Koelman, en Gerard Koetsier jullie brachten naast gezelligheid, vee! nieuwe en frisse 
ideeen mee. Beste Gerard, ik wil jou in het bijzonder bedanken voor je inzet bij ons 
gezarnenlijke artikel. 
Met vee! collega's van de afdeling Psychiattie en de afdeling Medische 
Psychologie & Psychotherapie heb ik a! die jaren heel prettig samengewerkt; 
medewerkers van beide secretariaten en de bibliotheek, psychiaters, arts-assistenten, 
co-assistenten, verpleegkundigen, therapeuten, collega-onderzoekers en collega-
docenten. Mede door hen ging ik iedere dag opgewekt op pad naar Rotterdam. 
In het bijzonder wil ik Hugo van Steenis, Dirk Stronks, Adriaan van 't 
Spijker, Tilleke Janssen, Marinel Cavelaars noemen. Beste Hugo, ons contact was niet 
zonder spanningen, maar je blijft in mijn herionering. Beste Dirk, jouw literaire gave 
en spitsvondige grappen maakte elk koffierondje aantrekkelijk. Lieve Adriaan en 
heste Til, jullie zorgden voor aangename onderbrekingen van rnijn strakke werkritme. 
l'cste Marine!, je hebt een unieke benaderiog van de wereld, die vaak verhelderend is. 
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Het was een voorrecht dee! uit te maken van de aio groep van de afdeling 
Medische Psychologie & Psychotherapie. Lieve Cecile Janssens, Chantal Kerssens, 
Jacqueline Mourik, Litanja Lodder, Marleen Duisterhof, Paula Bresser, Silvia van 
Dooren, en Vivian Merlijn ik zal jullie miss en! Ondanks mijn verre werkplek belden 
jullie mij trouw voor de lunch. Daarnaast denk ik met genoegen terug aan aile aio 
eten~es, barrels, sinterklaasavonden, verjaardagen, barbecues en sportactiviteiten. De 
levensthema's van het moment waarmee we worstelden stonden in onze gesprekken 
centraal. Dit schept een band. Een dikke kus voor een ieder. 
Aan mijn collega~promovendi van de AMS lees dub wil ik zeggen dat ik met 
hen een inspirerende en leuke tijd heb gehad tijdens de bijeenkomsten op de VU en 
tijdens internationale congressen. 
De !eden van de korfbalvereniging Oranje Nassau wil ik bedanken voor de 
gezelligheid, ontspanning en support in de afgelopen jaren. Hierdoor werden de 
stressvolle perioden draaglijk. De tijd die ik met jullie doorbreng valt onder 'high 
quality time'. 
Het Ieven vliedt gelijk het vlood Lieve Gea Schutte, Marja Keesen, Petra 
Zijp, Marijke van Nispen, Ingrid van Duyvenbode en Caroline Dekkers onze 
vriendschap heeft de jaren doorstaan en daarom is zij mij zo dierbaar. Nu het 
proefschrift is afgerond staat er een nleuwe levensfase voor de deur die ik ook met 
jullie wil delen. 
Lieve Marcel Jansen, bet bleek dat liefde, veelliefde en energie, vee! energie 
niet genoeg of miss chien juist te veel waren om samen verder te gaan. Bedankt voor 
jouw bijdrage aan dit proefschrift en de vele goede dingen die je mij hebt gegeven. 
M:ijn zus en broer zijn onlosmakelijk met mijn Ieven verb on den. Lieve 
Jolanda, de band met jou is heel bijzonder en hecht. Lieve Matthieu, jij beheerst het 
echte Ieven en samen met Sandra zorg je ervoor (het kost wat energie) dat ik 
enigszins bij blijf in deze snelle maatschappij. Aile dtie, bedankt voor jullie liefde en 
steun. 
De grote rol van mijn ouders bij het tot stand komen van dit proefschrift kan 
niet in enkele regels worden beschreven. Lieve papa, jij vertegenwoordigt in mijn 
ogen de goedheid van de wereld. Ik ben blij dat jij ook deze gebeurtenis kan 
meemaken. Lieve mamma, ik heb al vee! gezegd. Ik wil hieraan toevoegen dat je voor 
mij onvervangbaar bent als moeder. 
Lieve Vivian, jouw positieve houding, goede psychologische inzichten, 
oprechte belangstelling en vriendschap zorgden voor een extra dimensie tijdens de 
laatste jaren van mijn aio~schap. Ik ben van mening dat ik een goede keuze heb 
gemaakt om jou als paranimf te vragen, hoewel jij steeds hebt benadrukt dat dit nog 
maar moet blijken. Ik wee! dat je goed voor me zal zorgen tijdens de verdediging 
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(met name dat koele glaasje water!). Hierdoor zie ik de verdediging met vertrouwen 
tegemoet. 
Lieve Marieke Gieteling en Kees-Jan Korving, jullie hebben een speciale 
plaats in mijn Ieven. Het is jammer dat Peru zo ver weg is. Marieke, het is heerlijk om 
in jouw gezelschap te zijn vanwege je spontaniteit, goedheid, heldere visies en 
levenskracht. Jij brengt actie in mijn bestaan als denker. Ik voel me vereerd dat je 
tijdens het uur van de waarheid aan mijn zijde staat als goede vriendin en co-auteur 
van mijn eerste artikel. Ik hoop dat onze vriendschap lang mag blijven duren. 
Lieve Joke, Rene en de kleine Lieke Veltman, bij julie voel ik me thuis en kan 
ik mezelf zijn. Samen gingen we van artikel naar artikel. In de slotfase motiveerden 
jullie mij om er nog even flink tegenaan te gaan. Naast het proefschrift waren er nog 
genoeg andere onden.verpen over voor de urenlange telefoongesprekken met jou, 
Joke. Zander jullie aanwezigheid is de dag straks niet compleet. 
Querido Luis Enrique Cordova Arias, tu reviviste mi coraz6n. 1'v1i respuesta a 
tu pregunta es si. 
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